RxNorm Semantic Concepts Index - 205
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "205".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 20500 | S protein complement | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 20500 | S protein complement | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 20500 | S protein complement | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 20500 | S protein complement | Designated preferred name (PT) | NO | |
| RxCUI: 20500 | S protein complement | Full form of descriptor (FN) | NO | |
| RxCUI: 20500 | S protein complement | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050057 | hepatitis B surface antigen vaccine 20 MCG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2050057 | hepatitis B surface antigen vaccine 20 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2050057 | hepatitis B surface antigen vaccine 20 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2050058 | hepatitis B surface antigen vaccine Prefilled Syringe [Heplisav-B] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2050059 | HEPLISAV-B 20 MCG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2050059 | HEPLISAV-B 20 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2050059 | HEPLISAV-B 20 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2050059 | HEPLISAV-B 20 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2050059 | HEPLISAV-B 20 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2050060 | hepatitis B surface antigen vaccine 0.04 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050061 | hepatitis B surface antigen vaccine 0.04 MG/ML Prefilled Syringe [Heplisav-B] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050061 | hepatitis B surface antigen vaccine 0.04 MG/ML Prefilled Syringe [Heplisav-B] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050062 | beta-citronellol, (S)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2050063 | 8-p-menthene-1,2-diol, (+)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2050064 | C12-19 alkane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2050066 | salicylic acid Topical Oil | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2050067 | salicylic acid 1.8 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050067 | salicylic acid 1.8 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050067 | salicylic acid 1.8 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050121 | PropoThesia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2050122 | propofol 10 MG/ML [PropoThesia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2050123 | propofol Injectable Suspension [PropoThesia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2050124 | PropoThesia Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2050125 | PropoThesia 10 MG/mL Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050125 | PropoThesia 10 MG/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050125 | PropoThesia 10 MG/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050174 | Mometasone furoate anhydrous | Designated preferred name (PT) | NO | |
| RxCUI: 2050174 | Mometasone furoate anhydrous | Full form of descriptor (FN) | NO | |
| RxCUI: 205022 | aluminum hydroxide 40 MG/ML / magnesium hydroxide 45 MG/ML / simethicone 4 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205023 | salicylic acid 3 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205023 | salicylic acid 3 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205023 | salicylic acid 3 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205033 | ergoloid mesylates, USP 1 MG Sublingual Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205036 | glycerin 30 MG/ML Irrigation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050367 | dextromethorphan HBr 5 MG / pseudoephedrine HCl 15 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050367 | dextromethorphan HBr 5 MG / pseudoephedrine HCl 15 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050367 | dextromethorphan HBr 5 MG / pseudoephedrine HCl 15 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050374 | influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.09 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2050375 | influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2050376 | influenza A virus A/Michigan/45/2015 (H1N1) antigen / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen / influenza B virus B/Maryland/15/2016 antigen / influenza B virus B/Phuket/3073/2013 antigen | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2050377 | influenza virus vaccine 2018-2019 (quadrivalent generic for Flublok - Michigan/Singapore/Maryland/Phuket) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050377 | influenza virus vaccine 2018-2019 (quadrivalent generic for Flublok - Michigan/Singapore/Maryland/Phuket) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050377 | influenza virus vaccine 2018-2019 (quadrivalent generic for Flublok - Michigan/Singapore/Maryland/Phuket) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050378 | Flublok Quadrivalent 2018-2019 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2050379 | influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML [Flublok Quadrivalent 2018-2019] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2050380 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flublok Quadrivalent 2018-2019] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2050381 | Flublok Quadrivalent 2018-2019 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2050382 | FLUBLOK QUADRIVALENT 2018-2019 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050382 | FLUBLOK QUADRIVALENT 2018-2019 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050382 | FLUBLOK QUADRIVALENT 2018-2019 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050383 | influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050384 | influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2018-2019] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050415 | aminopropanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2050416 | influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2050417 | influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2050418 | influenza virus vaccine 2018-2019 (trivalent - Michigan/Singapore/Maryland) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050418 | influenza virus vaccine 2018-2019 (trivalent - Michigan/Singapore/Maryland) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050418 | influenza virus vaccine 2018-2019 (trivalent - Michigan/Singapore/Maryland) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050419 | Fluzone 2018-2019 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2050420 | influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML [Fluzone 2018-2019] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2050421 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone 2018-2019] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2050422 | Fluzone 2018-2019 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2050423 | Fluzone 2018-2019 high-dose vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050423 | Fluzone 2018-2019 high-dose vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050423 | Fluzone 2018-2019 high-dose vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050424 | influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050425 | influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2018-2019] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050429 | sulfur 0.071 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2050430 | salicylic acid 3 % / sulfur 7.1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050430 | salicylic acid 3 % / sulfur 7.1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050430 | salicylic acid 3 % / sulfur 7.1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205068 | sodium citrate 90 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205073 | chromous chloride 0.002 MG/ML / copper sulfate 0.2 MG/ML / manganese chloride 0.16 MG/ML / zinc chloride 0.8 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205074 | calcium carbonate 850 MG (Ca 340 MG) Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205074 | calcium carbonate 850 MG (Ca 340 MG) Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2050747 | Bos taurus adrenal cortex preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 205075 | calcium carbonate 550 MG (Ca 220 MG) Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205075 | calcium carbonate 550 MG (Ca 220 MG) Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050751 | sorbitan monocaprylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2050758 | influenza virus vaccine 2018-2019 (trivalent - Singapore/Singapore/Maryland) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050758 | influenza virus vaccine 2018-2019 (trivalent - Singapore/Singapore/Maryland) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050758 | influenza virus vaccine 2018-2019 (trivalent - Singapore/Singapore/Maryland) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050759 | Fluad 2018-2019 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2050760 | influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML [Fluad 2018-2019] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2050761 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad 2018-2019] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2050762 | Fluad 2018-2019 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2050763 | FLUAD 2018-2019 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050763 | FLUAD 2018-2019 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050763 | FLUAD 2018-2019 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050764 | influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050765 | influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2018-2019] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050766 | influenza virus vaccine 2018-2019 (trivalent - Singapore/Singapore/Maryland) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050766 | influenza virus vaccine 2018-2019 (trivalent - Singapore/Singapore/Maryland) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050766 | influenza virus vaccine 2018-2019 (trivalent - Singapore/Singapore/Maryland) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050767 | Afluria 2018-2019 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2050768 | influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML [Afluria 2018-2019] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2050769 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria 2018-2019] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2050770 | Afluria 2018-2019 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2050771 | afluria 2018-2019 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050771 | afluria 2018-2019 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050771 | afluria 2018-2019 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050772 | influenza virus vaccine 2018-2019 (quadrivalent - Michigan/Singapore/Maryland/Phuket) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050772 | influenza virus vaccine 2018-2019 (quadrivalent - Michigan/Singapore/Maryland/Phuket) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050772 | influenza virus vaccine 2018-2019 (quadrivalent - Michigan/Singapore/Maryland/Phuket) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050773 | Fluzone Quadrivalent 2018-2019 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2050774 | influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2018-2019] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2050775 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2018-2019] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2050776 | Fluzone Quadrivalent 2018-2019 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2050777 | Fluzone Quadrivalent 2018-2019 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050777 | Fluzone Quadrivalent 2018-2019 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050777 | Fluzone Quadrivalent 2018-2019 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050778 | influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050779 | influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2018-2019] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050780 | influenza virus vaccine 2018-2019 (quadrivalent - Michigan/Singapore/Maryland/Phuket) 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050780 | influenza virus vaccine 2018-2019 (quadrivalent - Michigan/Singapore/Maryland/Phuket) 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050780 | influenza virus vaccine 2018-2019 (quadrivalent - Michigan/Singapore/Maryland/Phuket) 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050781 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Fluzone Quadrivalent 2018-2019] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2050782 | Fluzone Quadrivalent 2018-2019 vaccine 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050782 | Fluzone Quadrivalent 2018-2019 vaccine 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050782 | Fluzone Quadrivalent 2018-2019 vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050783 | influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050784 | influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2018-2019] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050785 | influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050786 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2018-2019] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2050787 | Fluzone Quadrivalent 2018-2019 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050787 | Fluzone Quadrivalent 2018-2019 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050787 | Fluzone Quadrivalent 2018-2019 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050788 | influenza virus vaccine 2018-2019 (quadrivalent - Michigan/Singapore/Maryland/Phuket) 0.25 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050788 | influenza virus vaccine 2018-2019 (quadrivalent - Michigan/Singapore/Maryland/Phuket) 0.25 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050788 | influenza virus vaccine 2018-2019 (quadrivalent - Michigan/Singapore/Maryland/Phuket) 0.25 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050789 | Fluzone Quadrivalent Pediatric Dose for 6-35 Months of Age 2018-2019 Vaccine 0.25 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050789 | Fluzone Quadrivalent Pediatric Dose for 6-35 Months of Age 2018-2019 Vaccine 0.25 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050789 | Fluzone Quadrivalent Pediatric Dose for 6-35 Months of Age 2018-2019 Vaccine 0.25 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050791 | Afluria Quadrivalent 2018-2019 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2050792 | influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria Quadrivalent 2018-2019] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2050793 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2018-2019] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2050794 | Afluria Quadrivalent 2018-2019 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2050795 | afluria Quadrivalent 2018-2019 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050795 | afluria Quadrivalent 2018-2019 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050795 | afluria Quadrivalent 2018-2019 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050796 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria Quadrivalent 2018-2019] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2050797 | afluria Quadrivalent 2018-2019 vaccine 0.5 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050797 | afluria Quadrivalent 2018-2019 vaccine 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050797 | afluria Quadrivalent 2018-2019 vaccine 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050798 | influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2018-2019] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050799 | influenza B virus antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 20508 | Cellobiose oxidase | Designated preferred name (PT) | NO | |
| RxCUI: 20508 | Cellobiose oxidase | Full form of descriptor (FN) | NO | |
| RxCUI: 2050801 | influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus antigen 0.03 MG/ML [Afluria 2018-2019] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2050802 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria 2018-2019] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2050803 | Afluria 2018-2019 vaccine 0.5 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050803 | Afluria 2018-2019 vaccine 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050803 | Afluria 2018-2019 vaccine 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050804 | influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050805 | influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus antigen 0.03 MG/ML Prefilled Syringe [Afluria 2018-2019] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2050806 | Aspergillus nidulans allergenic extract 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2050807 | Aspergillus nidulans allergenic extract Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2050808 | Aspergillus nidulans allergenic extract Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2050809 | Emericella nidulans allergenic extract 100 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050809 | Emericella nidulans allergenic extract 100 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050809 | Emericella nidulans allergenic extract 100 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205082 | calcium gluconate 1 GM Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205082 | calcium gluconate 1 GM Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 20509 | Cellobiose phosphorylase | Designated preferred name (PT) | NO | |
| RxCUI: 20509 | Cellobiose phosphorylase | Full form of descriptor (FN) | NO | |
| RxCUI: 2050944 | influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe [Afluria 2018-2019] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205097 | coal tar 2 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205097 | coal tar 2 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205097 | coal tar 2 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2050976 | ethanol 0.74 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2050977 | ethanol 74 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2050977 | ethanol 74 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2050977 | ethanol 74 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050977 | ethanol 74 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2050978 | Coptis japonica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2050979 | Robinia pseudoacacia flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 205098 | coal tar 5 % / colloidal sulfur 1.5 % / salicylic acid 2 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205098 | coal tar 5 % / colloidal sulfur 1.5 % / salicylic acid 2 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205099 | coal tar 4.3 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205099 | coal tar 4.3 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205099 | coal tar 4.3 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205099 | coal tar 4.3 % Medicated Shampoo | Designated preferred name (PT) | NO | |
| RxCUI: 205099 | coal tar 4.3 % Medicated Shampoo | Full form of descriptor (FN) | NO | |
| RxCUI: 2050992 | Iodine (131-I) labeled monoclonal antibody | Designated preferred name (PT) | NO | |
| RxCUI: 2050992 | Iodine (131-I) labeled monoclonal antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 2050992 | Iodine (131-I) labeled monoclonal antibody | British preferred term (PTGB) | NO | |
| RxCUI: 2050997 | Equine antithymocyte immunoglobulin | Designated preferred name (PT) | NO | |
| RxCUI: 2050997 | Equine antithymocyte immunoglobulin | Full form of descriptor (FN) | NO | |
| RxCUI: 2051 | Carboprost | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2051 | Carboprost | Designated preferred name (PT) | YES | |
| RxCUI: 2051 | Carboprost | Full form of descriptor (FN) | YES | |
| RxCUI: 2051 | Carboprost | Designated preferred name (PT) | YES | |
| RxCUI: 2051 | Carboprost | Full form of descriptor (FN) | YES | |
| RxCUI: 20510 | Cellobiose dehydrogenase (quinone) | Designated preferred name (PT) | NO | |
| RxCUI: 20510 | Cellobiose dehydrogenase (quinone) | Full form of descriptor (FN) | NO | |
| RxCUI: 20510 | Cellobiose dehydrogenase (quinone) | Designated preferred name (PT) | NO | |
| RxCUI: 20510 | Cellobiose dehydrogenase (quinone) | Full form of descriptor (FN) | NO | |
| RxCUI: 205100 | coal tar 3 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205100 | coal tar 3 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205100 | coal tar 3 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2051004 | Human tick borne encephalitis immunoglobulin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2051004 | Human tick borne encephalitis immunoglobulin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2051005 | Indium (111-In) labeled monoclonal antibody | Designated preferred name (PT) | NO | |
| RxCUI: 2051005 | Indium (111-In) labeled monoclonal antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 2051005 | Indium (111-In) labeled monoclonal antibody | British preferred term (PTGB) | NO | |
| RxCUI: 2051007 | Radioisotope labeled human immunoglobulin G | Designated preferred name (PT) | NO | |
| RxCUI: 2051007 | Radioisotope labeled human immunoglobulin G | Full form of descriptor (FN) | NO | |
| RxCUI: 2051007 | Radioisotope labeled human immunoglobulin G | British preferred term (PTGB) | NO | |
| RxCUI: 2051008 | Radioisotope labeled monoclonal antibody | Designated preferred name (PT) | NO | |
| RxCUI: 2051008 | Radioisotope labeled monoclonal antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 2051008 | Radioisotope labeled monoclonal antibody | British preferred term (PTGB) | NO | |
| RxCUI: 2051011 | Immunoglobulin G antibody to Streptococcus pneumoniae 10A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051011 | Immunoglobulin G antibody to Streptococcus pneumoniae 10A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051011 | Immunoglobulin G antibody to Streptococcus pneumoniae 10A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051011 | Immunoglobulin G antibody to Streptococcus pneumoniae 10A | Full form of descriptor (FN) | NO | |
| RxCUI: 2051011 | Immunoglobulin G antibody to Streptococcus pneumoniae 10A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051011 | Immunoglobulin G antibody to Streptococcus pneumoniae 10A | Designated preferred name (PT) | NO | |
| RxCUI: 2051012 | Immunoglobulin G antibody to Streptococcus pneumoniae 11A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051012 | Immunoglobulin G antibody to Streptococcus pneumoniae 11A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051012 | Immunoglobulin G antibody to Streptococcus pneumoniae 11A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051012 | Immunoglobulin G antibody to Streptococcus pneumoniae 11A | Full form of descriptor (FN) | NO | |
| RxCUI: 2051012 | Immunoglobulin G antibody to Streptococcus pneumoniae 11A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051012 | Immunoglobulin G antibody to Streptococcus pneumoniae 11A | Designated preferred name (PT) | NO | |
| RxCUI: 2051016 | Immunoglobulin G antibody to Streptococcus pneumoniae 18F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051016 | Immunoglobulin G antibody to Streptococcus pneumoniae 18F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051016 | Immunoglobulin G antibody to Streptococcus pneumoniae 18F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051016 | Immunoglobulin G antibody to Streptococcus pneumoniae 18F | Full form of descriptor (FN) | NO | |
| RxCUI: 2051016 | Immunoglobulin G antibody to Streptococcus pneumoniae 18F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051016 | Immunoglobulin G antibody to Streptococcus pneumoniae 18F | Designated preferred name (PT) | NO | |
| RxCUI: 2051018 | Immunoglobulin G antibody to Streptococcus pneumoniae 19F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051018 | Immunoglobulin G antibody to Streptococcus pneumoniae 19F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051018 | Immunoglobulin G antibody to Streptococcus pneumoniae 19F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051018 | Immunoglobulin G antibody to Streptococcus pneumoniae 19F | Full form of descriptor (FN) | NO | |
| RxCUI: 2051018 | Immunoglobulin G antibody to Streptococcus pneumoniae 19F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051018 | Immunoglobulin G antibody to Streptococcus pneumoniae 19F | Designated preferred name (PT) | NO | |
| RxCUI: 2051020 | Immunoglobulin G antibody to Streptococcus pneumoniae 22F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051020 | Immunoglobulin G antibody to Streptococcus pneumoniae 22F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051020 | Immunoglobulin G antibody to Streptococcus pneumoniae 22F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051020 | Immunoglobulin G antibody to Streptococcus pneumoniae 22F | Full form of descriptor (FN) | NO | |
| RxCUI: 2051020 | Immunoglobulin G antibody to Streptococcus pneumoniae 22F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051020 | Immunoglobulin G antibody to Streptococcus pneumoniae 22F | Designated preferred name (PT) | NO | |
| RxCUI: 2051022 | Immunoglobulin G antibody to Streptococcus pneumoniae 33F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051022 | Immunoglobulin G antibody to Streptococcus pneumoniae 33F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051022 | Immunoglobulin G antibody to Streptococcus pneumoniae 33F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051022 | Immunoglobulin G antibody to Streptococcus pneumoniae 33F | Full form of descriptor (FN) | NO | |
| RxCUI: 2051022 | Immunoglobulin G antibody to Streptococcus pneumoniae 33F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051022 | Immunoglobulin G antibody to Streptococcus pneumoniae 33F | Designated preferred name (PT) | NO | |
| RxCUI: 2051026 | Immunoglobulin G antibody to Streptococcus pneumoniae 7F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051026 | Immunoglobulin G antibody to Streptococcus pneumoniae 7F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051026 | Immunoglobulin G antibody to Streptococcus pneumoniae 7F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051026 | Immunoglobulin G antibody to Streptococcus pneumoniae 7F | Full form of descriptor (FN) | NO | |
| RxCUI: 2051026 | Immunoglobulin G antibody to Streptococcus pneumoniae 7F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051026 | Immunoglobulin G antibody to Streptococcus pneumoniae 7F | Designated preferred name (PT) | NO | |
| RxCUI: 2051029 | Immunoglobulin G antibody to Streptococcus pneumoniae 7A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051029 | Immunoglobulin G antibody to Streptococcus pneumoniae 7A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051029 | Immunoglobulin G antibody to Streptococcus pneumoniae 7A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051029 | Immunoglobulin G antibody to Streptococcus pneumoniae 7A | Full form of descriptor (FN) | NO | |
| RxCUI: 2051029 | Immunoglobulin G antibody to Streptococcus pneumoniae 7A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051029 | Immunoglobulin G antibody to Streptococcus pneumoniae 7A | Designated preferred name (PT) | NO | |
| RxCUI: 205104 | salicylic acid 2 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205104 | salicylic acid 2 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205104 | salicylic acid 2 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205104 | salicylic acid 2 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2051048 | Fusidic acid 10 mg/g prolonged-release eye drops | Designated preferred name (PT) | NO | |
| RxCUI: 2051048 | Fusidic acid 10 mg/g prolonged-release eye drops | Full form of descriptor (FN) | NO | |
| RxCUI: 205105 | selenious acid 0.2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205106 | selenious acid 0.05 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2051061 | Metformin hydrochloride 1 g prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2051061 | Metformin hydrochloride 1 g prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2051065 | Morphine sulfate 10 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2051065 | Morphine sulfate 10 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 205107 | salicylic acid 2 % / sulfur 2 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205107 | salicylic acid 2 % / sulfur 2 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2051076 | Glyceryl trinitrate 625 microgram/hour prolonged-release transdermal patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051076 | Glyceryl trinitrate 625 microgram/hour prolonged-release transdermal patch | Designated preferred name (PT) | NO | |
| RxCUI: 2051076 | Glyceryl trinitrate 625 microgram/hour prolonged-release transdermal patch | Full form of descriptor (FN) | NO | |
| RxCUI: 205111 | FESO4 75 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205111 | FESO4 75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205114 | lactic acid 5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205114 | lactic acid 5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205116 | aluminum hydroxide 500 MG / magnesium hydroxide 450 MG / simethicone 40 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205116 | aluminum hydroxide 500 MG / magnesium hydroxide 450 MG / simethicone 40 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205116 | aluminum hydroxide 500 MG / magnesium hydroxide 450 MG / simethicone 40 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205121 | mineral oil 100 % Enema | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205121 | mineral oil 100 % Enema | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205121 | mineral oil 100 % Enema | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2051262 | Mesalazine 1 g gastro-resistant and prolonged-release oral granules sachet | Designated preferred name (PT) | NO | |
| RxCUI: 2051262 | Mesalazine 1 g gastro-resistant and prolonged-release oral granules sachet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051262 | Mesalazine 1 g gastro-resistant and prolonged-release oral granules sachet | Full form of descriptor (FN) | NO | |
| RxCUI: 205127 | zinc gluconate 77 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205128 | zinc oxide 10 % Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205128 | zinc oxide 10 % Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205128 | zinc oxide 10 % Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2051305 | Glyceryl trinitrate 208.333 microgram/hour prolonged-release transdermal patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051305 | Glyceryl trinitrate 208.333 microgram/hour prolonged-release transdermal patch | Designated preferred name (PT) | NO | |
| RxCUI: 2051305 | Glyceryl trinitrate 208.333 microgram/hour prolonged-release transdermal patch | Full form of descriptor (FN) | NO | |
| RxCUI: 2051306 | Glyceryl trinitrate 416.667 microgram/hour prolonged-release transdermal patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051306 | Glyceryl trinitrate 416.667 microgram/hour prolonged-release transdermal patch | Designated preferred name (PT) | NO | |
| RxCUI: 2051306 | Glyceryl trinitrate 416.667 microgram/hour prolonged-release transdermal patch | Full form of descriptor (FN) | NO | |
| RxCUI: 2051307 | Buprenorphine 35 microgram/hour prolonged-release transdermal patch | Designated preferred name (PT) | NO | |
| RxCUI: 2051307 | Buprenorphine 35 microgram/hour prolonged-release transdermal patch | Full form of descriptor (FN) | NO | |
| RxCUI: 2051308 | Buprenorphine 52.5 microgram/hour prolonged-release transdermal patch | Designated preferred name (PT) | NO | |
| RxCUI: 2051308 | Buprenorphine 52.5 microgram/hour prolonged-release transdermal patch | Full form of descriptor (FN) | NO | |
| RxCUI: 2051309 | Buprenorphine 70 microgram/hour prolonged-release transdermal patch | Designated preferred name (PT) | NO | |
| RxCUI: 2051309 | Buprenorphine 70 microgram/hour prolonged-release transdermal patch | Full form of descriptor (FN) | NO | |
| RxCUI: 2051311 | Bupropion hydrochloride 150 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2051311 | Bupropion hydrochloride 150 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2051332 | Estradiol 2.083 microgram/hour and norethindrone acetate 7.083 microgram/hour prolonged-release transdermal patch | Designated preferred name (PT) | NO | |
| RxCUI: 2051332 | Estradiol 2.083 microgram/hour and norethindrone acetate 7.083 microgram/hour prolonged-release transdermal patch | British preferred term (PTGB) | NO | |
| RxCUI: 2051332 | Estradiol 2.083 microgram/hour and norethindrone acetate 7.083 microgram/hour prolonged-release transdermal patch | Full form of descriptor (FN) | NO | |
| RxCUI: 2051376 | Product containing precisely quinidine bisulfate 250 milligram/1 each prolonged-release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2051376 | Product containing precisely quinidine bisulfate 250 milligram/1 each prolonged-release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 205139 | phenolphthalein 15 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205139 | phenolphthalein 15 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2051426 | Sodium valproate 200 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2051426 | Sodium valproate 200 mg prolonged-release oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051426 | Sodium valproate 200 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2051427 | Sodium valproate 300 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2051427 | Sodium valproate 300 mg prolonged-release oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051427 | Sodium valproate 300 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2051428 | Sodium valproate 500 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2051428 | Sodium valproate 500 mg prolonged-release oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051428 | Sodium valproate 500 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 205150 | coal tar 2 % / colloidal sulfur 1.1 % / salicylic acid 1.5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205150 | coal tar 2 % / colloidal sulfur 1.1 % / salicylic acid 1.5 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205157 | phenol 1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205157 | phenol 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2051582 | Vaccinium vitis-idaea fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2051584 | Substance with adrenergic neurone blocker mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2051584 | Substance with adrenergic neurone blocker mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051584 | Substance with adrenergic neurone blocker mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2051586 | Product containing beta-3 adrenergic receptor agonist (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2051586 | Product containing beta-3 adrenergic receptor agonist (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2051587 | Blood pooling imaging agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051587 | Blood pooling imaging agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051588 | Bone imaging agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051588 | Bone imaging agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051589 | Bone marrow imaging agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051589 | Bone marrow imaging agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051590 | Brain imaging agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051590 | Brain imaging agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051591 | Colorectal imaging agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051591 | Colorectal imaging agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051592 | Product containing dopamine receptor D2 antagonist (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2051592 | Product containing dopamine receptor D2 antagonist (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2051593 | Endocrine and exocrine imaging agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051593 | Endocrine and exocrine imaging agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051594 | Endocrine imaging agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051594 | Endocrine imaging agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051597 | Product containing gamma-aminobutyric acid receptor agonist (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2051597 | Product containing gamma-aminobutyric acid receptor agonist (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2051598 | Product containing glucocorticoid receptor antagonist (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2051598 | Product containing glucocorticoid receptor antagonist (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2051600 | Heart and cardiovascular imaging agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051600 | Heart and cardiovascular imaging agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051601 | Hepatobiliary imaging agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051601 | Hepatobiliary imaging agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051605 | Infection and inflammation imaging agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051605 | Infection and inflammation imaging agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051606 | Interleukin-4 receptor alpha antagonist-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2051606 | Interleukin-4 receptor alpha antagonist-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2051607 | Kidney imaging agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051607 | Kidney imaging agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051608 | Liver and spleen imaging agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051608 | Liver and spleen imaging agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051609 | Lung imaging agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051609 | Lung imaging agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051610 | Lung perfusion imaging agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051610 | Lung perfusion imaging agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051611 | Lung ventilation imaging agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051611 | Lung ventilation imaging agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051612 | Lymphatic system imaging agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051612 | Lymphatic system imaging agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051613 | Substance with lymphocyte function-associated antigen 1 antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2051613 | Substance with lymphocyte function-associated antigen 1 antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2051613 | Substance with lymphocyte function-associated antigen 1 antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2051613 | Substance with lymphocyte function-associated antigen 1 antagonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051613 | Substance with lymphocyte function-associated antigen 1 antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2051616 | Myocardial imaging agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051616 | Myocardial imaging agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051618 | Product containing nicotinic receptor antagonist (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2051618 | Product containing nicotinic receptor antagonist (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 205162 | salicylic acid 1 % Medicated Bar Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205162 | salicylic acid 1 % Medicated Bar Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205162 | salicylic acid 1 % Medicated Bar Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2051620 | Product containing progesterone receptor antagonist (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2051620 | Product containing progesterone receptor antagonist (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2051621 | Selective beta-3 adrenoceptor stimulant | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051621 | Selective beta-3 adrenoceptor stimulant | Designated preferred name (PT) | NO | |
| RxCUI: 2051621 | Selective beta-3 adrenoceptor stimulant | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051621 | Selective beta-3 adrenoceptor stimulant | Full form of descriptor (FN) | NO | |
| RxCUI: 2051622 | Product containing sigma-1 receptor agonist (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2051622 | Product containing sigma-1 receptor agonist (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2051623 | Substance with dopamine receptor D2 antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2051623 | Substance with dopamine receptor D2 antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2051624 | Substance with glucocorticoid receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2051624 | Substance with glucocorticoid receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2051625 | Substance with nicotinic receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2051625 | Substance with nicotinic receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2051626 | Substance with progesterone receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2051626 | Substance with progesterone receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2051627 | Substance with sigma-1 receptor agonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2051627 | Substance with sigma-1 receptor agonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2051628 | Tumor imaging agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051628 | Tumor imaging agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051628 | Tumor imaging agent | British preferred term (PTGB) | NO | |
| RxCUI: 2051629 | Non-essential amino acid free formula | Designated preferred name (PT) | NO | |
| RxCUI: 2051629 | Non-essential amino acid free formula | Full form of descriptor (FN) | NO | |
| RxCUI: 2051630 | Non-essential amino acid free infant formula | Designated preferred name (PT) | NO | |
| RxCUI: 2051630 | Non-essential amino acid free infant formula | Full form of descriptor (FN) | NO | |
| RxCUI: 2051632 | Modular amino acid-free infant formula component | Designated preferred name (PT) | NO | |
| RxCUI: 2051632 | Modular amino acid-free infant formula component | Full form of descriptor (FN) | NO | |
| RxCUI: 2051633 | Modified amino acid composition formula | Designated preferred name (PT) | NO | |
| RxCUI: 2051633 | Modified amino acid composition formula | Full form of descriptor (FN) | NO | |
| RxCUI: 2051635 | Isoleucine, leucine and valine-free formula | Designated preferred name (PT) | NO | |
| RxCUI: 2051635 | Isoleucine, leucine and valine-free formula | Full form of descriptor (FN) | NO | |
| RxCUI: 2051636 | Isoleucine, leucine and valine-free infant formula | Designated preferred name (PT) | NO | |
| RxCUI: 2051636 | Isoleucine, leucine and valine-free infant formula | Full form of descriptor (FN) | NO | |
| RxCUI: 2051637 | Leucine-free formula | Designated preferred name (PT) | NO | |
| RxCUI: 2051637 | Leucine-free formula | Full form of descriptor (FN) | NO | |
| RxCUI: 2051638 | Leucine-free infant formula | Designated preferred name (PT) | NO | |
| RxCUI: 2051638 | Leucine-free infant formula | Full form of descriptor (FN) | NO | |
| RxCUI: 2051639 | Low calcium and vitamin D-free infant formula | Designated preferred name (PT) | NO | |
| RxCUI: 2051639 | Low calcium and vitamin D-free infant formula | Full form of descriptor (FN) | NO | |
| RxCUI: 2051640 | Lysine and tryptophan-free formula | Designated preferred name (PT) | NO | |
| RxCUI: 2051640 | Lysine and tryptophan-free formula | Full form of descriptor (FN) | NO | |
| RxCUI: 2051641 | Lysine and tryptophan-free infant formula | Designated preferred name (PT) | NO | |
| RxCUI: 2051641 | Lysine and tryptophan-free infant formula | Full form of descriptor (FN) | NO | |
| RxCUI: 2051642 | Methionine and valine-free and low in isoleucine and threonine formula | Designated preferred name (PT) | NO | |
| RxCUI: 2051642 | Methionine and valine-free and low in isoleucine and threonine formula | Full form of descriptor (FN) | NO | |
| RxCUI: 2051643 | Methionine and valine-free and low in isoleucine and threonine infant formula | Designated preferred name (PT) | NO | |
| RxCUI: 2051643 | Methionine and valine-free and low in isoleucine and threonine infant formula | Full form of descriptor (FN) | NO | |
| RxCUI: 2051644 | Methionine-free formula | Designated preferred name (PT) | NO | |
| RxCUI: 2051644 | Methionine-free formula | Full form of descriptor (FN) | NO | |
| RxCUI: 2051645 | Methionine-free infant formula | Designated preferred name (PT) | NO | |
| RxCUI: 2051645 | Methionine-free infant formula | Full form of descriptor (FN) | NO | |
| RxCUI: 2051646 | Modified amino acid composition infant formula | Designated preferred name (PT) | NO | |
| RxCUI: 2051646 | Modified amino acid composition infant formula | Full form of descriptor (FN) | NO | |
| RxCUI: 2051647 | Modular carbohydrate formula component | Designated preferred name (PT) | NO | |
| RxCUI: 2051647 | Modular carbohydrate formula component | Full form of descriptor (FN) | NO | |
| RxCUI: 2051648 | Modular energy formula component | Designated preferred name (PT) | NO | |
| RxCUI: 2051648 | Modular energy formula component | Full form of descriptor (FN) | NO | |
| RxCUI: 2051649 | Modular fiber formula component | Designated preferred name (PT) | NO | |
| RxCUI: 2051649 | Modular fiber formula component | Full form of descriptor (FN) | NO | |
| RxCUI: 2051649 | Modular fiber formula component | British preferred term (PTGB) | NO | |
| RxCUI: 2051650 | Modular formula component | Designated preferred name (PT) | NO | |
| RxCUI: 2051650 | Modular formula component | Full form of descriptor (FN) | NO | |
| RxCUI: 2051651 | Modular hydrolyzed protein infant formula component | Designated preferred name (PT) | NO | |
| RxCUI: 2051651 | Modular hydrolyzed protein infant formula component | Full form of descriptor (FN) | NO | |
| RxCUI: 2051652 | Modular infant formula component | Designated preferred name (PT) | NO | |
| RxCUI: 2051652 | Modular infant formula component | Full form of descriptor (FN) | NO | |
| RxCUI: 2051653 | Modular lipid formula component | Designated preferred name (PT) | NO | |
| RxCUI: 2051653 | Modular lipid formula component | Full form of descriptor (FN) | NO | |
| RxCUI: 2051654 | Modular protein and vitamin and mineral formula component | Designated preferred name (PT) | NO | |
| RxCUI: 2051654 | Modular protein and vitamin and mineral formula component | Full form of descriptor (FN) | NO | |
| RxCUI: 2051655 | Modular protein formula component | Designated preferred name (PT) | NO | |
| RxCUI: 2051655 | Modular protein formula component | Full form of descriptor (FN) | NO | |
| RxCUI: 2051656 | Infant formula for prematurity | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051656 | Infant formula for prematurity | Designated preferred name (PT) | NO | |
| RxCUI: 2051656 | Infant formula for prematurity | Full form of descriptor (FN) | NO | |
| RxCUI: 2051657 | Reduced lactose infant formula | Designated preferred name (PT) | NO | |
| RxCUI: 2051657 | Reduced lactose infant formula | Full form of descriptor (FN) | NO | |
| RxCUI: 2051658 | Genetically modified T-lymphocyte | Designated preferred name (PT) | NO | |
| RxCUI: 2051658 | Genetically modified T-lymphocyte | Full form of descriptor (FN) | NO | |
| RxCUI: 2051658 | Genetically modified T-lymphocyte | Designated preferred name (PT) | NO | |
| RxCUI: 2051658 | Genetically modified T-lymphocyte | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051658 | Genetically modified T-lymphocyte | Full form of descriptor (FN) | NO | |
| RxCUI: 2051661 | Mediator of immune response and inflammation | Designated preferred name (PT) | NO | |
| RxCUI: 2051661 | Mediator of immune response and inflammation | Full form of descriptor (FN) | NO | |
| RxCUI: 2051663 | Substance with norepinephrine reuptake inhibitor and serotonin reuptake inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051663 | Substance with norepinephrine reuptake inhibitor and serotonin reuptake inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051663 | Substance with norepinephrine reuptake inhibitor and serotonin reuptake inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2051663 | Substance with norepinephrine reuptake inhibitor and serotonin reuptake inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2051663 | Substance with norepinephrine reuptake inhibitor and serotonin reuptake inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2051663 | Substance with norepinephrine reuptake inhibitor and serotonin reuptake inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051663 | Substance with norepinephrine reuptake inhibitor and serotonin reuptake inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2051667 | Antiparasitic-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2051667 | Antiparasitic-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2051674 | Glacial acetic acid- and oxyquinoline-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2051674 | Glacial acetic acid- and oxyquinoline-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 205168 | cycloSPORINE 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205168 | cycloSPORINE 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205168 | cycloSPORINE 50 MG Oral Capsule | Designated preferred name (PT) | NO | |
| RxCUI: 205168 | cycloSPORINE 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205168 | cycloSPORINE 50 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205168 | cycloSPORINE 50 MG Oral Capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2051685 | Acrylic acid and/or acrylic acid derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2051685 | Acrylic acid and/or acrylic acid derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2051685 | Acrylic acid and/or acrylic acid derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2051685 | Acrylic acid and/or acrylic acid derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2051687 | Glycerol 4 g rectal suppository | Designated preferred name (PT) | NO | |
| RxCUI: 2051687 | Glycerol 4 g rectal suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051687 | Glycerol 4 g rectal suppository | Full form of descriptor (FN) | NO | |
| RxCUI: 2051688 | Substance with centrally acting acetylcholinesterase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2051688 | Substance with centrally acting acetylcholinesterase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2051688 | Substance with centrally acting acetylcholinesterase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2051688 | Substance with centrally acting acetylcholinesterase inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051688 | Substance with centrally acting acetylcholinesterase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2051692 | Fumaria | Designated preferred name (PT) | NO | |
| RxCUI: 2051692 | Fumaria | Full form of descriptor (FN) | NO | |
| RxCUI: 2051724 | Benzisoxazole derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2051724 | Benzisoxazole derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2051724 | Benzisoxazole derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2051724 | Benzisoxazole derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2051727 | Chromium supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2051727 | Chromium supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 205173 | salicylic acid 1.8 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205173 | salicylic acid 1.8 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205173 | salicylic acid 1.8 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2051731 | Morphinane alkaloid | Designated preferred name (PT) | NO | |
| RxCUI: 2051731 | Morphinane alkaloid | Full form of descriptor (FN) | NO | |
| RxCUI: 2051736 | Iodine supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2051736 | Iodine supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2051738 | Amphotericin B phospholipid complex | Designated preferred name (PT) | NO | |
| RxCUI: 2051738 | Amphotericin B phospholipid complex | Full form of descriptor (FN) | NO | |
| RxCUI: 205174 | salicylic acid 4 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205174 | salicylic acid 4 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205174 | salicylic acid 4 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2051740 | Benzothiadiazine | Designated preferred name (PT) | NO | |
| RxCUI: 2051740 | Benzothiadiazine | Full form of descriptor (FN) | NO | |
| RxCUI: 2051740 | Benzothiadiazine | Designated preferred name (PT) | NO | |
| RxCUI: 2051740 | Benzothiadiazine | Full form of descriptor (FN) | NO | |
| RxCUI: 205175 | cycloSPORINE 250 MG in 5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205175 | cycloSPORINE 250 MG in 5 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 205175 | cycloSPORINE 250 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205175 | cycloSPORINE 250 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205175 | cycloSPORINE 250 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205175 | cycloSPORINE 250 MG in 5 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 205175 | cycloSPORINE 250 MG in 5 ML Injection | Designated preferred name (PT) | YES | |
| RxCUI: 205175 | cycloSPORINE 250 MG in 5 ML Injection | Full form of descriptor (FN) | YES | |
| RxCUI: 2051750 | Anhydrous colestyramine | Designated preferred name (PT) | NO | |
| RxCUI: 2051750 | Anhydrous colestyramine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051750 | Anhydrous colestyramine | Full form of descriptor (FN) | NO | |
| RxCUI: 2051753 | Sugar derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2051753 | Sugar derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2051753 | Sugar derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2051753 | Sugar derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2051753 | Sugar derivative | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051758 | Multivitamin multimineral supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2051758 | Multivitamin multimineral supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2051776 | Glycoamino acid | Designated preferred name (PT) | NO | |
| RxCUI: 2051776 | Glycoamino acid | Full form of descriptor (FN) | NO | |
| RxCUI: 2051787 | Substance with isocitrate dehydrogenase-2 inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2051787 | Substance with isocitrate dehydrogenase-2 inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2051787 | Substance with isocitrate dehydrogenase-2 inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2051787 | Substance with isocitrate dehydrogenase-2 inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051787 | Substance with isocitrate dehydrogenase-2 inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2051789 | Manganese supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2051789 | Manganese supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2051792 | Biotin supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2051792 | Biotin supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2051796 | Iron II ion | Designated preferred name (PT) | NO | |
| RxCUI: 2051796 | Iron II ion | Full form of descriptor (FN) | NO | |
| RxCUI: 2051796 | Iron II ion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051800 | Medicinal product categorised by chemical element | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051800 | Medicinal product categorised by chemical element | Designated preferred name (PT) | NO | |
| RxCUI: 2051800 | Medicinal product categorised by chemical element | Full form of descriptor (FN) | NO | |
| RxCUI: 2051801 | Medicinal product categorised by disposition | British preferred term (PTGB) | NO | |
| RxCUI: 2051801 | Medicinal product categorised by disposition | Designated preferred name (PT) | NO | |
| RxCUI: 2051801 | Medicinal product categorised by disposition | Full form of descriptor (FN) | NO | |
| RxCUI: 2051806 | Flavodate | Designated preferred name (PT) | NO | |
| RxCUI: 2051806 | Flavodate | Full form of descriptor (FN) | NO | |
| RxCUI: 205181 | chlorophyllin copper complex 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205181 | chlorophyllin copper complex 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2051818 | Hedera leaf | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051818 | Hedera leaf | Full form of descriptor (FN) | NO | |
| RxCUI: 2051818 | Hedera leaf | Designated preferred name (PT) | NO | |
| RxCUI: 205182 | chlorophyllin copper complex 14 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205182 | chlorophyllin copper complex 14 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2051820 | Medicinal product categorised by structure | British preferred term (PTGB) | NO | |
| RxCUI: 2051820 | Medicinal product categorised by structure | Designated preferred name (PT) | NO | |
| RxCUI: 2051820 | Medicinal product categorised by structure | Full form of descriptor (FN) | NO | |
| RxCUI: 2051821 | Medicinal product categorised by therapeutic role | British preferred term (PTGB) | NO | |
| RxCUI: 2051821 | Medicinal product categorised by therapeutic role | Designated preferred name (PT) | NO | |
| RxCUI: 2051821 | Medicinal product categorised by therapeutic role | Full form of descriptor (FN) | NO | |
| RxCUI: 2051823 | Boron supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2051823 | Boron supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2051825 | Cobalt supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2051825 | Cobalt supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2051831 | Pimelate | Designated preferred name (PT) | NO | |
| RxCUI: 2051831 | Pimelate | Full form of descriptor (FN) | NO | |
| RxCUI: 2051838 | Allocystathionine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051838 | Allocystathionine | Designated preferred name (PT) | NO | |
| RxCUI: 2051838 | Allocystathionine | Full form of descriptor (FN) | NO | |
| RxCUI: 2051841 | Beef derived substance | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051841 | Beef derived substance | Designated preferred name (PT) | NO | |
| RxCUI: 2051841 | Beef derived substance | Full form of descriptor (FN) | NO | |
| RxCUI: 2051848 | Mineralocorticoid agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051848 | Mineralocorticoid agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051851 | Niacin supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2051851 | Niacin supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2051852 | Nicotine cyclodextrin complex | Designated preferred name (PT) | NO | |
| RxCUI: 2051852 | Nicotine cyclodextrin complex | Full form of descriptor (FN) | NO | |
| RxCUI: 2051853 | Product containing plant agent | Designated preferred name (PT) | NO | |
| RxCUI: 2051853 | Product containing plant agent | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051853 | Product containing plant agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2051860 | Codeine hydrochloride anhydrous | Designated preferred name (PT) | NO | |
| RxCUI: 2051860 | Codeine hydrochloride anhydrous | Full form of descriptor (FN) | NO | |
| RxCUI: 2051861 | Equine derived substance | Designated preferred name (PT) | NO | |
| RxCUI: 2051861 | Equine derived substance | Full form of descriptor (FN) | NO | |
| RxCUI: 2051863 | Fluorinated corticosteroid | Designated preferred name (PT) | NO | |
| RxCUI: 2051863 | Fluorinated corticosteroid | Full form of descriptor (FN) | NO | |
| RxCUI: 2051863 | Fluorinated corticosteroid | Designated preferred name (PT) | NO | |
| RxCUI: 2051863 | Fluorinated corticosteroid | Full form of descriptor (FN) | NO | |
| RxCUI: 2051867 | Porcine brain-derived peptide | Designated preferred name (PT) | NO | |
| RxCUI: 2051867 | Porcine brain-derived peptide | Full form of descriptor (FN) | NO | |
| RxCUI: 2051868 | Pork derived substance | Designated preferred name (PT) | NO | |
| RxCUI: 2051868 | Pork derived substance | Full form of descriptor (FN) | NO | |
| RxCUI: 2051868 | Pork derived substance | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051873 | Colistin sulfate 50000 unit/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2051873 | Colistin sulfate 50000 unit/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2051877 | Product containing dihydroxyphenylalanine decarboxylase inhibitor (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2051877 | Product containing dihydroxyphenylalanine decarboxylase inhibitor (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 205188 | ferrous sulfate 160 MG / folic acid 0.4 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205188 | ferrous sulfate 160 MG / folic acid 0.4 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205188 | ferrous sulfate 160 MG / folic acid 0.4 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051880 | Molybdenum supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2051880 | Molybdenum supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2051884 | Substance with Hepatitis C virus protein NS5B inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2051884 | Substance with Hepatitis C virus protein NS5B inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2051884 | Substance with Hepatitis C virus protein NS5B inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2051884 | Substance with Hepatitis C virus protein NS5B inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051884 | Substance with Hepatitis C virus protein NS5B inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2051886 | Pantothenic acid supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2051886 | Pantothenic acid supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2051888 | Leucovorin calcium pentahydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2051888 | Leucovorin calcium pentahydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2051891 | Dimeticone 1000 | Designated preferred name (PT) | NO | |
| RxCUI: 2051891 | Dimeticone 1000 | Full form of descriptor (FN) | NO | |
| RxCUI: 2051895 | Gamma-aminoadipate | Designated preferred name (PT) | NO | |
| RxCUI: 2051895 | Gamma-aminoadipate | Full form of descriptor (FN) | NO | |
| RxCUI: 2051895 | Gamma-aminoadipate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051895 | Gamma-aminoadipate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051901 | Azo derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2051901 | Azo derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2051901 | Azo derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2051901 | Azo derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2051906 | Butyrophenone derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2051906 | Butyrophenone derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2051908 | Substance with cystic fibrosis transmembrane conductance regulator potentiator mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2051908 | Substance with cystic fibrosis transmembrane conductance regulator potentiator mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2051908 | Substance with cystic fibrosis transmembrane conductance regulator potentiator mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2051908 | Substance with cystic fibrosis transmembrane conductance regulator potentiator mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051908 | Substance with cystic fibrosis transmembrane conductance regulator potentiator mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2051910 | Chloride supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2051910 | Chloride supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2051913 | Common hawthorn | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051913 | Common hawthorn | Designated preferred name (PT) | NO | |
| RxCUI: 2051913 | Common hawthorn | Full form of descriptor (FN) | NO | |
| RxCUI: 2051914 | Diornithine oxoglurate dihydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2051914 | Diornithine oxoglurate dihydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2051916 | Human milk fortifier | Designated preferred name (PT) | NO | |
| RxCUI: 2051916 | Human milk fortifier | Full form of descriptor (FN) | NO | |
| RxCUI: 2051917 | Hydroxyamino acid | Designated preferred name (PT) | NO | |
| RxCUI: 2051917 | Hydroxyamino acid | Full form of descriptor (FN) | NO | |
| RxCUI: 2051918 | Pasteurella multocida antiserum | Designated preferred name (PT) | NO | |
| RxCUI: 2051918 | Pasteurella multocida antiserum | Full form of descriptor (FN) | NO | |
| RxCUI: 2051924 | Ballota nigra | Designated preferred name (PT) | NO | |
| RxCUI: 2051924 | Ballota nigra | Full form of descriptor (FN) | NO | |
| RxCUI: 2051925 | Ballota nigra flowering top | Designated preferred name (PT) | NO | |
| RxCUI: 2051925 | Ballota nigra flowering top | Full form of descriptor (FN) | NO | |
| RxCUI: 2051932 | Folate supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2051932 | Folate supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2051939 | Formalin fumes | Designated preferred name (PT) | NO | |
| RxCUI: 2051939 | Formalin fumes | Full form of descriptor (FN) | NO | |
| RxCUI: 2051941 | Insoluble fiber | Designated preferred name (PT) | NO | |
| RxCUI: 2051941 | Insoluble fiber | Full form of descriptor (FN) | NO | |
| RxCUI: 2051941 | Insoluble fiber | British preferred term (PTGB) | NO | |
| RxCUI: 2051943 | Lifitegrast sodium | Designated preferred name (PT) | NO | |
| RxCUI: 2051943 | Lifitegrast sodium | Full form of descriptor (FN) | NO | |
| RxCUI: 2051945 | Light magnesium carbonate | Designated preferred name (PT) | NO | |
| RxCUI: 2051945 | Light magnesium carbonate | Full form of descriptor (FN) | NO | |
| RxCUI: 2051946 | Tilia sapwood extract | Designated preferred name (PT) | NO | |
| RxCUI: 2051946 | Tilia sapwood extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051946 | Tilia sapwood extract | Full form of descriptor (FN) | NO | |
| RxCUI: 2051953 | Product containing pregnane (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2051953 | Product containing pregnane (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2051954 | Product containing microbial agent (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2051954 | Product containing microbial agent (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2051956 | Product containing rhenium radioisotope (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2051956 | Product containing rhenium radioisotope (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2051956 | Product containing rhenium radioisotope (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2051956 | Product containing rhenium radioisotope (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2051964 | Radioisotope labeled leukocytes | Designated preferred name (PT) | NO | |
| RxCUI: 2051964 | Radioisotope labeled leukocytes | Full form of descriptor (FN) | NO | |
| RxCUI: 2051964 | Radioisotope labeled leukocytes | British preferred term (PTGB) | NO | |
| RxCUI: 2051970 | Pygeum africanum whole | Designated preferred name (PT) | NO | |
| RxCUI: 2051970 | Pygeum africanum whole | Full form of descriptor (FN) | NO | |
| RxCUI: 2051970 | Pygeum africanum whole | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205198 | bacitracin 0.5 UNT/MG / lidocaine 0.004 MG/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2051983 | Product containing samarium radioisotope (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2051983 | Product containing samarium radioisotope (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2051983 | Product containing samarium radioisotope (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2051983 | Product containing samarium radioisotope (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2051988 | Secretin human pentahydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 2051988 | Secretin human pentahydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 205199 | niacin Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2051990 | Substance with hydroxyquinoline structure | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2051990 | Substance with hydroxyquinoline structure | Designated preferred name (PT) | NO | |
| RxCUI: 2051990 | Substance with hydroxyquinoline structure | Full form of descriptor (FN) | NO | |
| RxCUI: 2052007 | Indium pentetate calcium | Designated preferred name (PT) | NO | |
| RxCUI: 2052007 | Indium pentetate calcium | Full form of descriptor (FN) | NO | |
| RxCUI: 2052014 | Trans-cinnamoylglycine | Designated preferred name (PT) | NO | |
| RxCUI: 2052014 | Trans-cinnamoylglycine | Full form of descriptor (FN) | NO | |
| RxCUI: 2052015 | Sodium dihydrogen phosphate dodecahydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2052015 | Sodium dihydrogen phosphate dodecahydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2052015 | Sodium dihydrogen phosphate dodecahydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2052015 | Sodium dihydrogen phosphate dodecahydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2052018 | Tricyclic compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052018 | Tricyclic compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052024 | Soluble fiber | Designated preferred name (PT) | NO | |
| RxCUI: 2052024 | Soluble fiber | Full form of descriptor (FN) | NO | |
| RxCUI: 2052024 | Soluble fiber | British preferred term (PTGB) | NO | |
| RxCUI: 2052031 | Valerylglycine | Designated preferred name (PT) | NO | |
| RxCUI: 2052031 | Valerylglycine | Full form of descriptor (FN) | NO | |
| RxCUI: 2052032 | Riboflavin supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2052032 | Riboflavin supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2052038 | Thiamin supplement | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2052038 | Thiamin supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2052038 | Thiamin supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 205204 | urea 40 GM per 150 ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205204 | urea 40 GM per 150 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2052040 | Vitamin A supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2052040 | Vitamin A supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2052058 | Substance categorized by disposition | Designated preferred name (PT) | NO | |
| RxCUI: 2052058 | Substance categorized by disposition | Full form of descriptor (FN) | NO | |
| RxCUI: 2052059 | Substance categorised by structure | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2052059 | Substance categorised by structure | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2052059 | Substance categorised by structure | Designated preferred name (PT) | NO | |
| RxCUI: 2052059 | Substance categorised by structure | Full form of descriptor (FN) | NO | |
| RxCUI: 2052059 | Substance categorised by structure | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2052061 | Product containing wax (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052061 | Product containing wax (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052063 | Aluminium and/or aluminium compound | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2052063 | Aluminium and/or aluminium compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052063 | Aluminium and/or aluminium compound | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2052063 | Aluminium and/or aluminium compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052063 | Aluminium and/or aluminium compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052063 | Aluminium and/or aluminium compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052064 | Incassia 28 Day | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2052064 | Incassia 28 Day | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2052064 | Incassia 28 Day | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2052077 | Aluminium hydroxide- and belladonna alkaloid-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2052077 | Aluminium hydroxide- and belladonna alkaloid-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2052077 | Aluminium hydroxide- and belladonna alkaloid-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2052089 | Glibenclamide 6.3 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2052089 | Glibenclamide 6.3 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2052089 | Glibenclamide 6.3 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2052093 | Product containing ascorbic acid and cetylpyridinium (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052093 | Product containing ascorbic acid and cetylpyridinium (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052094 | Product containing ascorbic acid and cyanocobalamin and ferrous fumarate (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052094 | Product containing ascorbic acid and cyanocobalamin and ferrous fumarate (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052101 | Product containing belladonna alkaloid and ergotamine and phenobarbital (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052101 | Product containing belladonna alkaloid and ergotamine and phenobarbital (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052102 | Belladonna alkaloid- and secbutabarbital-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2052102 | Belladonna alkaloid- and secbutabarbital-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2052102 | Belladonna alkaloid- and secbutabarbital-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2052103 | Product containing belladonna alkaloid and magnesium trisilicate (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052103 | Product containing belladonna alkaloid and magnesium trisilicate (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052104 | Product containing belladonna alkaloid and opium alkaloid (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052104 | Product containing belladonna alkaloid and opium alkaloid (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052105 | Bismuth and/or bismuth compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052105 | Bismuth and/or bismuth compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052105 | Bismuth and/or bismuth compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052105 | Bismuth and/or bismuth compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052106 | Boron and/or boron compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052106 | Boron and/or boron compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052106 | Boron and/or boron compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052106 | Boron and/or boron compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052129 | Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052129 | Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 205217 | sulfur 2 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205217 | sulfur 2 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205217 | sulfur 2 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205218 | NH4Cl 486 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205218 | NH4Cl 486 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2052244 | Product containing calcium and risedronic acid (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052244 | Product containing calcium and risedronic acid (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052245 | Product containing candesartan and hydrochlorothiazide (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052245 | Product containing candesartan and hydrochlorothiazide (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052262 | Ovis aries whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2052276 | Carboxylic acid and/or carboxylic acid derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2052276 | Carboxylic acid and/or carboxylic acid derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2052276 | Carboxylic acid and/or carboxylic acid derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2052276 | Carboxylic acid and/or carboxylic acid derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 205228 | iodine 5 % / potassium iodide 10 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205228 | iodine 5 % / potassium iodide 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205228 | iodine 5 % / potassium iodide 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205228 | iodine 5 % / potassium iodide 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205228 | iodine 5 % / potassium iodide 10 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205228 | iodine 5 % / potassium iodide 10 % Topical Solution | Designated preferred name (PT) | YES | |
| RxCUI: 205228 | iodine 5 % / potassium iodide 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205228 | iodine 5 % / potassium iodide 10 % Topical Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 2052280 | Cerium and/or cerium compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052280 | Cerium and/or cerium compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052280 | Cerium and/or cerium compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052280 | Cerium and/or cerium compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052291 | Cobalt and/or cobalt compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052291 | Cobalt and/or cobalt compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052291 | Cobalt and/or cobalt compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052291 | Cobalt and/or cobalt compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052294 | Product containing colistin and hydrocortisone and neomycin (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052294 | Product containing colistin and hydrocortisone and neomycin (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052298 | Corticosteroid and/or corticosteroid derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2052298 | Corticosteroid and/or corticosteroid derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2052299 | Cromoglicic acid- and isoprenaline-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2052299 | Cromoglicic acid- and isoprenaline-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2052299 | Cromoglicic acid- and isoprenaline-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 20523 | UDPglucose-beta-D-glucan glucosyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 20523 | UDPglucose-beta-D-glucan glucosyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 20523 | UDPglucose-beta-D-glucan glucosyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 20523 | UDPglucose-beta-D-glucan glucosyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 20523 | UDPglucose-beta-D-glucan glucosyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205230 | chlormezanone 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2052303 | Erbium and/or erbium compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052303 | Erbium and/or erbium compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052303 | Erbium and/or erbium compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052303 | Erbium and/or erbium compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052305 | Ethanolamine and/or ethanolamine derivative-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2052305 | Ethanolamine and/or ethanolamine derivative-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2052308 | Ethylenediamine and/or ethylenediamine derivative-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2052308 | Ethylenediamine and/or ethylenediamine derivative-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 205231 | sodium phenylbutyrate 1000 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2052311 | Gadolinium and/or gadolinium compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052311 | Gadolinium and/or gadolinium compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052311 | Gadolinium and/or gadolinium compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052311 | Gadolinium and/or gadolinium compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052314 | Gallium and/or gallium compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052314 | Gallium and/or gallium compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052314 | Gallium and/or gallium compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052314 | Gallium and/or gallium compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052316 | Product containing hydrocodone and potassium guaiacolsulfonate (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052316 | Product containing hydrocodone and potassium guaiacolsulfonate (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052319 | Iodine and/or iodine compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052319 | Iodine and/or iodine compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052319 | Iodine and/or iodine compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052319 | Iodine and/or iodine compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052321 | Lanthanum and/or lanthanum compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052321 | Lanthanum and/or lanthanum compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052321 | Lanthanum and/or lanthanum compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052321 | Lanthanum and/or lanthanum compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052322 | Lithium and/or lithium compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052322 | Lithium and/or lithium compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052322 | Lithium and/or lithium compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052322 | Lithium and/or lithium compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052325 | Product containing loteprednol and tobramycin (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052325 | Product containing loteprednol and tobramycin (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052328 | Manganese and/or manganese compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052328 | Manganese and/or manganese compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052328 | Manganese and/or manganese compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052328 | Manganese and/or manganese compound | Full form of descriptor (FN) | NO | |
| RxCUI: 205233 | calcium carbonate 700 MG (Ca 280 MG) / magnesium hydroxide 300 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205233 | calcium carbonate 700 MG (Ca 280 MG) / magnesium hydroxide 300 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205233 | calcium carbonate 700 MG (Ca 280 MG) / magnesium hydroxide 300 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2052331 | Nickel and/or nickel compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052331 | Nickel and/or nickel compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052331 | Nickel and/or nickel compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052331 | Nickel and/or nickel compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052333 | Phenothiazine and/or phenothiazine derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2052333 | Phenothiazine and/or phenothiazine derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2052333 | Phenothiazine and/or phenothiazine derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2052333 | Phenothiazine and/or phenothiazine derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2052338 | Phosphorus and/or phosphorus compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052338 | Phosphorus and/or phosphorus compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052338 | Phosphorus and/or phosphorus compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052338 | Phosphorus and/or phosphorus compound | Full form of descriptor (FN) | NO | |
| RxCUI: 205234 | calcium carbonate 550 MG / magnesium hydroxide 125 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205234 | calcium carbonate 550 MG / magnesium hydroxide 125 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205234 | calcium carbonate 550 MG / magnesium hydroxide 125 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2052340 | Potassium and/or potassium compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052340 | Potassium and/or potassium compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052340 | Potassium and/or potassium compound | Designated preferred name (PT) | NO | |
| RxCUI: 2052340 | Potassium and/or potassium compound | Full form of descriptor (FN) | NO | |
| RxCUI: 2052341 | Product containing propionic acid and/or propionic acid derivative (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052341 | Product containing propionic acid and/or propionic acid derivative (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052341 | Product containing propionic acid and/or propionic acid derivative (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052341 | Product containing propionic acid and/or propionic acid derivative (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052343 | Protamine and/or protamine derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2052343 | Protamine and/or protamine derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2052347 | Product containing strontium and/or strontium compound (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052347 | Product containing strontium and/or strontium compound (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052347 | Product containing strontium and/or strontium compound (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052347 | Product containing strontium and/or strontium compound (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052348 | Product containing sulfur and/or sulfur compound (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052348 | Product containing sulfur and/or sulfur compound (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052348 | Product containing sulfur and/or sulfur compound (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052348 | Product containing sulfur and/or sulfur compound (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052350 | Product containing titanium and/or titanium compound (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052350 | Product containing titanium and/or titanium compound (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052350 | Product containing titanium and/or titanium compound (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052350 | Product containing titanium and/or titanium compound (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052351 | Turpentine and/or turpentine derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2052351 | Turpentine and/or turpentine derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2052352 | Product containing urea and/or urea derivative (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052352 | Product containing urea and/or urea derivative (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052352 | Product containing urea and/or urea derivative (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052352 | Product containing urea and/or urea derivative (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052355 | Product containing zinc and/or zinc compound (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052355 | Product containing zinc and/or zinc compound (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052355 | Product containing zinc and/or zinc compound (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2052355 | Product containing zinc and/or zinc compound (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2052398 | aluminum chloride 213 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2052399 | aluminum chloride 21.3 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2052399 | aluminum chloride 21.3 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2052399 | aluminum chloride 21.3 % Mouthwash | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2052407 | hypochlorous acid 0.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2052408 | hypochlorous acid 0.02 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2052408 | hypochlorous acid 0.02 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2052408 | hypochlorous acid 0.02 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205241 | belladonna alkaloids 0.12 MG / caffeine 100 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2052423 | sodium nitroprusside 20 MG in 100 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2052423 | sodium nitroprusside 20 MG in 100 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2052423 | sodium nitroprusside 20 MG in 100 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2052424 | NIPRIDE RTU 20 MG in 100 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2052424 | NIPRIDE RTU 20 MG in 100 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2052424 | NIPRIDE RTU 20 MG in 100 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2052424 | NIPRIDE RTU 20 MG in 100 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205243 | ZNO 0.05 MG/MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205243 | ZNO 0.05 MG/MG Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205247 | vit-B3 10 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205247 | vit-B3 10 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205247 | vit-B3 10 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205247 | vit-B3 10 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205248 | lactic acid 2 % / urea 10 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205248 | lactic acid 2 % / urea 10 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2052503 | tacrolimus 0.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 205251 | acetaminophen 160 MG / aspirin 230 MG / caffeine 33 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205251 | acetaminophen 160 MG / aspirin 230 MG / caffeine 33 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205251 | acetaminophen 160 MG / aspirin 230 MG / caffeine 33 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205252 | mineral oil 100 % Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205252 | mineral oil 100 % Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205255 | diphtheria toxoid vaccine 12.5 UNT / tetanus toxoid vaccine 5 UNT per 0.5 ML Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205255 | diphtheria toxoid vaccine 12.5 UNT / tetanus toxoid vaccine 5 UNT per 0.5 ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205256 | diphtheria toxoid vaccine 10 UNT / tetanus toxoid vaccine 5 UNT per 0.5 ML Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205256 | diphtheria toxoid vaccine 10 UNT / tetanus toxoid vaccine 5 UNT per 0.5 ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205257 | diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205259 | tetanus toxoid vaccine, inactivated 2 UNT / diphtheria toxoid vaccine, inactivated (Td) 2 UNT in 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205259 | tetanus toxoid vaccine, inactivated 2 UNT / diphtheria toxoid vaccine, inactivated (Td) 2 UNT in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205259 | tetanus toxoid vaccine, inactivated 2 UNT / diphtheria toxoid vaccine, inactivated (Td) 2 UNT in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2052603 | tacrolimus Granule Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2052604 | tacrolimus Granules for Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2052605 | tacrolimus 0.2 MG Granules for Oral Suspension | Full form of descriptor (FN) | YES | |
| RxCUI: 2052605 | tacrolimus 0.2 MG Granules for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2052605 | tacrolimus 0.2 MG Granules for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2052605 | tacrolimus 0.2 MG Granules for Oral Suspension | Designated preferred name (PT) | YES | |
| RxCUI: 2052606 | tacrolimus 0.2 MG [Prograf] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2052607 | tacrolimus Granules for Oral Suspension [Prograf] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2052608 | Prograf Granule Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2052609 | Prograf 0.2 MG Granules for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2052609 | Prograf 0.2 MG Granules for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2052609 | Prograf 0.2 MG Granules for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205262 | tetanus toxoid vaccine, inactivated 20 UNT/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205270 | interferon alfa-2b 15000000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2052703 | tacrolimus 1 MG Granules for Oral Suspension | Full form of descriptor (FN) | YES | |
| RxCUI: 2052703 | tacrolimus 1 MG Granules for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2052703 | tacrolimus 1 MG Granules for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2052703 | tacrolimus 1 MG Granules for Oral Suspension | Designated preferred name (PT) | YES | |
| RxCUI: 2052704 | Prograf 1 MG Granules for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2052704 | Prograf 1 MG Granules for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2052704 | Prograf 1 MG Granules for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205271 | interferon alfa-2a 25000000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205276 | mangafodipir 7.57 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205281 | aspirin 262.5 MG / caffeine 32.5 MG / salicylamide 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205281 | aspirin 262.5 MG / caffeine 32.5 MG / salicylamide 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205281 | aspirin 262.5 MG / caffeine 32.5 MG / salicylamide 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2052813 | phytosterols 450 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2052814 | phytosterols 450 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2052814 | phytosterols 450 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205282 | resorcinol 3 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205282 | resorcinol 3 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2052821 | Relexxii | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2052822 | methylphenidate hydrochloride 72 MG [Relexxii] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2052823 | methylphenidate Extended Release Oral Tablet [Relexxii] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2052824 | Relexxii Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2052825 | Relexxii Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2052826 | RELEXXII 72 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2052826 | RELEXXII 72 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2052826 | RELEXXII 72 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2052826 | RELEXXII 72 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2052827 | methylphenidate hydrochloride 72 MG Extended Release Oral Tablet [Relexxii] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2052827 | methylphenidate hydrochloride 72 MG Extended Release Oral Tablet [Relexxii] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205284 | leflunomide 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205284 | leflunomide 10 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 205284 | leflunomide 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205284 | leflunomide 10 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 205285 | leflunomide 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205285 | leflunomide 20 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 205285 | leflunomide 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205285 | leflunomide 20 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2052857 | glycopyrronium tosylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 205286 | leflunomide 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205286 | leflunomide 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 205286 | leflunomide 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205286 | leflunomide 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2052872 | plazomicin sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2052872 | plazomicin sulfate | Designated preferred name (PT) | NO | |
| RxCUI: 2052872 | plazomicin sulfate | Full form of descriptor (FN) | NO | |
| RxCUI: 205288 | APAP 240 MG / Caffeine 16 MG / Phenylpropanolamine 18.75 MG / salicylamide 120 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205288 | APAP 240 MG / Caffeine 16 MG / Phenylpropanolamine 18.75 MG / salicylamide 120 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205289 | coal tar 2 % / lactic acid 5 % / salicylic acid 3 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205289 | coal tar 2 % / lactic acid 5 % / salicylic acid 3 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205290 | efavirenz 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205290 | efavirenz 200 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 205290 | efavirenz 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205290 | efavirenz 200 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 205291 | efavirenz 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205291 | efavirenz 100 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 205291 | efavirenz 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205291 | efavirenz 100 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2052918 | acetyl tetrapeptide-5 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2052919 | dyclonine hydrochloride 2 MG / menthol 6 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2052919 | dyclonine hydrochloride 2 MG / menthol 6 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205292 | efavirenz 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205292 | efavirenz 50 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 205292 | efavirenz 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205292 | efavirenz 50 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2052920 | Sucrets Sore Throat | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2052921 | dyclonine hydrochloride 2 MG / menthol 6 MG [Sucrets Sore Throat] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2052922 | dyclonine / menthol Oral Lozenge [Sucrets Sore Throat] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2052923 | Sucrets Sore Throat Lozenge Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2052924 | Sucrets Sore Throat Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2052925 | Sucrets Sore Throat 2 MG / 6 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2052925 | Sucrets Sore Throat 2 MG / 6 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2052925 | Sucrets Sore Throat 2 MG / 6 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205296 | interferon alfa-2a 12 million UNT/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205296 | interferon alfa-2a 12 million UNT/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205296 | interferon alfa-2a 12 million UNT/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205301 | predniSONE 5 MG in 1 mL Concentrate for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205301 | predniSONE 5 MG in 1 mL Concentrate for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205301 | predniSONE 5 MG in 1 mL Concentrate for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 205301 | predniSONE 5 MG in 1 mL Concentrate for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205301 | predniSONE 5 MG in 1 mL Concentrate for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 205304 | telmisartan 40 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 205304 | telmisartan 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205304 | telmisartan 40 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 205304 | telmisartan 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205305 | telmisartan 80 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 205305 | telmisartan 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205305 | telmisartan 80 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 205305 | telmisartan 80 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2053080 | Product containing precisely sermorelin (as sermorelin acetate) 50 microgram/1 ampule powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053080 | Product containing precisely sermorelin (as sermorelin acetate) 50 microgram/1 ampule powder for conventional release solution for injection (clinical drug) | British preferred term (PTGB) | NO | |
| RxCUI: 2053080 | Product containing precisely sermorelin (as sermorelin acetate) 50 microgram/1 ampule powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 205314 | insulin, regular, pork 500 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205315 | topiramate 25 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 205315 | topiramate 25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205315 | topiramate 25 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 205315 | topiramate 25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2053157 | Cefradine 50 mg/mL oral solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053157 | Cefradine 50 mg/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2053157 | Cefradine 50 mg/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2053158 | Chlorhexidine diacetate 10 mg/g cutaneous powder | Designated preferred name (PT) | NO | |
| RxCUI: 2053158 | Chlorhexidine diacetate 10 mg/g cutaneous powder | Full form of descriptor (FN) | NO | |
| RxCUI: 2053159 | Chlorhexidine gluconate 10 mg/g cutaneous cream | Designated preferred name (PT) | NO | |
| RxCUI: 2053159 | Chlorhexidine gluconate 10 mg/g cutaneous cream | Full form of descriptor (FN) | NO | |
| RxCUI: 205316 | topiramate 15 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 205316 | topiramate 15 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205316 | topiramate 15 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 205316 | topiramate 15 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2053160 | Chlorhexidine gluconate 50 mg/mL cutaneous solution | Designated preferred name (PT) | NO | |
| RxCUI: 2053160 | Chlorhexidine gluconate 50 mg/mL cutaneous solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2053164 | Diclofenac diethylammonium 11.6 mg/g cutaneous gel | Designated preferred name (PT) | NO | |
| RxCUI: 2053164 | Diclofenac diethylammonium 11.6 mg/g cutaneous gel | Full form of descriptor (FN) | NO | |
| RxCUI: 2053166 | Diflucortolone valerate 3 mg/g cutaneous cream | Designated preferred name (PT) | NO | |
| RxCUI: 2053166 | Diflucortolone valerate 3 mg/g cutaneous cream | Full form of descriptor (FN) | NO | |
| RxCUI: 2053167 | Dihydrocodeine tartrate 2 mg/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2053167 | Dihydrocodeine tartrate 2 mg/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 205317 | Calcium Chloride 0.3 MG/ML / K+ Chloride 0.3 MG/ML / NaCl 8.6 MG/ML Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205317 | Calcium Chloride 0.3 MG/ML / K+ Chloride 0.3 MG/ML / NaCl 8.6 MG/ML Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205317 | Calcium Chloride 0.3 MG/ML / K+ Chloride 0.3 MG/ML / NaCl 8.6 MG/ML Irrigation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2053178 | Fluocortolone hexanoate 2.5 mg/g and fluocortolone pivalate 2.5 mg/g cutaneous cream | Designated preferred name (PT) | NO | |
| RxCUI: 2053178 | Fluocortolone hexanoate 2.5 mg/g and fluocortolone pivalate 2.5 mg/g cutaneous cream | Full form of descriptor (FN) | NO | |
| RxCUI: 2053188 | Lansoprazole 30 mg granules for gastro-resistant oral suspension sachet | Designated preferred name (PT) | NO | |
| RxCUI: 2053188 | Lansoprazole 30 mg granules for gastro-resistant oral suspension sachet | Full form of descriptor (FN) | NO | |
| RxCUI: 2053191 | Magnesium alginate 87.5 mg and sodium alginate 225 mg powder for oral suspension sachet | Designated preferred name (PT) | NO | |
| RxCUI: 2053191 | Magnesium alginate 87.5 mg and sodium alginate 225 mg powder for oral suspension sachet | Full form of descriptor (FN) | NO | |
| RxCUI: 205320 | follitropin beta 75 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205322 | celecoxib 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205322 | celecoxib 100 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 205322 | celecoxib 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205322 | celecoxib 100 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 205323 | celecoxib 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205323 | celecoxib 200 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 205323 | celecoxib 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205323 | celecoxib 200 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 205324 | modafinil 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205324 | modafinil 200 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 205324 | modafinil 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205324 | modafinil 200 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2053244 | Product containing precisely sodium chloride 50 milligram/1 milliliter conventional release eye drops (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053244 | Product containing precisely sodium chloride 50 milligram/1 milliliter conventional release eye drops (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2053245 | Habitrol Combination Kit Steps 1-3 Transdermal System (56) | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 2053245 | Habitrol Combination Kit Steps 1-3 Transdermal System (56) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053245 | Habitrol Combination Kit Steps 1-3 Transdermal System (56) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053245 | Habitrol Combination Kit Steps 1-3 Transdermal System (56) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053245 | Habitrol Combination Kit Steps 1-3 Transdermal System (56) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2053250 | Product containing precisely tioconazole 283 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053250 | Product containing precisely tioconazole 283 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2053255 | Paracetamol- and sodium salicylate-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053255 | Paracetamol- and sodium salicylate-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053255 | Paracetamol- and sodium salicylate-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053256 | Amino acid-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053256 | Amino acid-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053257 | Aspirin- and pravastatin-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053257 | Aspirin- and pravastatin-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 205326 | lisinopril 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205326 | lisinopril 30 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 205326 | lisinopril 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205326 | lisinopril 30 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2053260 | Belladonna alkaloid-containing product in rectal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053260 | Belladonna alkaloid-containing product in rectal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053261 | Benzoin- and menthol-containing product in pulmonary dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053261 | Benzoin- and menthol-containing product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053262 | Benzylpenicilloyl polylysine-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053262 | Benzylpenicilloyl polylysine-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053265 | sodium gentisate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2053267 | Bovine isophane insulin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053267 | Bovine isophane insulin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053268 | Caffeine- and sodium benzoate-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053268 | Caffeine- and sodium benzoate-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053270 | Calcium- and risedronic acid-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053270 | Calcium- and risedronic acid-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053271 | Carbidopa- and levodopa-containing product in enteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053271 | Carbidopa- and levodopa-containing product in enteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053273 | Cobalt chloride-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053273 | Cobalt chloride-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053274 | Cobalt-57-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053274 | Cobalt-57-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053275 | Cobalt-57-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053275 | Cobalt-57-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053277 | Dexibuprofen-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053277 | Dexibuprofen-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053278 | Adrenaline- and zinc sulfate-containing product in ocular dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053278 | Adrenaline- and zinc sulfate-containing product in ocular dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053278 | Adrenaline- and zinc sulfate-containing product in ocular dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053279 | Ferric pyrophosphate-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053279 | Ferric pyrophosphate-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 205328 | lamiVUDine 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205328 | lamiVUDine 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205328 | lamiVUDine 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 205328 | lamiVUDine 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205328 | lamiVUDine 100 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 205328 | lamiVUDine 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2053280 | Follitropin delta-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053280 | Follitropin delta-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053281 | Metaiodobenzylguanidine (131-I) | Designated preferred name (PT) | YES | |
| RxCUI: 2053281 | Metaiodobenzylguanidine (131-I) | Full form of descriptor (FN) | YES | |
| RxCUI: 2053281 | Metaiodobenzylguanidine (131-I) | Designated preferred name (PT) | YES | |
| RxCUI: 2053281 | Metaiodobenzylguanidine (131-I) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2053281 | Metaiodobenzylguanidine (131-I) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053281 | Metaiodobenzylguanidine (131-I) | Full form of descriptor (FN) | YES | |
| RxCUI: 2053283 | iobenguane I-131 15 MCI/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2053286 | iobenguane I-131 15 MCI/ML in 2 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2053286 | iobenguane I-131 15 MCI/ML in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2053286 | iobenguane I-131 15 MCI/ML in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053287 | Azedra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2053288 | iobenguane I-131 15 MCI/ML [Azedra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 205329 | miglitol 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205329 | miglitol 25 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 205329 | miglitol 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205329 | miglitol 25 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2053290 | Azedra Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2053291 | AZEDRA DOSIMETRIC 15 MCI/mL in 2 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053291 | AZEDRA DOSIMETRIC 15 MCI/mL in 2 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2053291 | AZEDRA DOSIMETRIC 15 MCI/mL in 2 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053291 | AZEDRA DOSIMETRIC 15 MCI/mL in 2 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2053291 | AZEDRA DOSIMETRIC 15 MCI/mL in 2 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053292 | iobenguane I-131 15 MCI/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2053293 | iobenguane I-131 15 MCI/ML Injection [Azedra] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053293 | iobenguane I-131 15 MCI/ML Injection [Azedra] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2053294 | Heparinoid- and salicylic acid-containing product in transdermal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053294 | Heparinoid- and salicylic acid-containing product in transdermal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053295 | Histamine-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053295 | Histamine-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053296 | iobenguane I-131 15 MCI/ML in 22.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2053296 | iobenguane I-131 15 MCI/ML in 22.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2053296 | iobenguane I-131 15 MCI/ML in 22.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053297 | AZEDRA THERAPEUTIC 15 MCI/mL in 22.5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053297 | AZEDRA THERAPEUTIC 15 MCI/mL in 22.5 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2053297 | AZEDRA THERAPEUTIC 15 MCI/mL in 22.5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053297 | AZEDRA THERAPEUTIC 15 MCI/mL in 22.5 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2053297 | AZEDRA THERAPEUTIC 15 MCI/mL in 22.5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205330 | miglitol 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205330 | miglitol 50 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 205330 | miglitol 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205330 | miglitol 50 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2053301 | Interferon alfa-2b-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053301 | Interferon alfa-2b-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053304 | Lithium-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053304 | Lithium-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053305 | Nonacog beta pegol-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053305 | Nonacog beta pegol-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053306 | Nonoxinol-containing product in vaginal dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053306 | Nonoxinol-containing product in vaginal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053306 | Nonoxinol-containing product in vaginal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053308 | Potassium aminobenzoate-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053308 | Potassium aminobenzoate-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053309 | Product manufactured as cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053309 | Product manufactured as cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 205331 | miglitol 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205331 | miglitol 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 205331 | miglitol 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205331 | miglitol 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2053310 | Product manufactured as dental dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053310 | Product manufactured as dental dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053311 | Product manufactured as endocervical dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053311 | Product manufactured as endocervical dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053312 | Product manufactured as enteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053312 | Product manufactured as enteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053313 | Product manufactured as gingival dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053313 | Product manufactured as gingival dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053314 | Product manufactured as oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053314 | Product manufactured as oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053315 | Product manufactured as pulmonary dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053315 | Product manufactured as pulmonary dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053316 | Product manufactured as transdermal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053316 | Product manufactured as transdermal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053317 | Product manufactured as urethral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053317 | Product manufactured as urethral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053318 | Product containing riboflavin in ocular dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053318 | Product containing riboflavin in ocular dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2053319 | Product containing selenium-75 in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053319 | Product containing selenium-75 in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 205332 | methyldopa 250 MG / chlorothiazide 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205332 | methyldopa 250 MG / chlorothiazide 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2053320 | Product containing selenium-75 in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053320 | Product containing selenium-75 in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2053322 | Product containing sodium hypochlorite in cutaneous dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053322 | Product containing sodium hypochlorite in cutaneous dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2053325 | Product containing sodium salicylate in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053325 | Product containing sodium salicylate in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2053326 | Product containing talimogene laherparepvec in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053326 | Product containing talimogene laherparepvec in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2053329 | Product containing thyroid hormone in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053329 | Product containing thyroid hormone in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 205333 | estradiol 1.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205333 | estradiol 1.5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 205333 | estradiol 1.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205333 | estradiol 1.5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2053331 | Product containing tripotassium dicitratobismuthate in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053331 | Product containing tripotassium dicitratobismuthate in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2053332 | Product containing yttrium-90 in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053332 | Product containing yttrium-90 in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2053334 | zinc gluconate trihydrate 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2053335 | zinc gluconate Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2053336 | zinc (as zinc gluconate trihydrate) 10 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2053336 | zinc (as zinc gluconate trihydrate) 10 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2053336 | zinc (as zinc gluconate trihydrate) 10 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053336 | zinc (as zinc gluconate trihydrate) 10 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053337 | zinc gluconate trihydrate 1 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2053340 | Chromium (51-Cr) labeled erythrocytes | Designated preferred name (PT) | NO | |
| RxCUI: 2053340 | Chromium (51-Cr) labeled erythrocytes | Full form of descriptor (FN) | NO | |
| RxCUI: 2053340 | Chromium (51-Cr) labeled erythrocytes | British preferred term (PTGB) | NO | |
| RxCUI: 2053343 | Antigen of Hector Battifora mesothelial-1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053343 | Antigen of Hector Battifora mesothelial-1 | Full form of descriptor (FN) | NO | |
| RxCUI: 2053343 | Antigen of Hector Battifora mesothelial-1 | Designated preferred name (PT) | NO | |
| RxCUI: 2053343 | Antigen of Hector Battifora mesothelial-1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053345 | Indium (111-In) labeled granulocyte | Designated preferred name (PT) | NO | |
| RxCUI: 2053345 | Indium (111-In) labeled granulocyte | Full form of descriptor (FN) | NO | |
| RxCUI: 2053345 | Indium (111-In) labeled granulocyte | British preferred term (PTGB) | NO | |
| RxCUI: 2053346 | Indium (111-In) labeled mixed leukocyte | Designated preferred name (PT) | NO | |
| RxCUI: 2053346 | Indium (111-In) labeled mixed leukocyte | Full form of descriptor (FN) | NO | |
| RxCUI: 2053346 | Indium (111-In) labeled mixed leukocyte | British preferred term (PTGB) | NO | |
| RxCUI: 2053347 | Indium (111-In) labeled octreotide | Designated preferred name (PT) | NO | |
| RxCUI: 2053347 | Indium (111-In) labeled octreotide | Full form of descriptor (FN) | NO | |
| RxCUI: 2053347 | Indium (111-In) labeled octreotide | British preferred term (PTGB) | NO | |
| RxCUI: 205335 | benzocaine 6 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2053356 | Iodine (125-I) liothyronine | Designated preferred name (PT) | NO | |
| RxCUI: 2053356 | Iodine (125-I) liothyronine | Full form of descriptor (FN) | NO | |
| RxCUI: 2053359 | Lutetium (177-Lu) labeled somatostatin analog | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053359 | Lutetium (177-Lu) labeled somatostatin analog | Full form of descriptor (FN) | NO | |
| RxCUI: 2053359 | Lutetium (177-Lu) labeled somatostatin analog | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053359 | Lutetium (177-Lu) labeled somatostatin analog | Designated preferred name (PT) | NO | |
| RxCUI: 2053359 | Lutetium (177-Lu) labeled somatostatin analog | British preferred term (PTGB) | NO | |
| RxCUI: 205336 | hydrogen peroxide 1.5 % Mucous Membrane Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205336 | hydrogen peroxide 1.5 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205336 | hydrogen peroxide 1.5 % Mucous Membrane Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2053361 | Antigen of cyclin dependent kinase inhibitor p27 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053361 | Antigen of cyclin dependent kinase inhibitor p27 | Full form of descriptor (FN) | NO | |
| RxCUI: 2053361 | Antigen of cyclin dependent kinase inhibitor p27 | Designated preferred name (PT) | NO | |
| RxCUI: 2053361 | Antigen of cyclin dependent kinase inhibitor p27 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053362 | Potassium (K-42) chloride | Designated preferred name (PT) | NO | |
| RxCUI: 2053362 | Potassium (K-42) chloride | Full form of descriptor (FN) | NO | |
| RxCUI: 205337 | magnesium carbonate 250 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205337 | magnesium carbonate 250 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205337 | magnesium carbonate 250 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2053370 | Technetium (99m-Tc) exametazime labeled leukocytes | Designated preferred name (PT) | NO | |
| RxCUI: 2053370 | Technetium (99m-Tc) exametazime labeled leukocytes | Full form of descriptor (FN) | NO | |
| RxCUI: 2053370 | Technetium (99m-Tc) exametazime labeled leukocytes | British preferred term (PTGB) | NO | |
| RxCUI: 2053371 | Technetium (99m-Tc) human serum albumin | Designated preferred name (PT) | NO | |
| RxCUI: 2053371 | Technetium (99m-Tc) human serum albumin | Full form of descriptor (FN) | NO | |
| RxCUI: 2053372 | Technetium (99m-Tc) labeled granulocytes | Designated preferred name (PT) | NO | |
| RxCUI: 2053372 | Technetium (99m-Tc) labeled granulocytes | Full form of descriptor (FN) | NO | |
| RxCUI: 2053372 | Technetium (99m-Tc) labeled granulocytes | British preferred term (PTGB) | NO | |
| RxCUI: 2053373 | Technetium (99m-Tc) pentetic acid | Designated preferred name (PT) | NO | |
| RxCUI: 2053373 | Technetium (99m-Tc) pentetic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 205338 | chloroxine 2 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205338 | chloroxine 2 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205338 | chloroxine 2 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205338 | chloroxine 2 % Medicated Shampoo | Designated preferred name (PT) | NO | |
| RxCUI: 205338 | chloroxine 2 % Medicated Shampoo | Full form of descriptor (FN) | NO | |
| RxCUI: 2053381 | Yttrium (90-Y) labeled somatostatin analog | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053381 | Yttrium (90-Y) labeled somatostatin analog | Full form of descriptor (FN) | NO | |
| RxCUI: 2053381 | Yttrium (90-Y) labeled somatostatin analog | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053381 | Yttrium (90-Y) labeled somatostatin analog | Designated preferred name (PT) | NO | |
| RxCUI: 2053381 | Yttrium (90-Y) labeled somatostatin analog | British preferred term (PTGB) | NO | |
| RxCUI: 205342 | bacitracin 400 UNT / hydrocortisone 10 MG / neomycin 3.5 MG / polymyxin B 10,000 UNT per GM Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205342 | bacitracin 400 UNT / hydrocortisone 10 MG / neomycin 3.5 MG / polymyxin B 10,000 UNT per GM Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205342 | bacitracin 400 UNT / hydrocortisone 10 MG / neomycin 3.5 MG / polymyxin B 10,000 UNT per GM Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205342 | bacitracin 400 UNT / hydrocortisone 10 MG / neomycin 3.5 MG / polymyxin B 10,000 UNT per GM Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053436 | tildrakizumab | Full form of descriptor (FN) | YES | |
| RxCUI: 2053436 | tildrakizumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2053436 | tildrakizumab | Designated preferred name (PT) | YES | |
| RxCUI: 2053436 | tildrakizumab | Full form of descriptor (FN) | YES | |
| RxCUI: 2053436 | tildrakizumab | Designated preferred name (PT) | YES | |
| RxCUI: 2053437 | Cochlearia officinalis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2053438 | Conium maculatum fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2053439 | Olea europaea flower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2053440 | Phytolacca octandra leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2053441 | Populus alba leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2053442 | Prunus dulcis flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2053443 | Sambucus nigra flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2053444 | Vincetoxicum atratum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2053449 | tildrakizumab-asmn | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2053450 | tildrakizumab-asmn 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2053451 | tildrakizumab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2053451 | tildrakizumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2053451 | tildrakizumab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2053452 | tildrakizumab Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2053453 | tildrakizumab-asmn 100 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2053453 | tildrakizumab-asmn 100 MG in 1 ML Prefilled Syringe | Full form of descriptor (FN) | YES | |
| RxCUI: 2053453 | tildrakizumab-asmn 100 MG in 1 ML Prefilled Syringe | Designated preferred name (PT) | YES | |
| RxCUI: 2053453 | tildrakizumab-asmn 100 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2053453 | tildrakizumab-asmn 100 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053454 | Ilumya | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2053455 | tildrakizumab-asmn 100 MG/ML [Ilumya] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2053456 | tildrakizumab Prefilled Syringe [Ilumya] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2053457 | Ilumya Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2053458 | ILUMYA 100 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053458 | ILUMYA 100 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2053458 | ILUMYA 100 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2053458 | ILUMYA 100 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053459 | tildrakizumab-asmn 100 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2053460 | tildrakizumab-asmn 100 MG/ML Prefilled Syringe [Ilumya] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053460 | tildrakizumab-asmn 100 MG/ML Prefilled Syringe [Ilumya] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205347 | chlorpheniramine maleate 5 MG / phenylephrine HCl 10 MG / phenylpropanolamine HCl 40 MG / phenyltoloxamine citrate 15 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205347 | chlorpheniramine maleate 5 MG / phenylephrine HCl 10 MG / phenylpropanolamine HCl 40 MG / phenyltoloxamine citrate 15 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205347 | chlorpheniramine maleate 5 MG / phenylephrine HCl 10 MG / phenylpropanolamine HCl 40 MG / phenyltoloxamine citrate 15 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2053485 | 1,2-dimyristoyl-sn-glycero-3-carboxaminopropylpolyethylene glycol 2000 methyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2053486 | 1-(3,5-bis(trifluoromethyl)phenyl)ethanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2053487 | chitosan high molecular weight (400-800 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2053488 | MC-3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2053488 | MC-3 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053489 | Magnolia officinalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 205349 | chlorpheniramine maleate 0.5 MG/ML / phenylephrine hydrochloride 1.25 MG/ML / phenylpropanolamine hydrochloride 5 MG/ML / phenyltoloxamine citrate 2 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2053490 | patisiran | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2053490 | patisiran | Designated preferred name (PT) | YES | |
| RxCUI: 2053490 | patisiran | Full form of descriptor (FN) | YES | |
| RxCUI: 2053490 | patisiran | Designated preferred name (PT) | YES | |
| RxCUI: 2053490 | patisiran | Full form of descriptor (FN) | YES | |
| RxCUI: 2053491 | patisiran sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2053491 | patisiran sodium | Designated preferred name (PT) | YES | |
| RxCUI: 2053491 | patisiran sodium | Full form of descriptor (FN) | YES | |
| RxCUI: 2053495 | fish oil (containing omega-3 acids) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2053496 | fish oil (containing omega-3 acids) 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2053497 | fish oil (containing omega-3 acids) Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2053498 | fish oil (containing omega-3 acids) Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2053499 | fish oil (containg omega-3 fatty acids) 10 % in 50 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2053499 | fish oil (containg omega-3 fatty acids) 10 % in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2053499 | fish oil (containg omega-3 fatty acids) 10 % in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053499 | fish oil (containg omega-3 fatty acids) 10 % in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053500 | Omegaven | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2053501 | fish oil (containing omega-3 acids) 100 MG/ML [Omegaven] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2053502 | fish oil (containing omega-3 acids) Injection [Omegaven] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2053503 | Omegaven Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2053504 | Omegaven 10 % in 50 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2053504 | Omegaven 10 % in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053504 | Omegaven 10 % in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2053504 | Omegaven 10 % in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053505 | fish oil (containing omega-3 acids) 100 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2053506 | fish oil (containing omega-3 acids) 100 MG/ML Injection [Omegaven] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2053506 | fish oil (containing omega-3 acids) 100 MG/ML Injection [Omegaven] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053507 | ivacaftor / lumacaftor Granule Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2053508 | ivacaftor / lumacaftor Oral Granules | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2053509 | ivacaftor 125 MG / lumacaftor 100 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2053509 | ivacaftor 125 MG / lumacaftor 100 MG Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205351 | belladonna alkaloids 0.12 MG / caffeine 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2053510 | ivacaftor / lumacaftor Oral Granules [ORKAMBI] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2053511 | ORKAMBI Granule Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2053512 | ORKAMBI 100 MG / 125 MG Oral Granules | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2053512 | ORKAMBI 100 MG / 125 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053512 | ORKAMBI 100 MG / 125 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2053513 | fish oil (containg omega-3 fatty acids) 10 % in 100 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2053513 | fish oil (containg omega-3 fatty acids) 10 % in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2053513 | fish oil (containg omega-3 fatty acids) 10 % in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053513 | fish oil (containg omega-3 fatty acids) 10 % in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053514 | Omegaven 10 % in 100 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2053514 | Omegaven 10 % in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053514 | Omegaven 10 % in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2053514 | Omegaven 10 % in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053515 | ivacaftor 188 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2053516 | lumacaftor 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2053517 | ivacaftor 188 MG / lumacaftor 150 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2053517 | ivacaftor 188 MG / lumacaftor 150 MG Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2053518 | ivacaftor 188 MG / lumacaftor 150 MG [ORKAMBI] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2053519 | ORKAMBI 150 MG / 188 MG Oral Granules | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2053519 | ORKAMBI 150 MG / 188 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053519 | ORKAMBI 150 MG / 188 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205352 | chlorpheniramine maleate 4 MG / phenylephrine hydrochloride 10 MG / phenylpropanolamine hydrochloride 50 MG / pyrilamine maleate 25 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2053522 | patisiran Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2053522 | patisiran Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2053522 | patisiran Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2053523 | patisiran Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2053524 | patisiran lipid complex 10 MG in 5 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2053524 | patisiran lipid complex 10 MG in 5 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2053524 | patisiran lipid complex 10 MG in 5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053525 | Onpattro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2053527 | patisiran Injection [Onpattro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2053528 | Onpattro Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2053529 | onpattro 10 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053529 | onpattro 10 MG in 5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2053529 | onpattro 10 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2053529 | onpattro 10 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053530 | patisiran lipid complex 2 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2053531 | patisiran lipid complex 2 MG/ML Injection [Onpattro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053531 | patisiran lipid complex 2 MG/ML Injection [Onpattro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205357 | cefmetazole 370 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205358 | cefmetazole 250 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2053585 | Hexastarch 60 mg/mL solution for infusion | Designated preferred name (PT) | NO | |
| RxCUI: 2053585 | Hexastarch 60 mg/mL solution for infusion | Full form of descriptor (FN) | NO | |
| RxCUI: 205359 | Bretylium tosilate 50 mg/mL solution for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205359 | Bretylium tosilate 50 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 205359 | Bretylium tosilate 50 mg/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205359 | Bretylium tosilate 50 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 205359 | Bretylium tosilate 50 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 205359 | Bretylium tosilate 50 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2053614 | Alteplase 10 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053614 | Alteplase 10 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2053615 | Alteplase 20 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053615 | Alteplase 20 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2053629 | Cetrorelix (as cetrorelix acetate) 3 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053629 | Cetrorelix (as cetrorelix acetate) 3 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2053631 | Coagulation factor XIII 1250 unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053631 | Coagulation factor XIII 1250 unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2053632 | Coagulation factor XIII 250 unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053632 | Coagulation factor XIII 250 unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 205364 | reserpine 0.125 MG / chlorthalidone 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205364 | reserpine 0.125 MG / chlorthalidone 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2053643 | Disodium pamidronate 15 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053643 | Disodium pamidronate 15 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 205365 | reserpine 0.25 MG / chlorthalidone 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205365 | reserpine 0.25 MG / chlorthalidone 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2053653 | Etanercept 25 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053653 | Etanercept 25 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2053654 | Etanercept 50 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053654 | Etanercept 50 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2053669 | Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053669 | Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2053670 | Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053670 | Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2053671 | Glucagon hydrochloride 1 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053671 | Glucagon hydrochloride 1 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2053672 | Gonadorelin (as gonadorelin hydrochloride) 100 microgram powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053672 | Gonadorelin (as gonadorelin hydrochloride) 100 microgram powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 205368 | anthralin 0.25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205368 | anthralin 0.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205368 | anthralin 0.25 % Topical Cream | Designated preferred name (PT) | NO | |
| RxCUI: 205368 | anthralin 0.25 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205368 | anthralin 0.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205368 | anthralin 0.25 % Topical Cream | Full form of descriptor (FN) | NO | |
| RxCUI: 2053700 | Interferon alfa-2b 1 million unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053700 | Interferon alfa-2b 1 million unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2053713 | Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053713 | Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2053714 | Lenograstim 13.4 million unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053714 | Lenograstim 13.4 million unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2053716 | Leuprorelin acetate 11.25 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053716 | Leuprorelin acetate 11.25 mg powder for solution for injection vial | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053716 | Leuprorelin acetate 11.25 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2053719 | Leuprorelin acetate 3.75 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053719 | Leuprorelin acetate 3.75 mg powder for solution for injection vial | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053719 | Leuprorelin acetate 3.75 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2053751 | Palivizumab 100 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053751 | Palivizumab 100 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2053752 | Palivizumab 50 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053752 | Palivizumab 50 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2053777 | Product containing precisely sodium fusidate 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053777 | Product containing precisely sodium fusidate 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2053788 | Product containing precisely teicoplanin 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053788 | Product containing precisely teicoplanin 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2053789 | Product containing precisely teicoplanin 400 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053789 | Product containing precisely teicoplanin 400 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2053793 | Product containing precisely tenoxicam 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053793 | Product containing precisely tenoxicam 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2053800 | Product containing precisely treosulfan 5 gram/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053800 | Product containing precisely treosulfan 5 gram/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2053803 | Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053803 | Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2053806 | Sodium valproate 400 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2053806 | Sodium valproate 400 mg powder for solution for injection vial | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053806 | Sodium valproate 400 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2053807 | Product containing precisely vecuronium bromide 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053807 | Product containing precisely vecuronium bromide 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2053808 | Product containing precisely vinblastine sulfate 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053808 | Product containing precisely vinblastine sulfate 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2053818 | Salbutamol (as salbutamol sulfate) 100 microgram/actuation pressurized suspension for inhalation | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053818 | Salbutamol (as salbutamol sulfate) 100 microgram/actuation pressurized suspension for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053818 | Salbutamol (as salbutamol sulfate) 100 microgram/actuation pressurized suspension for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053818 | Salbutamol (as salbutamol sulfate) 100 microgram/actuation pressurized suspension for inhalation | British preferred term (PTGB) | NO | |
| RxCUI: 2053818 | Salbutamol (as salbutamol sulfate) 100 microgram/actuation pressurized suspension for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053819 | Salbutamol (as salbutamol sulfate) 95 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053819 | Salbutamol (as salbutamol sulfate) 95 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053819 | Salbutamol (as salbutamol sulfate) 95 microgram/actuation powder for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053822 | Beclometasone dipropionate 100 microgram/actuation powder for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053822 | Beclometasone dipropionate 100 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053822 | Beclometasone dipropionate 100 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053823 | Beclometasone dipropionate 200 microgram/actuation powder for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053823 | Beclometasone dipropionate 200 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053823 | Beclometasone dipropionate 200 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053824 | Beclometasone dipropionate 200 microgram/actuation pressurized solution for inhalation | British preferred term (PTGB) | NO | |
| RxCUI: 2053824 | Beclometasone dipropionate 200 microgram/actuation pressurized solution for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053824 | Beclometasone dipropionate 200 microgram/actuation pressurized solution for inhalation | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053824 | Beclometasone dipropionate 200 microgram/actuation pressurized solution for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053824 | Beclometasone dipropionate 200 microgram/actuation pressurized solution for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053825 | Beclometasone dipropionate 250 microgram/actuation powder for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053825 | Beclometasone dipropionate 250 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053825 | Beclometasone dipropionate 250 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053826 | Beclometasone dipropionate 250 microgram/actuation pressurized solution for inhalation | British preferred term (PTGB) | NO | |
| RxCUI: 2053826 | Beclometasone dipropionate 250 microgram/actuation pressurized solution for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053826 | Beclometasone dipropionate 250 microgram/actuation pressurized solution for inhalation | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053826 | Beclometasone dipropionate 250 microgram/actuation pressurized solution for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053826 | Beclometasone dipropionate 250 microgram/actuation pressurized solution for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053827 | Beclometasone dipropionate 400 microgram/actuation powder for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053827 | Beclometasone dipropionate 400 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053827 | Beclometasone dipropionate 400 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053828 | Beclometasone dipropionate 50 microgram/actuation powder for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053828 | Beclometasone dipropionate 50 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053828 | Beclometasone dipropionate 50 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053829 | Beclometasone dipropionate 50 microgram/actuation pressurized solution for inhalation | British preferred term (PTGB) | NO | |
| RxCUI: 2053829 | Beclometasone dipropionate 50 microgram/actuation pressurized solution for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053829 | Beclometasone dipropionate 50 microgram/actuation pressurized solution for inhalation | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053829 | Beclometasone dipropionate 50 microgram/actuation pressurized solution for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053829 | Beclometasone dipropionate 50 microgram/actuation pressurized solution for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053831 | Budesonide 100 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053831 | Budesonide 100 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053832 | Budesonide 100 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053832 | Budesonide 100 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053833 | Budesonide 200 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053833 | Budesonide 200 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053835 | Codeine phosphate 600 microgram/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2053835 | Codeine phosphate 600 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2053836 | Dexamethasone (as dexamethasone sodium phosphate) 400 microgram/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2053836 | Dexamethasone (as dexamethasone sodium phosphate) 400 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2053838 | Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | British preferred term (PTGB) | NO | |
| RxCUI: 2053838 | Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053838 | Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053839 | Fluticasone propionate 125 microgram/actuation pressurised suspension for inhalation | British preferred term (PTGB) | NO | |
| RxCUI: 2053839 | Fluticasone propionate 125 microgram/actuation pressurised suspension for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053839 | Fluticasone propionate 125 microgram/actuation pressurised suspension for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053840 | Fluticasone propionate 25 microgram/actuation pressurized suspension for inhalation | British preferred term (PTGB) | NO | |
| RxCUI: 2053840 | Fluticasone propionate 25 microgram/actuation pressurized suspension for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053840 | Fluticasone propionate 25 microgram/actuation pressurized suspension for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053841 | Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | British preferred term (PTGB) | NO | |
| RxCUI: 2053841 | Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053841 | Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053842 | Fluticasone propionate 250 microgram/actuation pressurized suspension for inhalation | British preferred term (PTGB) | NO | |
| RxCUI: 2053842 | Fluticasone propionate 250 microgram/actuation pressurized suspension for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053842 | Fluticasone propionate 250 microgram/actuation pressurized suspension for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053843 | Fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | British preferred term (PTGB) | NO | |
| RxCUI: 2053843 | Fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053843 | Fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053844 | Fluticasone propionate 50 microgram/actuation pressurized suspension for inhalation | British preferred term (PTGB) | NO | |
| RxCUI: 2053844 | Fluticasone propionate 50 microgram/actuation pressurized suspension for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053844 | Fluticasone propionate 50 microgram/actuation pressurized suspension for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053845 | Fluticasone propionate 500 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053845 | Fluticasone propionate 500 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053848 | Formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053848 | Formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053849 | Ipratropium bromide 20 microgram/actuation pressurised solution for inhalation | British preferred term (PTGB) | NO | |
| RxCUI: 2053849 | Ipratropium bromide 20 microgram/actuation pressurised solution for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053849 | Ipratropium bromide 20 microgram/actuation pressurised solution for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053850 | Ipratropium bromide 40 microgram/actuation pressurised solution for inhalation | British preferred term (PTGB) | NO | |
| RxCUI: 2053850 | Ipratropium bromide 40 microgram/actuation pressurised solution for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053850 | Ipratropium bromide 40 microgram/actuation pressurised solution for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053851 | Methadone hydrochloride 400 microgram/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2053851 | Methadone hydrochloride 400 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2053852 | Mometasone furoate 200 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053852 | Mometasone furoate 200 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053853 | Mometasone furoate 400 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053853 | Mometasone furoate 400 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053854 | Mometasone furoate 50 microgram/actuation nasal spray | Designated preferred name (PT) | NO | |
| RxCUI: 2053854 | Mometasone furoate 50 microgram/actuation nasal spray | Full form of descriptor (FN) | NO | |
| RxCUI: 2053855 | Pholcodine 400 microgram/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2053855 | Pholcodine 400 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2053857 | Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2053857 | Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | British preferred term (PTGB) | NO | |
| RxCUI: 2053857 | Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2053862 | Product containing precisely tazarotene 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053862 | Product containing precisely tazarotene 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2053864 | glycol salicylate 35 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2053865 | menthol 35 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2053866 | glycol salicylate / menthol Medicated Patch | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2053867 | glycol salicylate 35 MG / menthol 35 MG Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2053867 | glycol salicylate 35 MG / menthol 35 MG Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2053870 | Substance with receptor activator of nuclear factor kappa-B ligand inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2053870 | Substance with receptor activator of nuclear factor kappa-B ligand inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2053870 | Substance with receptor activator of nuclear factor kappa-B ligand inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2053870 | Substance with receptor activator of nuclear factor kappa-B ligand inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053870 | Substance with receptor activator of nuclear factor kappa-B ligand inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2053873 | Product containing precisely calcium carbonate 50 milligram/1 milliliter and light kaolin 100 milligram/1 milliliter conventional release oral suspension (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2053873 | Product containing precisely calcium carbonate 50 milligram/1 milliliter and light kaolin 100 milligram/1 milliliter conventional release oral suspension (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2053874 | Human rhinovirus antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053874 | Human rhinovirus antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 2053874 | Human rhinovirus antigen | Designated preferred name (PT) | NO | |
| RxCUI: 2053874 | Human rhinovirus antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053892 | Streptococcus pneumoniae Danish serotype 1 capsular polysaccharide Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053892 | Streptococcus pneumoniae Danish serotype 1 capsular polysaccharide Ag | Full form of descriptor (FN) | NO | |
| RxCUI: 2053892 | Streptococcus pneumoniae Danish serotype 1 capsular polysaccharide Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053892 | Streptococcus pneumoniae Danish serotype 1 capsular polysaccharide Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053892 | Streptococcus pneumoniae Danish serotype 1 capsular polysaccharide Ag | Designated preferred name (PT) | NO | |
| RxCUI: 2053894 | Streptococcus pneumoniae Danish serotype 14 capsular polysaccharide Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053894 | Streptococcus pneumoniae Danish serotype 14 capsular polysaccharide Ag | Full form of descriptor (FN) | NO | |
| RxCUI: 2053894 | Streptococcus pneumoniae Danish serotype 14 capsular polysaccharide Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053894 | Streptococcus pneumoniae Danish serotype 14 capsular polysaccharide Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053894 | Streptococcus pneumoniae Danish serotype 14 capsular polysaccharide Ag | Designated preferred name (PT) | NO | |
| RxCUI: 2053897 | Streptococcus pneumoniae Danish serotype 3 capsular polysaccharide Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053897 | Streptococcus pneumoniae Danish serotype 3 capsular polysaccharide Ag | Full form of descriptor (FN) | NO | |
| RxCUI: 2053897 | Streptococcus pneumoniae Danish serotype 3 capsular polysaccharide Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053897 | Streptococcus pneumoniae Danish serotype 3 capsular polysaccharide Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053897 | Streptococcus pneumoniae Danish serotype 3 capsular polysaccharide Ag | Designated preferred name (PT) | NO | |
| RxCUI: 2053899 | Streptococcus pneumoniae Danish serotype 4 capsular polysaccharide Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053899 | Streptococcus pneumoniae Danish serotype 4 capsular polysaccharide Ag | Full form of descriptor (FN) | NO | |
| RxCUI: 2053899 | Streptococcus pneumoniae Danish serotype 4 capsular polysaccharide Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053899 | Streptococcus pneumoniae Danish serotype 4 capsular polysaccharide Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053899 | Streptococcus pneumoniae Danish serotype 4 capsular polysaccharide Ag | Designated preferred name (PT) | NO | |
| RxCUI: 2053901 | Streptococcus pneumoniae Danish serotype 8 capsular polysaccharide Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053901 | Streptococcus pneumoniae Danish serotype 8 capsular polysaccharide Ag | Full form of descriptor (FN) | NO | |
| RxCUI: 2053901 | Streptococcus pneumoniae Danish serotype 8 capsular polysaccharide Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053901 | Streptococcus pneumoniae Danish serotype 8 capsular polysaccharide Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053901 | Streptococcus pneumoniae Danish serotype 8 capsular polysaccharide Ag | Designated preferred name (PT) | NO | |
| RxCUI: 2053902 | Streptococcus pneumoniae Danish serotype 7A capsular polysaccharide Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053902 | Streptococcus pneumoniae Danish serotype 7A capsular polysaccharide Ag | Full form of descriptor (FN) | NO | |
| RxCUI: 2053902 | Streptococcus pneumoniae Danish serotype 7A capsular polysaccharide Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053902 | Streptococcus pneumoniae Danish serotype 7A capsular polysaccharide Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053902 | Streptococcus pneumoniae Danish serotype 7A capsular polysaccharide Ag | Designated preferred name (PT) | NO | |
| RxCUI: 2053914 | Elaeagnus angustifolia pollen | Designated preferred name (PT) | NO | |
| RxCUI: 2053914 | Elaeagnus angustifolia pollen | Full form of descriptor (FN) | NO | |
| RxCUI: 2053918 | Radioisotope labeled cholecystokinin | Designated preferred name (PT) | NO | |
| RxCUI: 2053918 | Radioisotope labeled cholecystokinin | Full form of descriptor (FN) | NO | |
| RxCUI: 2053918 | Radioisotope labeled cholecystokinin | British preferred term (PTGB) | NO | |
| RxCUI: 2053921 | Metronidazole-containing product in dental dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053921 | Metronidazole-containing product in dental dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053922 | Adrenaline-containing product in dental dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2053922 | Adrenaline-containing product in dental dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2053922 | Adrenaline-containing product in dental dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2053926 | sodium zirconium cyclosilicate 10000 MG [Lokelma] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2053927 | Lokelma 10 GM Powder for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2053927 | Lokelma 10 GM Powder for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053927 | Lokelma 10 GM Powder for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2053927 | Lokelma 10 GM Powder for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2054023 | tafenoquine | Full form of descriptor (FN) | YES | |
| RxCUI: 2054023 | tafenoquine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2054023 | tafenoquine | Designated preferred name (PT) | YES | |
| RxCUI: 2054023 | tafenoquine | Full form of descriptor (FN) | YES | |
| RxCUI: 2054023 | tafenoquine | Designated preferred name (PT) | YES | |
| RxCUI: 2054068 | mogamulizumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2054068 | mogamulizumab | Designated preferred name (PT) | YES | |
| RxCUI: 2054068 | mogamulizumab | Full form of descriptor (FN) | YES | |
| RxCUI: 2054068 | mogamulizumab | Designated preferred name (PT) | YES | |
| RxCUI: 2054068 | mogamulizumab | Full form of descriptor (FN) | YES | |
| RxCUI: 2054069 | Cedrus libani whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2054070 | Alnus viridis subsp. crispa leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2054071 | Acer campestre leaf bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2054072 | Cercis siliquastrum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2054073 | Cornus sanguinea whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2054074 | Carpinus betulus flower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2054075 | Citrus limon flowering top oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2054076 | menthol 4 % / methyl salicylate 0.5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2054076 | menthol 4 % / methyl salicylate 0.5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2054076 | menthol 4 % / methyl salicylate 0.5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2054077 | mogamulizumab-kpkc | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2054078 | mogamulizumab-kpkc 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2054079 | mogamulizumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2054079 | mogamulizumab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2054079 | mogamulizumab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2054080 | mogamulizumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2054081 | mogamulizumab-kpkc 20 MG in 5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2054081 | mogamulizumab-kpkc 20 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054081 | mogamulizumab-kpkc 20 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054082 | Poteligeo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2054083 | mogamulizumab-kpkc 4 MG/ML [Poteligeo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2054084 | mogamulizumab Injection [Poteligeo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2054085 | Poteligeo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2054086 | POTELIGEO 20 MG in 5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2054086 | POTELIGEO 20 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054086 | POTELIGEO 20 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054086 | POTELIGEO 20 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054087 | mogamulizumab-kpkc 4 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2054088 | mogamulizumab-kpkc 4 MG/ML Injection [Poteligeo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2054088 | mogamulizumab-kpkc 4 MG/ML Injection [Poteligeo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2054091 | tafenoquine succinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2054091 | tafenoquine succinate | Designated preferred name (PT) | YES | |
| RxCUI: 2054091 | tafenoquine succinate | Full form of descriptor (FN) | YES | |
| RxCUI: 2054092 | tafenoquine 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2054093 | tafenoquine Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2054093 | tafenoquine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2054093 | tafenoquine Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2054094 | tafenoquine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2054095 | tafenoquine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2054096 | tafenoquine 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054096 | tafenoquine 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054096 | tafenoquine 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2054097 | Arakoda | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2054098 | tafenoquine 100 MG [Arakoda] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2054099 | tafenoquine Oral Tablet [Arakoda] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2054100 | Arakoda Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2054101 | Arakoda Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2054102 | Arakoda 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054102 | Arakoda 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054102 | Arakoda 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2054103 | direct blue 2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2054104 | nonanoic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2054104 | nonanoic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2054105 | pelargonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2054107 | glycopyrronium Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2054108 | glycopyrronium Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2054108 | glycopyrronium Topical Product | Designated preferred name (PT) | YES | |
| RxCUI: 2054108 | glycopyrronium Topical Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2054109 | glycopyrronium Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2054111 | Qbrexza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2054113 | glycopyrronium Medicated Pad [Qbrexza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2054114 | Qbrexza Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2054115 | Qbrexza Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2054117 | glycopyrronium 24 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2054118 | glycopyrronium 2.4 % Medicated Cloth | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054118 | glycopyrronium 2.4 % Medicated Cloth | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054118 | glycopyrronium 2.4 % Medicated Cloth | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2054119 | glycopyrronium 24 MG/ML [Qbrexza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2054120 | Qbrexza 2.4 % Medicated Cloth | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2054120 | Qbrexza 2.4 % Medicated Cloth | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054120 | Qbrexza 2.4 % Medicated Cloth | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054120 | Qbrexza 2.4 % Medicated Cloth | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054122 | Vitamin D analog | Designated preferred name (PT) | NO | |
| RxCUI: 2054122 | Vitamin D analog | Full form of descriptor (FN) | NO | |
| RxCUI: 2054122 | Vitamin D analog | British preferred term (PTGB) | NO | |
| RxCUI: 2054123 | menthol 19.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2054124 | camphor 3.1 % / menthol 1.95 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2054124 | camphor 3.1 % / menthol 1.95 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2054124 | camphor 3.1 % / menthol 1.95 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2054156 | lenvatinib 4 MG Daily Dose 30 Day Supply Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2054156 | lenvatinib 4 MG Daily Dose 30 Day Supply Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054156 | lenvatinib 4 MG Daily Dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054157 | Lenvima 4 MG daily dose 30 Day Supply Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2054157 | Lenvima 4 MG daily dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054157 | Lenvima 4 MG daily dose 30 Day Supply Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054158 | lenvatinib 12 MG Daily Dose 30 Day Supply Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2054158 | lenvatinib 12 MG Daily Dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054158 | lenvatinib 12 MG Daily Dose 30 Day Supply Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054158 | lenvatinib 12 MG Daily Dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054159 | Lenvima 12 MG daily dose 30 Day Supply Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2054159 | Lenvima 12 MG daily dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054159 | Lenvima 12 MG daily dose 30 Day Supply Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054160 | Albuminex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2054162 | albumin human, USP Injection [Albuminex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2054163 | Albuminex Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2054166 | albumin human-kjda | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2054167 | albumin human-kjda 250 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2054168 | albumin human-kjda 25 % in 50 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2054168 | albumin human-kjda 25 % in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054168 | albumin human-kjda 25 % in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054168 | albumin human-kjda 25 % in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054169 | albumin human-kjda 250 MG/ML [Albuminex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2054170 | ALBUMINEX 25 % in 50 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2054170 | ALBUMINEX 25 % in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054170 | ALBUMINEX 25 % in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054170 | ALBUMINEX 25 % in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054171 | albumin human-kjda 250 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2054172 | albumin human-kjda 250 MG/ML Injection [Albuminex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2054173 | albumin human-kjda 25 % in 100 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2054173 | albumin human-kjda 25 % in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054173 | albumin human-kjda 25 % in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054173 | albumin human-kjda 25 % in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054174 | ALBUMINEX 25 % in 100 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2054174 | ALBUMINEX 25 % in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054174 | ALBUMINEX 25 % in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054174 | ALBUMINEX 25 % in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054177 | Antigen of Influenza B virus B/Colorado/06/2017 (B/Victoria/2/87 lineage)-like virus strain split virion hemagglutinin | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2054177 | Antigen of Influenza B virus B/Colorado/06/2017 (B/Victoria/2/87 lineage)-like virus strain split virion hemagglutinin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2054177 | Antigen of Influenza B virus B/Colorado/06/2017 (B/Victoria/2/87 lineage)-like virus strain split virion hemagglutinin | Full form of descriptor (FN) | NO | |
| RxCUI: 2054177 | Antigen of Influenza B virus B/Colorado/06/2017 (B/Victoria/2/87 lineage)-like virus strain split virion hemagglutinin | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2054177 | Antigen of Influenza B virus B/Colorado/06/2017 (B/Victoria/2/87 lineage)-like virus strain split virion hemagglutinin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2054177 | Antigen of Influenza B virus B/Colorado/06/2017 (B/Victoria/2/87 lineage)-like virus strain split virion hemagglutinin | Full form of descriptor (FN) | NO | |
| RxCUI: 2054177 | Antigen of Influenza B virus B/Colorado/06/2017 (B/Victoria/2/87 lineage)-like virus strain split virion hemagglutinin | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2054177 | Antigen of Influenza B virus B/Colorado/06/2017 (B/Victoria/2/87 lineage)-like virus strain split virion hemagglutinin | British preferred term (PTGB) | NO | |
| RxCUI: 2054177 | Antigen of Influenza B virus B/Colorado/06/2017 (B/Victoria/2/87 lineage)-like virus strain split virion hemagglutinin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2054177 | Antigen of Influenza B virus B/Colorado/06/2017 (B/Victoria/2/87 lineage)-like virus strain split virion hemagglutinin | Designated preferred name (PT) | NO | |
| RxCUI: 2054177 | Antigen of Influenza B virus B/Colorado/06/2017 (B/Victoria/2/87 lineage)-like virus strain split virion hemagglutinin | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2054177 | Antigen of Influenza B virus B/Colorado/06/2017 (B/Victoria/2/87 lineage)-like virus strain split virion hemagglutinin | British preferred term (PTGB) | NO | |
| RxCUI: 2054177 | Antigen of Influenza B virus B/Colorado/06/2017 (B/Victoria/2/87 lineage)-like virus strain split virion hemagglutinin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2054177 | Antigen of Influenza B virus B/Colorado/06/2017 (B/Victoria/2/87 lineage)-like virus strain split virion hemagglutinin | Designated preferred name (PT) | NO | |
| RxCUI: 2054177 | Antigen of Influenza B virus B/Colorado/06/2017 (B/Victoria/2/87 lineage)-like virus strain split virion hemagglutinin | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2054180 | influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen / influenza B virus B/Colorado/06/2017 antigen / influenza B virus B/Phuket/3073/2013 antigen | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2054182 | Flumist Quadrivalent 2018-2019 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2054184 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [Flumist Quadrivalent 2018-2019] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2054185 | Flumist Quadrivalent 2018-2019 Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2054186 | Flumist Quadrivalent 2018-2019 Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2054188 | Lactobacillus crispatus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2054215 | European hazel flower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2054215 | European hazel flower bud extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2054220 | albumin human-kjda 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2054221 | albumin human-kjda 5 % in 250 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2054221 | albumin human-kjda 5 % in 250 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054221 | albumin human-kjda 5 % in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054221 | albumin human-kjda 5 % in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054222 | albumin human-kjda 50 MG/ML [Albuminex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2054223 | ALBUMINEX 5 % in 250 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2054223 | ALBUMINEX 5 % in 250 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054223 | ALBUMINEX 5 % in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054223 | ALBUMINEX 5 % in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054224 | albumin human-kjda 50 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2054225 | albumin human-kjda 50 MG/ML Injection [Albuminex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2054226 | albumin human-kjda 5 % in 500 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2054226 | albumin human-kjda 5 % in 500 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054226 | albumin human-kjda 5 % in 500 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054226 | albumin human-kjda 5 % in 500 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054227 | ALBUMINEX 5 % in 500 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2054227 | ALBUMINEX 5 % in 500 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054227 | ALBUMINEX 5 % in 500 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054227 | ALBUMINEX 5 % in 500 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054252 | Migalastat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2054252 | Migalastat | Designated preferred name (PT) | YES | |
| RxCUI: 2054252 | Migalastat | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2054252 | Migalastat | Full form of descriptor (FN) | YES | |
| RxCUI: 2054252 | Migalastat | Designated preferred name (PT) | YES | |
| RxCUI: 2054252 | Migalastat | Full form of descriptor (FN) | YES | |
| RxCUI: 2054253 | migalastat 123 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2054253 | migalastat 123 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2054254 | migalastat Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2054254 | migalastat Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2054254 | migalastat Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2054254 | migalastat Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2054255 | migalastat Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2054255 | migalastat Pill | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2054256 | migalastat Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2054256 | migalastat Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2054257 | migALAstat 123 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 2054257 | migALAstat 123 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054257 | migALAstat 123 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2054257 | migALAstat 123 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054257 | migALAstat 123 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2054257 | migALAstat 123 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2054257 | migALAstat 123 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2054258 | Galafold | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2054259 | migalastat 123 MG [Galafold] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2054259 | migalastat 123 MG [Galafold] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2054260 | migalastat Oral Capsule [Galafold] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2054260 | migalastat Oral Capsule [Galafold] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2054261 | Galafold Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2054262 | Galafold Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2054263 | Galafold 123 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054263 | Galafold 123 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2054263 | Galafold 123 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054263 | Galafold 123 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054263 | Galafold 123 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2054263 | Galafold 123 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2054264 | Migalastat hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2054264 | Migalastat hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 2054264 | Migalastat hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2054264 | Migalastat hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 2054265 | Juniperus communis stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2054266 | migALAstat 123 MG 28 Day (4 Week) Wallet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054266 | migALAstat 123 MG 28 Day (4 Week) Wallet Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2054266 | migALAstat 123 MG 28 Day (4 Week) Wallet Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2054266 | migALAstat 123 MG 28 Day (4 Week) Wallet Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2054266 | migALAstat 123 MG 28 Day (4 Week) Wallet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054268 | valbenazine 40 MG / 80 MG Starter Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2054268 | valbenazine 40 MG / 80 MG Starter Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054268 | valbenazine 40 MG / 80 MG Starter Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054269 | INGREZZA 40 MG / 80 MG Starter Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2054269 | INGREZZA 40 MG / 80 MG Starter Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054269 | INGREZZA 40 MG / 80 MG Starter Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054270 | influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2054271 | influenza B virus B/Colorado/06/2017 antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2054272 | influenza virus vaccine 2018-2019 Quadrivalent Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2054272 | influenza virus vaccine 2018-2019 Quadrivalent Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2054272 | influenza virus vaccine 2018-2019 Quadrivalent Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2054273 | influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Colorado/06/2017 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML [Flumist Quadrivalent 2018-2019] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2054274 | FluMist Quadrivalent, 2018-2019 Formula Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2054274 | FluMist Quadrivalent, 2018-2019 Formula Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2054274 | FluMist Quadrivalent, 2018-2019 Formula Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2054275 | Galafold 123 MG 28 Day (4 Week) Wallet Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2054275 | Galafold 123 MG 28 Day (4 Week) Wallet Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2054275 | Galafold 123 MG 28 Day (4 Week) Wallet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054275 | Galafold 123 MG 28 Day (4 Week) Wallet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054280 | Free L-carnitine | Designated preferred name (PT) | NO | |
| RxCUI: 2054280 | Free L-carnitine | Full form of descriptor (FN) | NO | |
| RxCUI: 2054281 | Free carnitine | Designated preferred name (PT) | NO | |
| RxCUI: 2054281 | Free carnitine | Full form of descriptor (FN) | NO | |
| RxCUI: 2054285 | Mycoprotein | Designated preferred name (PT) | NO | |
| RxCUI: 2054285 | Mycoprotein | Full form of descriptor (FN) | NO | |
| RxCUI: 2054290 | Vitamin B12 supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2054290 | Vitamin B12 supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2054291 | Vitamin B6 supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2054291 | Vitamin B6 supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2054292 | Vitamin C supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2054292 | Vitamin C supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2054293 | Vitamin D supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2054293 | Vitamin D supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2054294 | Vitamin E supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2054294 | Vitamin E supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2054295 | Vitamin K supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2054295 | Vitamin K supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2054296 | Vitamin supplement | Designated preferred name (PT) | NO | |
| RxCUI: 2054296 | Vitamin supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 2054298 | Lithium fumes | Designated preferred name (PT) | NO | |
| RxCUI: 2054298 | Lithium fumes | Full form of descriptor (FN) | NO | |
| RxCUI: 205430 | deserpidine 0.25 MG Oral Tablet [Harmonyl] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205430 | deserpidine 0.25 MG Oral Tablet [Harmonyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2054304 | Hydrocotyle vulgaris whole | Designated preferred name (PT) | NO | |
| RxCUI: 2054304 | Hydrocotyle vulgaris whole | Full form of descriptor (FN) | NO | |
| RxCUI: 2054309 | estradiol 4 MCG (8) Vaginal Insert Maintenance Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2054309 | estradiol 4 MCG (8) Vaginal Insert Maintenance Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054309 | estradiol 4 MCG (8) Vaginal Insert Maintenance Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054310 | Imvexxy 4 MCG Maintenance Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2054310 | Imvexxy 4 MCG Maintenance Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054310 | Imvexxy 4 MCG Maintenance Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054312 | estradiol 4 MCG (18) Vaginal Insert Starter Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2054312 | estradiol 4 MCG (18) Vaginal Insert Starter Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054312 | estradiol 4 MCG (18) Vaginal Insert Starter Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054313 | Imvexxy 4 MCG Starter Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2054313 | Imvexxy 4 MCG Starter Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054313 | Imvexxy 4 MCG Starter Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054315 | estradiol 10 MCG 8 Vaginal Insert Maintenance Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2054315 | estradiol 10 MCG 8 Vaginal Insert Maintenance Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054315 | estradiol 10 MCG 8 Vaginal Insert Maintenance Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054316 | Imvexxy 10 MCG Maintenance Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2054316 | Imvexxy 10 MCG Maintenance Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054316 | Imvexxy 10 MCG Maintenance Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054317 | estradiol 10 MCG (18) Vaginal Insert Starter Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2054317 | estradiol 10 MCG (18) Vaginal Insert Starter Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054317 | estradiol 10 MCG (18) Vaginal Insert Starter Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054318 | Imvexxy 10 MCG Starter Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2054318 | Imvexxy 10 MCG Starter Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054318 | Imvexxy 10 MCG Starter Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 20545 | Cephaelin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 20545 | Cephaelin | Designated preferred name (PT) | NO | |
| RxCUI: 20545 | Cephaelin | Full form of descriptor (FN) | NO | |
| RxCUI: 20545 | Cephaelin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 20545 | Cephaelin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 20547 | Cefalonium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 20547 | Cefalonium | Designated preferred name (PT) | NO | |
| RxCUI: 20547 | Cefalonium | Full form of descriptor (FN) | NO | |
| RxCUI: 205474 | deserpidine 0.125 MG / hydrochlorothiazide 25 MG Oral Tablet [Oreticyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205474 | deserpidine 0.125 MG / hydrochlorothiazide 25 MG Oral Tablet [Oreticyl] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205474 | deserpidine 0.125 MG / hydrochlorothiazide 25 MG Oral Tablet [Oreticyl] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205474 | deserpidine 0.125 MG / hydrochlorothiazide 25 MG Oral Tablet [Oreticyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205474 | deserpidine 0.125 MG / hydrochlorothiazide 25 MG Oral Tablet [Oreticyl] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205476 | deserpidine 0.125 MG / hydrochlorothiazide 50 MG Oral Tablet [Oreticyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205476 | deserpidine 0.125 MG / hydrochlorothiazide 50 MG Oral Tablet [Oreticyl] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205476 | deserpidine 0.125 MG / hydrochlorothiazide 50 MG Oral Tablet [Oreticyl] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205476 | deserpidine 0.125 MG / hydrochlorothiazide 50 MG Oral Tablet [Oreticyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205476 | deserpidine 0.125 MG / hydrochlorothiazide 50 MG Oral Tablet [Oreticyl] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205478 | deserpidine 0.25 MG / hydrochlorothiazide 25 MG Oral Tablet [Oreticyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205478 | deserpidine 0.25 MG / hydrochlorothiazide 25 MG Oral Tablet [Oreticyl] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205478 | deserpidine 0.25 MG / hydrochlorothiazide 25 MG Oral Tablet [Oreticyl] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205478 | deserpidine 0.25 MG / hydrochlorothiazide 25 MG Oral Tablet [Oreticyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205478 | deserpidine 0.25 MG / hydrochlorothiazide 25 MG Oral Tablet [Oreticyl] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205480 | deserpidine 0.25 MG / methyclothiazide 5 MG Oral Tablet [Enduronyl] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205480 | deserpidine 0.25 MG / methyclothiazide 5 MG Oral Tablet [Enduronyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205481 | Rhinocort 32 MCG/ACTUAT Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205481 | Rhinocort 32 MCG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205481 | Rhinocort 32 MCG/ACTUAT Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205481 | Rhinocort 32 MCG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205482 | deserpidine 0.5 MG / methyclothiazide 5 MG Oral Tablet [Enduronyl] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205482 | deserpidine 0.5 MG / methyclothiazide 5 MG Oral Tablet [Enduronyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205483 | Dritho-Scalp 0.5 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205483 | Dritho-Scalp 0.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205483 | Dritho-Scalp 0.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205483 | Dritho-Scalp 0.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205484 | anthralin 5 MG/ML Topical Cream [Drithocreme] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205484 | anthralin 5 MG/ML Topical Cream [Drithocreme] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205484 | anthralin 5 MG/ML Topical Cream [Drithocreme] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205484 | anthralin 5 MG/ML Topical Cream [Drithocreme] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205485 | dextrothyroxine 1 MG Oral Tablet [Choloxin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205485 | dextrothyroxine 1 MG Oral Tablet [Choloxin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205486 | bumetanide 0.25 MG/ML Injectable Solution [Bumex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205486 | bumetanide 0.25 MG/ML Injectable Solution [Bumex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205487 | dextrothyroxine 4 MG Oral Tablet [Choloxin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205487 | dextrothyroxine 4 MG Oral Tablet [Choloxin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205488 | Bumex 0.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205488 | Bumex 0.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205488 | Bumex 0.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205489 | Bumex 1 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205489 | Bumex 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205489 | Bumex 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205490 | Bumex 2 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205490 | Bumex 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205490 | Bumex 2 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205491 | dirithromycin 250 MG Delayed Release Oral Tablet [Dynabac] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205491 | dirithromycin 250 MG Delayed Release Oral Tablet [Dynabac] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205494 | Drithocreme 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205494 | Drithocreme 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205494 | Drithocreme 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205494 | Drithocreme 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205494 | Drithocreme 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205495 | MICANOL 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205495 | MICANOL 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205495 | MICANOL 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054968 | Stiripentol | Full form of descriptor (FN) | YES | |
| RxCUI: 2054968 | Stiripentol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2054968 | Stiripentol | Designated preferred name (PT) | YES | |
| RxCUI: 2054968 | Stiripentol | Full form of descriptor (FN) | YES | |
| RxCUI: 2054968 | Stiripentol | Designated preferred name (PT) | YES | |
| RxCUI: 2054969 | stiripentol 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 205497 | dezocine 5 MG/ML Injectable Solution [Dalgan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205497 | dezocine 5 MG/ML Injectable Solution [Dalgan] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2054970 | stiripentol Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2054970 | stiripentol Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2054970 | stiripentol Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2054971 | stiripentol Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2054972 | stiripentol Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2054973 | stiripentol 250 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2054973 | stiripentol 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054973 | stiripentol 250 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 2054973 | stiripentol 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2054974 | Diacomit | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2054975 | stiripentol 250 MG [Diacomit] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2054976 | stiripentol Oral Capsule [Diacomit] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2054977 | Diacomit Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2054978 | Diacomit Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2054979 | DIACOMIT 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054979 | DIACOMIT 250 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054979 | DIACOMIT 250 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2054980 | stiripentol 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2054981 | stiripentol 500 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2054981 | stiripentol 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054981 | stiripentol 500 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 2054981 | stiripentol 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2054982 | stiripentol 500 MG [Diacomit] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2054983 | DIACOMIT 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054983 | DIACOMIT 500 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054983 | DIACOMIT 500 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2054984 | lusutrombopag | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2054984 | lusutrombopag | Designated preferred name (PT) | YES | |
| RxCUI: 2054984 | lusutrombopag | Full form of descriptor (FN) | YES | |
| RxCUI: 2054984 | lusutrombopag | Designated preferred name (PT) | YES | |
| RxCUI: 2054984 | lusutrombopag | Full form of descriptor (FN) | YES | |
| RxCUI: 2054985 | lusutrombopag 3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2054986 | lusutrombopag Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2054986 | lusutrombopag Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2054986 | lusutrombopag Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2054987 | lusutrombopag Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2054988 | lusutrombopag Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2054989 | lusutrombopag 3 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054989 | lusutrombopag 3 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2054990 | Mulpleta | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2054991 | lusutrombopag 3 MG [Mulpleta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2054992 | lusutrombopag Oral Tablet [Mulpleta] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2054993 | Mulpleta Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2054994 | Mulpleta Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2054995 | MULPLETA 3 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2054995 | MULPLETA 3 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2054995 | MULPLETA 3 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2054996 | cellaburate (MW 12000, 32 & butyryl, 18 % acetyl) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2054997 | distearyl pentaerythritol diphosphite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2054998 | Ligustrum vulgare whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2054999 | potassium tartrate hemihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2055000 | Quercus robur flower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2055001 | Opuntia ficus-indica seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2055002 | Plantanus orientalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2055003 | Populus nigra leaf bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2055004 | Altreno | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2055005 | tretinoin 0.5 MG/ML [Altreno] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2055006 | tretinoin Topical Lotion [Altreno] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2055007 | Altreno Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2055008 | Altreno 0.05 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055008 | Altreno 0.05 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055008 | Altreno 0.05 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055008 | Altreno 0.05 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2055009 | stiripentol Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2055010 | stiripentol Powder for Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2055011 | stiripentol 500 MG Powder for Oral Suspension | Full form of descriptor (FN) | YES | |
| RxCUI: 2055011 | stiripentol 500 MG Powder for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055011 | stiripentol 500 MG Powder for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2055011 | stiripentol 500 MG Powder for Oral Suspension | Designated preferred name (PT) | YES | |
| RxCUI: 2055012 | stiripentol Powder for Oral Suspension [Diacomit] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2055013 | Diacomit Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2055014 | DIACOMIT 500 MG Powder for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055014 | DIACOMIT 500 MG Powder for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055014 | DIACOMIT 500 MG Powder for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2055015 | stiripentol 250 MG Powder for Oral Suspension | Full form of descriptor (FN) | YES | |
| RxCUI: 2055015 | stiripentol 250 MG Powder for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055015 | stiripentol 250 MG Powder for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2055015 | stiripentol 250 MG Powder for Oral Suspension | Designated preferred name (PT) | YES | |
| RxCUI: 2055016 | DIACOMIT 250 MG Powder for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055016 | DIACOMIT 250 MG Powder for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055016 | DIACOMIT 250 MG Powder for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2055019 | cycloSPORINE 0.9 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2055019 | cycloSPORINE 0.9 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055020 | cycloSPORINE Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2055020 | cycloSPORINE Ophthalmic Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055021 | cycloSPORINE 0.09 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055021 | cycloSPORINE 0.09 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055021 | cycloSPORINE 0.09 % Ophthalmic Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055021 | cycloSPORINE 0.09 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2055021 | cycloSPORINE 0.09 % Ophthalmic Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055022 | Cequa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2055023 | cycloSPORINE 0.9 MG/ML [Cequa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2055023 | cycloSPORINE 0.9 MG/ML [Cequa] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055024 | cycloSPORINE Ophthalmic Solution [Cequa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2055024 | cycloSPORINE Ophthalmic Solution [Cequa] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055025 | Cequa Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2055026 | Cequa 0.09 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055026 | Cequa 0.09 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055026 | Cequa 0.09 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055026 | Cequa 0.09 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2055026 | Cequa 0.09 % Ophthalmic Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055027 | Flucelvax Quadrivalent 2018-2019 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2055029 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax Quadrivalent 2018-2019] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2055030 | Flucelvax Quadrivalent 2018-2019 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2055031 | FLUCELVAX Quadrivalent 2018-2019 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2055031 | FLUCELVAX Quadrivalent 2018-2019 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2055031 | FLUCELVAX Quadrivalent 2018-2019 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2055032 | influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2018-2019] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2055033 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flucelvax Quadrivalent 2018-2019] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2055034 | FLUCELVAX Quadrivalent 2018-2019 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2055034 | FLUCELVAX Quadrivalent 2018-2019 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2055034 | FLUCELVAX Quadrivalent 2018-2019 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2055035 | leucovorin 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2055036 | leucovorin 500 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055036 | leucovorin 500 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055036 | leucovorin 500 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205508 | anthralin 0.001 MG/MG Topical Ointment [Anthra-Derm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205508 | anthralin 0.001 MG/MG Topical Ointment [Anthra-Derm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205508 | anthralin 0.001 MG/MG Topical Ointment [Anthra-Derm] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 20551 | Cephalosporin-C deacetylase | Designated preferred name (PT) | NO | |
| RxCUI: 20551 | Cephalosporin-C deacetylase | Full form of descriptor (FN) | NO | |
| RxCUI: 2055101 | Aloe arborescens whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2055102 | Loeselia mexicana whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2055103 | ticovirimat monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2055104 | Product containing tecovirimat (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 2055104 | Product containing tecovirimat (medicinal product) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2055104 | Product containing tecovirimat (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 2055104 | Product containing tecovirimat (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 2055104 | Product containing tecovirimat (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 2055105 | tecovirimat 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2055106 | Product containing tecovirimat in oral dose form (medicinal product form) | Full form of descriptor (FN) | YES | |
| RxCUI: 2055106 | Product containing tecovirimat in oral dose form (medicinal product form) | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2055106 | Product containing tecovirimat in oral dose form (medicinal product form) | Designated preferred name (PT) | YES | |
| RxCUI: 2055107 | tecovirimat Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2055108 | tecovirimat Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2055109 | tecovirimat 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055109 | tecovirimat 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2055110 | Tpoxx | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2055111 | tecovirimat 200 MG [Tpoxx] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2055112 | tecovirimat Oral Capsule [Tpoxx] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2055113 | Tpoxx Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2055114 | Tpoxx Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2055115 | TPOXX 200 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2055115 | TPOXX 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055115 | TPOXX 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205513 | anthralin 0.01 MG/MG Topical Ointment [Anthra-Derm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205513 | anthralin 0.01 MG/MG Topical Ointment [Anthra-Derm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205513 | anthralin 0.01 MG/MG Topical Ointment [Anthra-Derm] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205517 | anthralin 0.0025 MG/MG Topical Ointment [Anthra-Derm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205517 | anthralin 0.0025 MG/MG Topical Ointment [Anthra-Derm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205517 | anthralin 0.0025 MG/MG Topical Ointment [Anthra-Derm] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205521 | desogestrel 0.15 MG / ethinyl estradiol 0.03 MG Oral Tablet [Desogen (contraceptive)] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2055268 | qing feng teng stem extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2055268 | qing feng teng stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2055269 | hydroxypropyl cellulose (90000 WAMW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2055270 | lauroyl/myristoyl methyl glucamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2055271 | lysophosphatidylcholine, soybean | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2055272 | Alpinia officinarum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2055273 | Cinnamomum cassia twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2055274 | Cuminum cyminum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2055275 | Dipsacus chinensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 205528 | desonide 0.5 MG/ML Topical Cream [Delonide] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205528 | desonide 0.5 MG/ML Topical Cream [Delonide] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205528 | desonide 0.5 MG/ML Topical Cream [Delonide] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2055280 | loteprednol etabonate 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2055281 | loteprednol etabonate 1 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055281 | loteprednol etabonate 1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055281 | loteprednol etabonate 1 % Ophthalmic Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2055282 | Inveltys | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2055283 | loteprednol etabonate 10 MG/ML [Inveltys] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2055284 | loteprednol etabonate Ophthalmic Suspension [Inveltys] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2055285 | Inveltys Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2055286 | INVELTYS 1 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055286 | INVELTYS 1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055286 | INVELTYS 1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055286 | INVELTYS 1 % Ophthalmic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2055287 | camphor 3.5 % / menthol 5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2055287 | camphor 3.5 % / menthol 5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2055287 | camphor 3.5 % / menthol 5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2055288 | salicylic acid 0.003 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2055289 | salicylic acid 0.3 % Medicated Bar Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2055289 | salicylic acid 0.3 % Medicated Bar Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2055289 | salicylic acid 0.3 % Medicated Bar Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205529 | Desowen 0.05 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205529 | Desowen 0.05 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205529 | Desowen 0.05 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205529 | Desowen 0.05 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055290 | salicylic acid 29 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2055291 | salicylic acid 2.9 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2055291 | salicylic acid 2.9 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2055291 | salicylic acid 2.9 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2055292 | alpha-tocopherol acetate 0.0014 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2055293 | silicon dioxide 0.08 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2055294 | alpha tocopherol / silicon dioxide Dental Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2055295 | alpha tocopherol / silicon dioxide Oral Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2055296 | alpha tocopherol / silicon dioxide Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2055297 | alpha tocopherol / silicon dioxide Toothpaste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2055298 | alpha tocopherol / silicon dioxide Toothpaste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2055299 | alpha tocopherol / silicon dioxide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 205530 | DesOwen 0.05 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205530 | DesOwen 0.05 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205530 | DesOwen 0.05 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205530 | DesOwen 0.05 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055300 | alpha-Tocopherol acetate 0.14 % / silicon dioxide 8 % MG/MG Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2055300 | alpha-Tocopherol acetate 0.14 % / silicon dioxide 8 % MG/MG Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2055300 | alpha-Tocopherol acetate 0.14 % / silicon dioxide 8 % MG/MG Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2055303 | Mitigo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2055304 | morphine sulfate 10 MG/ML [Mitigo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2055305 | morphine Injection [Mitigo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2055306 | Mitigo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2055307 | MITIGO 200 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055307 | MITIGO 200 MG in 20 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2055307 | MITIGO 200 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055307 | MITIGO 200 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055307 | MITIGO 200 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055308 | morphine sulfate 10 MG/ML Injection [Mitigo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2055308 | morphine sulfate 10 MG/ML Injection [Mitigo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2055308 | morphine sulfate 10 MG/ML Injection [Mitigo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205531 | desonide 0.0005 MG/MG Topical Ointment [Tridesilon] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205531 | desonide 0.0005 MG/MG Topical Ointment [Tridesilon] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205531 | desonide 0.0005 MG/MG Topical Ointment [Tridesilon] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2055310 | morphine sulfate 25 MG/ML [Mitigo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2055311 | MITIGO 500 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055311 | MITIGO 500 MG in 20 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2055311 | MITIGO 500 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055311 | MITIGO 500 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055311 | MITIGO 500 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055312 | morphine sulfate 25 MG/ML Injection [Mitigo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2055312 | morphine sulfate 25 MG/ML Injection [Mitigo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2055312 | morphine sulfate 25 MG/ML Injection [Mitigo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2055315 | salicylic acid 1 % Medicated Liquid Soap (150 ML) / salicylic acid 1 % Topical Cream (35 ML) / salicylic acid 0.5 % Topical Cream (60 ML) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2055315 | salicylic acid 1 % Medicated Liquid Soap (150 ML) / salicylic acid 1 % Topical Cream (35 ML) / salicylic acid 0.5 % Topical Cream (60 ML) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205532 | PULMOZYME 1 MG/ML Inhalation Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205532 | PULMOZYME 1 MG/ML Inhalation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205532 | PULMOZYME 1 MG/ML Inhalation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205533 | Buprenex 0.3 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205533 | Buprenex 0.3 MG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205533 | Buprenex 0.3 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205533 | Buprenex 0.3 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205533 | Buprenex 0.3 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205534 | Desowen 0.05 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205534 | Desowen 0.05 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205534 | Desowen 0.05 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205534 | Desowen 0.05 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205535 | PROzac 10 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205535 | PROzac 10 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 205535 | PROzac 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205535 | PROzac 10 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 205535 | PROzac 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205535 | PROzac 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205535 | PROzac 10 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 205536 | doxacurium 1 MG/ML Injectable Solution [Nuromax] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205536 | doxacurium 1 MG/ML Injectable Solution [Nuromax] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205537 | Halotestin 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205537 | Halotestin 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205537 | Halotestin 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205541 | Ogen 0.625 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205541 | Ogen 0.625 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205541 | Ogen 0.625 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205541 | Ogen 0.625 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205542 | estropipate 0.75 MG Oral Tablet [Ortho-Est] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205542 | estropipate 0.75 MG Oral Tablet [Ortho-Est] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205542 | estropipate 0.75 MG Oral Tablet [Ortho-Est] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205544 | Cardura 8 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205544 | Cardura 8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205544 | Cardura 8 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205544 | Cardura 8 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205553 | guaifenesin 300 MG Extended Release Oral Capsule [Humibid Pediatric] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205553 | guaifenesin 300 MG Extended Release Oral Capsule [Humibid Pediatric] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205553 | guaifenesin 300 MG Extended Release Oral Capsule [Humibid Pediatric] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205562 | Emcyt 140 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205562 | Emcyt 140 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205562 | Emcyt 140 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2055635 | aluminum chloride Mucous Membrane Topical Solution [Gingi-Aid] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2055636 | Gingi-Aid Mucosal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2055637 | Gingi-Aid 25 % Mucous Membrane Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2055637 | Gingi-Aid 25 % Mucous Membrane Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2055637 | Gingi-Aid 25 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2055637 | Gingi-Aid 25 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2055640 | lanadelumab-flyo | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2055641 | lanadelumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2055641 | lanadelumab | Designated preferred name (PT) | YES | |
| RxCUI: 2055641 | lanadelumab | Full form of descriptor (FN) | YES | |
| RxCUI: 2055641 | lanadelumab | Designated preferred name (PT) | YES | |
| RxCUI: 2055641 | lanadelumab | Full form of descriptor (FN) | YES | |
| RxCUI: 2055642 | lanadelumab-flyo 150 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2055643 | lanadelumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2055643 | lanadelumab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2055643 | lanadelumab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2055644 | lanadelumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2055645 | lanadelumab-flyo 300 MG in 2 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2055645 | lanadelumab-flyo 300 MG in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055645 | lanadelumab-flyo 300 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055646 | Takhzyro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2055647 | lanadelumab-flyo 150 MG/ML [Takhzyro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2055648 | lanadelumab Injection [Takhzyro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2055649 | Takhzyro Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 205565 | guaifenesin 200 MG Oral Tablet [Breonesin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205565 | guaifenesin 200 MG Oral Tablet [Breonesin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205565 | guaifenesin 200 MG Oral Tablet [Breonesin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2055650 | TAKHZYRO 300 MG in 2 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2055650 | TAKHZYRO 300 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055650 | TAKHZYRO 300 MG in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055650 | TAKHZYRO 300 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055651 | lanadelumab-flyo 150 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2055652 | lanadelumab-flyo 150 MG/ML Injection [Takhzyro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2055652 | lanadelumab-flyo 150 MG/ML Injection [Takhzyro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2055654 | antihemophilic factor (recombinant), PEGylated-aucl | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2055655 | antihemophilic factor (recombinant) pegylated (damoctocog alfa pegol) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055655 | antihemophilic factor (recombinant) pegylated (damoctocog alfa pegol) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2055655 | antihemophilic factor (recombinant) pegylated (damoctocog alfa pegol) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055656 | antihemophilic factor (recombinant), PEGylated-aucl 1 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2055657 | damoctocog alfa pegol Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2055658 | damoctocog alfa pegol Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2055659 | antihemophilic factor (recombinant), PEGylated-aucl 1 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055659 | antihemophilic factor (recombinant), PEGylated-aucl 1 UNT Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205566 | guaifenesin 200 MG Oral Tablet [GG 200 NR] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205566 | guaifenesin 200 MG Oral Tablet [GG 200 NR] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205566 | guaifenesin 200 MG Oral Tablet [GG 200 NR] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2055660 | Jivi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2055661 | antihemophilic factor (recombinant), PEGylated-aucl 1 UNT [Jivi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2055662 | damoctocog alfa pegol Injection [Jivi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2055663 | Jivi Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2055664 | Jivi 1 UNT Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2055664 | Jivi 1 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055664 | Jivi 1 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055665 | risperiDONE 150 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2055665 | risperiDONE 150 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055666 | risperiDONE Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2055666 | risperiDONE Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055667 | risperiDONE 120 MG in 0.8 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2055667 | risperiDONE 120 MG in 0.8 mL Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055667 | risperiDONE 120 MG in 0.8 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055667 | risperiDONE 120 MG in 0.8 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055667 | risperiDONE 120 MG in 0.8 mL Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055668 | Perseris | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2055669 | risperiDONE 150 MG/ML [Perseris] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2055669 | risperiDONE 150 MG/ML [Perseris] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 205567 | guaifenesin 200 MG Oral Tablet [Glytuss] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205567 | guaifenesin 200 MG Oral Tablet [Glytuss] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205567 | guaifenesin 200 MG Oral Tablet [Glytuss] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2055670 | risperiDONE Prefilled Syringe [Perseris] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2055670 | risperiDONE Prefilled Syringe [Perseris] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055671 | Perseris Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2055672 | PERSERIS 120 MG in 0.8 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055672 | PERSERIS 120 MG in 0.8 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2055672 | PERSERIS 120 MG in 0.8 mL Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055672 | PERSERIS 120 MG in 0.8 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055672 | PERSERIS 120 MG in 0.8 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055673 | risperiDONE 150 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2055673 | risperiDONE 150 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2055674 | risperidone 150 MG/ML Prefilled Syringe [Perseris] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2055674 | risperidone 150 MG/ML Prefilled Syringe [Perseris] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2055674 | risperidone 150 MG/ML Prefilled Syringe [Perseris] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2055675 | risperiDONE 90 MG in 0.6 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2055675 | risperiDONE 90 MG in 0.6 mL Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055675 | risperiDONE 90 MG in 0.6 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055675 | risperiDONE 90 MG in 0.6 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055675 | risperiDONE 90 MG in 0.6 mL Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055676 | PERSERIS 90 MG in 0.6 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055676 | PERSERIS 90 MG in 0.6 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2055676 | PERSERIS 90 MG in 0.6 mL Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055676 | PERSERIS 90 MG in 0.6 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055676 | PERSERIS 90 MG in 0.6 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055677 | tecovirimat monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 205568 | guaifenesin 200 MG Oral Tablet [Iodrol NR] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205568 | guaifenesin 200 MG Oral Tablet [Iodrol NR] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205568 | guaifenesin 200 MG Oral Tablet [Iodrol NR] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205570 | guaifenesin 200 MG Oral Tablet [Organidin NR] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205570 | guaifenesin 200 MG Oral Tablet [Organidin NR] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205570 | guaifenesin 200 MG Oral Tablet [Organidin NR] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205574 | Halotestin 2 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205574 | Halotestin 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205574 | Halotestin 2 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2055742 | Tamarix gallica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2055743 | Sorbus domestica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2055746 | Sequoiadendron giganteum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2055747 | quaternium-53 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2055748 | Ulmus glabra whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2055749 | Viscum album stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2055750 | Viburnum lantana flower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2055751 | bacitracin 500 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT / pramoxine HCl 10 MG per GM Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2055751 | bacitracin 500 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT / pramoxine HCl 10 MG per GM Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2055751 | bacitracin 500 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT / pramoxine HCl 10 MG per GM Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2055752 | turpentine 300 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2055753 | methyl salicylate / turpentine Topical Oil | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2055754 | methyl salicylate 28 % / turpentine 30 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2055754 | methyl salicylate 28 % / turpentine 30 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2055754 | methyl salicylate 28 % / turpentine 30 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2055755 | Doravirine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2055755 | Doravirine | Designated preferred name (PT) | YES | |
| RxCUI: 2055755 | Doravirine | Full form of descriptor (FN) | YES | |
| RxCUI: 2055755 | Doravirine | Designated preferred name (PT) | YES | |
| RxCUI: 2055755 | Doravirine | Full form of descriptor (FN) | YES | |
| RxCUI: 2055756 | doravirine 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2055757 | Doravirine-containing product in oral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2055757 | Doravirine-containing product in oral dose form | Designated preferred name (PT) | YES | |
| RxCUI: 2055757 | Doravirine-containing product in oral dose form | Full form of descriptor (FN) | YES | |
| RxCUI: 2055758 | doravirine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2055759 | doravirine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 205576 | calcifediol 0.02 MG Oral Capsule [Calderol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205576 | calcifediol 0.02 MG Oral Capsule [Calderol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2055760 | doravirine 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055760 | doravirine 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2055760 | doravirine 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2055760 | doravirine 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2055761 | Pifeltro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2055762 | doravirine 100 MG [Pifeltro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2055763 | doravirine Oral Tablet [Pifeltro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2055764 | Pifeltro Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2055765 | Pifeltro Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2055766 | Pifeltro 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2055766 | Pifeltro 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055766 | Pifeltro 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055767 | doravine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 205577 | calcifediol 0.05 MG Oral Capsule [Calderol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205577 | calcifediol 0.05 MG Oral Capsule [Calderol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205577 | calcifediol 0.05 MG Oral Capsule [Calderol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2055774 | Delstrigo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2055777 | Delstrigo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2055778 | Delstrigo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2055805 | doravirine / lamivudine / tenofovir disoproxil Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2055805 | doravirine / lamivudine / tenofovir disoproxil Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055806 | doravirine / lamivudine / tenofovir disoproxil Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2055806 | doravirine / lamivudine / tenofovir disoproxil Pill | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055807 | doravirine / lamivudine / tenofovir disoproxil Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2055807 | doravirine / lamivudine / tenofovir disoproxil Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055808 | doravirine / lamivudine / tenofovir disoproxil | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2055808 | doravirine / lamivudine / tenofovir disoproxil | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055811 | doravirine / lamivudine / tenofovir disoproxil Oral Tablet [Delstrigo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2055811 | doravirine / lamivudine / tenofovir disoproxil Oral Tablet [Delstrigo] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055813 | doravirine 100 MG / lamiVUDine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055813 | doravirine 100 MG / lamiVUDine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055813 | doravirine 100 MG / lamiVUDine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2055813 | doravirine 100 MG / lamiVUDine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055814 | doravirine 100 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG [Delstrigo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2055814 | doravirine 100 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG [Delstrigo] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055815 | Delstrigo 100 MG / 300 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055815 | Delstrigo 100 MG / 300 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055815 | Delstrigo 100 MG / 300 MG / 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055815 | Delstrigo 100 MG / 300 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055815 | Delstrigo 100 MG / 300 MG / 300 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2055815 | Delstrigo 100 MG / 300 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2055906 | eravacycline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2055906 | eravacycline | Designated preferred name (PT) | YES | |
| RxCUI: 2055906 | eravacycline | Full form of descriptor (FN) | YES | |
| RxCUI: 2055906 | eravacycline | Designated preferred name (PT) | YES | |
| RxCUI: 2055906 | eravacycline | Full form of descriptor (FN) | YES | |
| RxCUI: 2055907 | eravacycline dihydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2055908 | eravacycline 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2055909 | eravacycline Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2055909 | eravacycline Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2055909 | eravacycline Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2055910 | eravacycline Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2055911 | eravacycline 50 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055911 | eravacycline 50 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055911 | eravacycline 50 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2055912 | Xerava | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2055913 | eravacycline 50 MG [Xerava] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2055914 | eravacycline Injection [Xerava] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2055915 | Xerava Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2055916 | XERAVA 50 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2055916 | XERAVA 50 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055916 | XERAVA 50 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055926 | Ethinylestradiol- and segesterone-containing product | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2055926 | Ethinylestradiol- and segesterone-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 2055926 | Ethinylestradiol- and segesterone-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055926 | Ethinylestradiol- and segesterone-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 2055929 | fostamatinib disodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 205595 | dexamethasone acetate 8 MG/ML Injectable Suspension [De-Sone LA] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205595 | dexamethasone acetate 8 MG/ML Injectable Suspension [De-Sone LA] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205595 | dexamethasone acetate 8 MG/ML Injectable Suspension [De-Sone LA] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205596 | dexamethasone acetate 8 MG/ML Injectable Suspension [Decadron-LA] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205596 | dexamethasone acetate 8 MG/ML Injectable Suspension [Decadron-LA] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205596 | dexamethasone acetate 8 MG/ML Injectable Suspension [Decadron-LA] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2055976 | ethinyl estradiol 0.000542 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2055977 | segesterone acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2055977 | segesterone acetate | Designated preferred name (PT) | YES | |
| RxCUI: 2055977 | segesterone acetate | Full form of descriptor (FN) | YES | |
| RxCUI: 2055978 | segesterone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2055978 | segesterone | Designated preferred name (PT) | YES | |
| RxCUI: 2055978 | segesterone | Full form of descriptor (FN) | YES | |
| RxCUI: 2055979 | segesterone acetate 0.00625 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 205598 | dexamethasone acetate 8 MG/ML Injectable Suspension [Dexacort-LA] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205598 | dexamethasone acetate 8 MG/ML Injectable Suspension [Dexacort-LA] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205598 | dexamethasone acetate 8 MG/ML Injectable Suspension [Dexacort-LA] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2055981 | Ethinylestradiol- and segesterone-containing product in vaginal dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2055981 | Ethinylestradiol- and segesterone-containing product in vaginal dose form | Designated preferred name (PT) | YES | |
| RxCUI: 2055981 | Ethinylestradiol- and segesterone-containing product in vaginal dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055981 | Ethinylestradiol- and segesterone-containing product in vaginal dose form | Full form of descriptor (FN) | YES | |
| RxCUI: 2055983 | segesterone acetate 0.15 MG / ethinyl estradiol 0.013 MG per 24HR One Year Vaginal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2055983 | segesterone acetate 0.15 MG / ethinyl estradiol 0.013 MG per 24HR One Year Vaginal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055983 | segesterone acetate 0.15 MG / ethinyl estradiol 0.013 MG per 24HR One Year Vaginal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055984 | Annovera | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2055985 | ethinyl estradiol 0.000542 MG/HR / segesterone acetate 0.00625 MG/HR [Annovera] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2055988 | Annovera Vaginal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2055989 | Annovera 0.15 MG / 0.013 MG per 24HR One Year Vaginal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2055989 | Annovera 0.15 MG / 0.013 MG per 24HR One Year Vaginal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2055989 | Annovera 0.15 MG / 0.013 MG per 24HR One Year Vaginal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2055990 | ethinyl estradiol 0.000542 MG/HR / segesterone acetate 0.00625 MG/HR Vaginal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2055991 | ethinyl estradiol 0.000542 MG/HR / segesterone acetate 0.00625 MG/HR Vaginal System [Annovera] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2056 | Carbonyl hemoglobin | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2056 | Carbonyl hemoglobin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2056 | Carbonyl hemoglobin | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2056 | Carbonyl hemoglobin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2056 | Carbonyl hemoglobin | British preferred term (PTGB) | NO | |
| RxCUI: 2056 | Carbonyl hemoglobin | Designated preferred name (PT) | NO | |
| RxCUI: 2056 | Carbonyl hemoglobin | Full form of descriptor (FN) | NO | |
| RxCUI: 2056 | Carbonyl hemoglobin | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2056 | Carbonyl hemoglobin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205604 | Vibramycin 100 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205604 | Vibramycin 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205604 | Vibramycin 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205604 | Vibramycin 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205606 | DORYX 100 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205606 | DORYX 100 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205606 | DORYX 100 MG Delayed Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2056061 | safflower acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2056062 | citronellyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2056063 | menthol 2.5 MG / pectin 2.8 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056063 | menthol 2.5 MG / pectin 2.8 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2056064 | Luden's Dual Relief | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2056065 | menthol 2.5 MG / pectin 2.8 MG [Luden's Dual Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2056066 | menthol / pectin Oral Lozenge [Luden's Dual Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2056067 | Luden's Dual Relief Lozenge Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2056068 | Luden's Dual Relief Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2056069 | Luden's Dual Relief 2.5 MG / 2.8 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056069 | Luden's Dual Relief 2.5 MG / 2.8 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056069 | Luden's Dual Relief 2.5 MG / 2.8 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2056073 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG per 20 mL Oral Solution) / 1 nighttime (dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG per 20 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2056073 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG per 20 mL Oral Solution) / 1 nighttime (dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG per 20 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2056073 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG per 20 mL Oral Solution) / 1 nighttime (dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG per 20 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056073 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG per 20 mL Oral Solution) / 1 nighttime (dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG per 20 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056073 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG per 20 mL Oral Solution) / 1 nighttime (dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG per 20 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 20561 | Ceramide cholinephosphotransferase | Designated preferred name (PT) | NO | |
| RxCUI: 20561 | Ceramide cholinephosphotransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 205610 | Cordran 0.05 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205610 | Cordran 0.05 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205610 | Cordran 0.05 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205610 | Cordran 0.05 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205611 | flurandrenolide 0.00025 MG/MG Topical Ointment [Cordran] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205611 | flurandrenolide 0.00025 MG/MG Topical Ointment [Cordran] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205611 | flurandrenolide 0.00025 MG/MG Topical Ointment [Cordran] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2056111 | Alpha-aminoadipate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2056111 | Alpha-aminoadipate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205612 | Cordran 0.05 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205612 | Cordran 0.05 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205612 | Cordran 0.05 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205612 | Cordran 0.05 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2056136 | Seproxetine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205614 | Halotestin 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205614 | Halotestin 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205614 | Halotestin 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205615 | doxycycline hyclate 100 MG Oral Tablet [Doxy Lemmon] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205615 | doxycycline hyclate 100 MG Oral Tablet [Doxy Lemmon] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205618 | Vibra-Tabs 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205618 | Vibra-Tabs 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205618 | Vibra-Tabs 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205619 | Monodox 50 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205619 | Monodox 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205619 | Monodox 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205621 | Monodox 100 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205621 | Monodox 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205621 | Monodox 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205621 | Monodox 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205625 | flurbiprofen 50 MG Oral Tablet [Ansaid] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205625 | flurbiprofen 50 MG Oral Tablet [Ansaid] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205626 | Ansaid 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205626 | Ansaid 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205626 | Ansaid 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2056288 | hydrolyzed sheep wool keratin (2000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2056289 | cetromonium methosulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2056290 | cetromonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 205641 | Marinol 2.5 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205641 | Marinol 2.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205641 | Marinol 2.5 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 205641 | Marinol 2.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205641 | Marinol 2.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205642 | Marinol 5 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205642 | Marinol 5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205642 | Marinol 5 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 205642 | Marinol 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205642 | Marinol 5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205643 | AmLactin 12 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205643 | AmLactin 12 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205643 | AmLactin 12 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205643 | AmLactin 12 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205645 | Marinol 10 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205645 | Marinol 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205645 | Marinol 10 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 205645 | Marinol 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205645 | Marinol 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056453 | biotin 2,500 MCG Chewable Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056453 | biotin 2,500 MCG Chewable Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056453 | biotin 2,500 MCG Chewable Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2056454 | cetearyl methicone (15000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2056455 | isostearyl ethylimidazolinium ethosulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2056456 | camphor 0.5 % / menthol 1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2056456 | camphor 0.5 % / menthol 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2056456 | camphor 0.5 % / menthol 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2056457 | camphor 0.059 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2056458 | methyl salicylate 0.046 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2056459 | camphor 5.9 % / menthol 0.8 % / methyl salicylate 4.6 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2056459 | camphor 5.9 % / menthol 0.8 % / methyl salicylate 4.6 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2056459 | camphor 5.9 % / menthol 0.8 % / methyl salicylate 4.6 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205646 | Eulexin 125 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205646 | Eulexin 125 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205646 | Eulexin 125 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2056461 | levothyroxine sodium 0.025 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2056462 | levothyroxine sodium 25 MCG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2056462 | levothyroxine sodium 25 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056462 | levothyroxine sodium 25 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056463 | levothyroxine sodium 0.025 MG/ML [Tirosint] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2056464 | levothyroxine Oral Solution [Tirosint] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2056465 | Tirosint Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2056466 | TIROSINT - SOL 25 MCG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2056466 | TIROSINT - SOL 25 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056466 | TIROSINT - SOL 25 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056467 | levothyroxine sodium 0.05 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2056468 | levothyroxine sodium 50 MCG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2056468 | levothyroxine sodium 50 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056468 | levothyroxine sodium 50 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056469 | levothyroxine sodium 0.05 MG/ML [Tirosint] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2056470 | TIROSINT - SOL 50 MCG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2056470 | TIROSINT - SOL 50 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056470 | TIROSINT - SOL 50 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056471 | levothyroxine sodium 0.075 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2056472 | levothyroxine sodium 75 MCG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2056472 | levothyroxine sodium 75 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056472 | levothyroxine sodium 75 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056473 | levothyroxine sodium 0.075 MG/ML [Tirosint] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2056474 | TIROSINT - SOL 75 MCG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2056474 | TIROSINT - SOL 75 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056474 | TIROSINT - SOL 75 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056475 | levothyroxine sodium 0.088 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2056476 | levothyroxine sodium 88 MCG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2056476 | levothyroxine sodium 88 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056476 | levothyroxine sodium 88 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056477 | levothyroxine sodium 0.088 MG/ML [Tirosint] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2056478 | TIROSINT - SOL 88 MCG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2056478 | TIROSINT - SOL 88 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056478 | TIROSINT - SOL 88 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056479 | levothyroxine sodium 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 205648 | guaifenesin 600 MG Extended Release Oral Tablet [Aquamist] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205648 | guaifenesin 600 MG Extended Release Oral Tablet [Aquamist] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205648 | guaifenesin 600 MG Extended Release Oral Tablet [Aquamist] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2056480 | levothyroxine sodium 100 MCG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2056480 | levothyroxine sodium 100 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056480 | levothyroxine sodium 100 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056481 | levothyroxine sodium 0.1 MG/ML [Tirosint] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2056482 | TIROSINT - SOL 100 MCG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2056482 | TIROSINT - SOL 100 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056482 | TIROSINT - SOL 100 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056483 | levothyroxine sodium 0.112 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2056484 | levothyroxine sodium 112 MCG per 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2056484 | levothyroxine sodium 112 MCG per 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056484 | levothyroxine sodium 112 MCG per 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056485 | levothyroxine sodium 0.112 MG/ML [Tirosint] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2056486 | TIROSINT - SOL 112 MCG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2056486 | TIROSINT - SOL 112 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056486 | TIROSINT - SOL 112 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056487 | levothyroxine sodium 0.125 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2056488 | levothyroxine sodium 125 MCG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2056488 | levothyroxine sodium 125 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056488 | levothyroxine sodium 125 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056489 | levothyroxine sodium 0.125 MG/ML [Tirosint] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 205649 | guaifenesin 600 MG Extended Release Oral Tablet [Bidex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205649 | guaifenesin 600 MG Extended Release Oral Tablet [Bidex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205649 | guaifenesin 600 MG Extended Release Oral Tablet [Bidex] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2056490 | TIROSINT - SOL 125 MCG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2056490 | TIROSINT - SOL 125 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056490 | TIROSINT - SOL 125 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056491 | levothyroxine sodium 0.013 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2056492 | levothyroxine sodium 13 MCG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2056492 | levothyroxine sodium 13 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056492 | levothyroxine sodium 13 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056493 | levothyroxine sodium 0.013 MG/ML [Tirosint] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2056494 | TIROSINT - SOL 13 MCG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2056494 | TIROSINT - SOL 13 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056494 | TIROSINT - SOL 13 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056495 | levothyroxine sodium 0.137 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2056496 | levothyroxine sodium 137 MCG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2056496 | levothyroxine sodium 137 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056496 | levothyroxine sodium 137 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056497 | levothyroxine sodium 0.137 MG/ML [Tirosint] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2056498 | TIROSINT - SOL 137 MCG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2056498 | TIROSINT - SOL 137 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056498 | TIROSINT - SOL 137 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056499 | levothyroxine sodium 0.15 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2056500 | levothyroxine sodium 150 MCG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2056500 | levothyroxine sodium 150 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056501 | levothyroxine sodium 0.15 MG/ML [Tirosint] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2056502 | TIROSINT - SOL 150 MCG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2056502 | TIROSINT - SOL 150 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056502 | TIROSINT - SOL 150 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056503 | levothyroxine sodium 0.175 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2056504 | levothyroxine sodium 175 MCG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2056504 | levothyroxine sodium 175 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056504 | levothyroxine sodium 175 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056505 | levothyroxine sodium 0.175 MG/ML [Tirosint] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2056506 | TIROSINT - SOL 175 MCG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2056506 | TIROSINT - SOL 175 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056506 | TIROSINT - SOL 175 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056507 | levothyroxine sodium 0.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2056508 | levothyroxine sodium 200 MCG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2056508 | levothyroxine sodium 200 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056508 | levothyroxine sodium 200 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056509 | levothyroxine sodium 0.2 MG/ML [Tirosint] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 205651 | guaifenesin 600 MG Extended Release Oral Tablet [Fenex-LA] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205651 | guaifenesin 600 MG Extended Release Oral Tablet [Fenex-LA] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205651 | guaifenesin 600 MG Extended Release Oral Tablet [Fenex-LA] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2056510 | TIROSINT - SOL 200 MCG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2056510 | TIROSINT - SOL 200 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056510 | TIROSINT - SOL 200 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056513 | menthol 2.5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2056513 | menthol 2.5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2056513 | menthol 2.5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205652 | guaifenesin 600 MG Extended Release Oral Tablet [G Bid] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205652 | guaifenesin 600 MG Extended Release Oral Tablet [G Bid] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205652 | guaifenesin 600 MG Extended Release Oral Tablet [G Bid] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2056521 | influenza A virus A/North Carolina/04/2016 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2056522 | influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2056523 | influenza B virus B/Iowa/06/2017 antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2056524 | influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2056525 | influenza B virus B/Singapore/INFTT-16-0610/2016 antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2056526 | influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2056527 | influenza A virus A/North Carolina/04/2016 (H3N2) antigen / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen / influenza B virus B/Iowa/06/2017 antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2056528 | influenza virus vaccine 2018-2019 (quadrivalent - Singapore/North Carolina/Iowa/Singapore) 0.5 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2056528 | influenza virus vaccine 2018-2019 (quadrivalent - Singapore/North Carolina/Iowa/Singapore) 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2056528 | influenza virus vaccine 2018-2019 (quadrivalent - Singapore/North Carolina/Iowa/Singapore) 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2056529 | influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2018-2019] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 205653 | guaifenesin 600 MG Extended Release Oral Tablet [Gua-SR] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205653 | guaifenesin 600 MG Extended Release Oral Tablet [Gua-SR] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205653 | guaifenesin 600 MG Extended Release Oral Tablet [Gua-SR] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2056531 | influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2056533 | influenza virus vaccine 2018-2019 (quadrivalent - Singapore/North Carolina/Iowa/Singapore) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2056533 | influenza virus vaccine 2018-2019 (quadrivalent - Singapore/North Carolina/Iowa/Singapore) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2056533 | influenza virus vaccine 2018-2019 (quadrivalent - Singapore/North Carolina/Iowa/Singapore) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205655 | guaifenesin 600 MG Extended Release Oral Tablet [Guaifenex LA] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205655 | guaifenesin 600 MG Extended Release Oral Tablet [Guaifenex LA] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205655 | guaifenesin 600 MG Extended Release Oral Tablet [Guaifenex LA] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205656 | guaifenesin 600 MG Extended Release Oral Tablet [Humavent LA] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205656 | guaifenesin 600 MG Extended Release Oral Tablet [Humavent LA] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205656 | guaifenesin 600 MG Extended Release Oral Tablet [Humavent LA] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205657 | guaifenesin 600 MG Extended Release Oral Tablet [Humibid L.A.] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205657 | guaifenesin 600 MG Extended Release Oral Tablet [Humibid L.A.] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205657 | guaifenesin 600 MG Extended Release Oral Tablet [Humibid L.A.] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205658 | guaifenesin 600 MG Extended Release Oral Tablet [Humigen LA] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205658 | guaifenesin 600 MG Extended Release Oral Tablet [Humigen LA] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205658 | guaifenesin 600 MG Extended Release Oral Tablet [Humigen LA] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205659 | Liquibid 600 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205659 | Liquibid 600 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205659 | Liquibid 600 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205659 | Liquibid 600 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205659 | Liquibid 600 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205661 | guaifenesin 600 MG Extended Release Oral Tablet [Mucobid-L.A.] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205661 | guaifenesin 600 MG Extended Release Oral Tablet [Mucobid-L.A.] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205661 | guaifenesin 600 MG Extended Release Oral Tablet [Mucobid-L.A.] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205662 | guaifenesin 600 MG Extended Release Oral Tablet [Pneumomist] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205662 | guaifenesin 600 MG Extended Release Oral Tablet [Pneumomist] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205662 | guaifenesin 600 MG Extended Release Oral Tablet [Pneumomist] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205664 | guaifenesin 600 MG Extended Release Oral Tablet [Respa-GF] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205664 | guaifenesin 600 MG Extended Release Oral Tablet [Respa-GF] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205664 | guaifenesin 600 MG Extended Release Oral Tablet [Respa-GF] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205665 | guaifenesin 600 MG Extended Release Oral Tablet [Sinumist] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205665 | guaifenesin 600 MG Extended Release Oral Tablet [Sinumist] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205665 | guaifenesin 600 MG Extended Release Oral Tablet [Sinumist] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205666 | guaifenesin 600 MG Extended Release Oral Tablet [Touro EX] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205666 | guaifenesin 600 MG Extended Release Oral Tablet [Touro EX] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205666 | guaifenesin 600 MG Extended Release Oral Tablet [Touro EX] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2056669 | erenumab-aooe 70 MG in 1 ML Auto-Injector 2-Pack (140 MG Dose) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2056669 | erenumab-aooe 70 MG in 1 ML Auto-Injector 2-Pack (140 MG Dose) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056669 | erenumab-aooe 70 MG in 1 ML Auto-Injector 2-Pack (140 MG Dose) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056670 | Aimovig Autoinjector 2-Pack (140 MG Dose) | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2056670 | Aimovig Autoinjector 2-Pack (140 MG Dose) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056670 | Aimovig Autoinjector 2-Pack (140 MG Dose) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056673 | sodium dithionite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2056680 | erenumab-aooe 70 MG in 1 ML Prefilled Syringe 2-Pack (140 MG Dose) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2056680 | erenumab-aooe 70 MG in 1 ML Prefilled Syringe 2-Pack (140 MG Dose) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2056680 | erenumab-aooe 70 MG in 1 ML Prefilled Syringe 2-Pack (140 MG Dose) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2056681 | Aimovig Prefilled Syringe 2-Pack (140 MG Dose) | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 2056681 | Aimovig Prefilled Syringe 2-Pack (140 MG Dose) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2056681 | Aimovig Prefilled Syringe 2-Pack (140 MG Dose) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205669 | Maxidex 0.1 % Ophthalmic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205669 | Maxidex 0.1 % Ophthalmic Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 205669 | Maxidex 0.1 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205669 | Maxidex 0.1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205669 | Maxidex 0.1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056690 | fremanezumab-vfrm | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2056691 | fremanezumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2056691 | fremanezumab | Designated preferred name (PT) | YES | |
| RxCUI: 2056691 | fremanezumab | Full form of descriptor (FN) | YES | |
| RxCUI: 2056691 | fremanezumab | Designated preferred name (PT) | YES | |
| RxCUI: 2056691 | fremanezumab | Full form of descriptor (FN) | YES | |
| RxCUI: 2056692 | fremanezumab-vfrm 150 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2056693 | fremanezumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2056693 | fremanezumab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2056693 | fremanezumab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2056694 | fremanezumab Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2056695 | fremanezumab-vfrm 225 MG in 1.5 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2056695 | fremanezumab-vfrm 225 MG in 1.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056695 | fremanezumab-vfrm 225 MG in 1.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056696 | Ajovy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2056697 | fremanezumab-vfrm 150 MG/ML [Ajovy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2056698 | fremanezumab Prefilled Syringe [Ajovy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2056699 | Ajovy Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2056700 | AJOVY 225 MG in 1.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056700 | AJOVY 225 MG in 1.5 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2056700 | AJOVY 225 MG in 1.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056700 | AJOVY 225 MG in 1.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056701 | remanezumab-vfrm 150 MG/mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2056701 | remanezumab-vfrm 150 MG/mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2056702 | Ajovy 150 MG/mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2056702 | Ajovy 150 MG/mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2056702 | Ajovy 150 MG/mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205671 | dexamethasone phosphate 1 MG/ML Ophthalmic Solution [AK-Dex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205671 | dexamethasone phosphate 1 MG/ML Ophthalmic Solution [AK-Dex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205671 | dexamethasone phosphate 1 MG/ML Ophthalmic Solution [AK-Dex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205671 | dexamethasone phosphate 1 MG/ML Ophthalmic Solution [AK-Dex] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205673 | dexamethasone phosphate 1 MG/ML Ophthalmic Solution [Dexasol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205673 | dexamethasone phosphate 1 MG/ML Ophthalmic Solution [Dexasol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205673 | dexamethasone phosphate 1 MG/ML Ophthalmic Solution [Dexasol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205673 | dexamethasone phosphate 1 MG/ML Ophthalmic Solution [Dexasol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205674 | droperidol 2.5 MG/ML / fentanyl 0.05 MG/ML Injectable Solution [Innovar] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205674 | droperidol 2.5 MG/ML / fentanyl 0.05 MG/ML Injectable Solution [Innovar] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2056742 | latanoprost Ophthalmic Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2056743 | latanoprost 0.005 % Ophthalmic Emulsion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056743 | latanoprost 0.005 % Ophthalmic Emulsion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056743 | latanoprost 0.005 % Ophthalmic Emulsion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2056744 | Xelpros | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2056745 | latanoprost 0.05 MG/ML [Xelpros] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2056746 | latanoprost Ophthalmic Suspension [Xelpros] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2056747 | Xelpros Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2056748 | Xelprox 0.005 % Ophthalmic Emulsion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2056748 | Xelprox 0.005 % Ophthalmic Emulsion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056748 | Xelprox 0.005 % Ophthalmic Emulsion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056748 | Xelprox 0.005 % Ophthalmic Emulsion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205675 | dexamethasone phosphate 0.0005 MG/MG Ophthalmic Ointment [AK-Dex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205675 | dexamethasone phosphate 0.0005 MG/MG Ophthalmic Ointment [AK-Dex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205675 | dexamethasone phosphate 0.0005 MG/MG Ophthalmic Ointment [AK-Dex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205675 | dexamethasone phosphate 0.0005 MG/MG Ophthalmic Ointment [AK-Dex] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205677 | dexamethasone phosphate 0.0005 MG/MG Ophthalmic Ointment [Dexasol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205677 | dexamethasone phosphate 0.0005 MG/MG Ophthalmic Ointment [Dexasol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205677 | dexamethasone phosphate 0.0005 MG/MG Ophthalmic Ointment [Dexasol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205677 | dexamethasone phosphate 0.0005 MG/MG Ophthalmic Ointment [Dexasol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205682 | amobarbital 100 MG / secobarbital 100 MG Oral Capsule [Tuinal] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205683 | dexamethasone 0.25 MG Oral Tablet [Decadron] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205683 | dexamethasone 0.25 MG Oral Tablet [Decadron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205683 | dexamethasone 0.25 MG Oral Tablet [Decadron] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205685 | amobarbital 200 MG / secobarbital 200 MG Oral Capsule [Tuinal] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205685 | amobarbital 200 MG / secobarbital 200 MG Oral Capsule [Tuinal] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205686 | FORMADON 10 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205686 | FORMADON 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205686 | FORMADON 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205686 | FORMADON 10 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205687 | Lazerformalyde 10 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205687 | Lazerformalyde 10 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205687 | Lazerformalyde 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205687 | Lazerformalyde 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205688 | formaldehyde 100 MG/ML Topical Spray [Formalyde-10] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205688 | formaldehyde 100 MG/ML Topical Spray [Formalyde-10] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205689 | FORMA-RAY 20 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205689 | FORMA-RAY 20 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205689 | FORMA-RAY 20 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205689 | FORMA-RAY 20 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056893 | codeine phosphate 10 MG / chlorpheniramine maleate 4 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2056893 | codeine phosphate 10 MG / chlorpheniramine maleate 4 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056893 | codeine phosphate 10 MG / chlorpheniramine maleate 4 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056894 | everolimus 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2056895 | everolimus 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056895 | everolimus 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2056896 | everolimus 1 MG [Zortress] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2056897 | ZORTRESS 1 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2056897 | ZORTRESS 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056897 | ZORTRESS 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056898 | pemetrexed disodium hemipentahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2056898 | pemetrexed disodium hemipentahydrate | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2056923 | microcrystalline cellulose 102 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2056924 | 2,2',3,3',4,4',5,5',6-nonachlorodiphenyl either | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2056925 | Capparis spinosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2056926 | palonosetron Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2056928 | palonosetron 0.05 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2056929 | palonosetron 0.25 MG in 5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2056929 | palonosetron 0.25 MG in 5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2056929 | palonosetron 0.25 MG in 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2056930 | Burn Jel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2056931 | lidocaine hydrochloride 0.02 MG/MG [Burn Jel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2056932 | lidocaine Topical Gel [Burn Jel] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2056933 | Burn Jel Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2056934 | Burn Jel 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2056934 | Burn Jel 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2056934 | Burn Jel 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2056934 | Burn Jel 2 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205696 | amoxapine 100 MG Oral Tablet [Asendin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205696 | amoxapine 100 MG Oral Tablet [Asendin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205697 | dyphylline 250 MG/ML Injectable Solution [Dilor] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205697 | dyphylline 250 MG/ML Injectable Solution [Dilor] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205698 | dyphylline 250 MG/ML Injectable Solution [Lufyllin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205698 | dyphylline 250 MG/ML Injectable Solution [Lufyllin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205699 | dyphylline 200 MG Oral Tablet [Dilor] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205699 | dyphylline 200 MG Oral Tablet [Dilor] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205700 | Lufyllin 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205700 | Lufyllin 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205700 | Lufyllin 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205701 | dyphylline 200 MG Oral Tablet [Neothylline] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205701 | dyphylline 200 MG Oral Tablet [Neothylline] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205702 | dexamethasone 1 MG/ML Oral Solution [Dexamethasone Intensol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205702 | dexamethasone 1 MG/ML Oral Solution [Dexamethasone Intensol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205702 | dexamethasone 1 MG/ML Oral Solution [Dexamethasone Intensol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205702 | dexamethasone 1 MG/ML Oral Solution [Dexamethasone Intensol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205703 | amoxapine 150 MG Oral Tablet [Asendin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205703 | amoxapine 150 MG Oral Tablet [Asendin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205704 | dyphylline 400 MG Oral Tablet [Dilor] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205704 | dyphylline 400 MG Oral Tablet [Dilor] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205705 | dyphylline 400 MG Oral Tablet [Neothylline] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205705 | dyphylline 400 MG Oral Tablet [Neothylline] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205706 | amoxapine 25 MG Oral Tablet [Asendin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205706 | amoxapine 25 MG Oral Tablet [Asendin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205709 | amoxapine 50 MG Oral Tablet [Asendin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205709 | amoxapine 50 MG Oral Tablet [Asendin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205710 | Decadron 1.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205710 | Decadron 1.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205710 | Decadron 1.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205710 | Decadron 1.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205712 | DECADRON 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205712 | DECADRON 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205712 | DECADRON 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205712 | DECADRON 4 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 205714 | dexamethasone 4 MG Oral Tablet [Hexadrol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205714 | dexamethasone 4 MG Oral Tablet [Hexadrol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205714 | dexamethasone 4 MG Oral Tablet [Hexadrol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057149 | telmisartan 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 205715 | furazolidone 3.33 MG/ML Oral Suspension [Furoxone] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205715 | furazolidone 3.33 MG/ML Oral Suspension [Furoxone] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205715 | furazolidone 3.33 MG/ML Oral Suspension [Furoxone] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057150 | telmisartan Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2057151 | telmisartan Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2057152 | telmisartan 10 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057153 | Semintra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2057154 | telmisartan 10 MG/ML [Semintra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2057155 | telmisartan Oral Solution [Semintra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2057156 | Semintra Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2057157 | Semintra Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2057158 | telmisartan 10 MG/ML Oral Solution [Semintra] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057158 | telmisartan 10 MG/ML Oral Solution [Semintra] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205716 | furazolidone 100 MG Oral Tablet [Furoxone] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205716 | furazolidone 100 MG Oral Tablet [Furoxone] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057160 | camphor 3 % / menthol 7 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057160 | camphor 3 % / menthol 7 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057160 | camphor 3 % / menthol 7 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205717 | DECADRON 6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205717 | DECADRON 6 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205717 | DECADRON 6 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205717 | DECADRON 6 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2057198 | filgrastim-aafi | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2057199 | filgrastim-aafi 0.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 205720 | amoxicillin 250 MG Oral Capsule [Biomox] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205720 | amoxicillin 250 MG Oral Capsule [Biomox] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057200 | filgrastim-aafi 300 MCG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2057200 | filgrastim-aafi 300 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2057200 | filgrastim-aafi 300 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2057200 | filgrastim-aafi 300 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2057201 | Nivestym | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2057202 | filgrastim-aafi 0.6 MG/ML [Nivestym] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2057203 | filgrastim Prefilled Syringe [Nivestym] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2057204 | Nivestym Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2057205 | Nivestym 300 MCG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2057205 | Nivestym 300 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2057205 | Nivestym 300 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2057205 | Nivestym 300 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2057206 | filgrastim-aafi 0.6 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057207 | filgrastim-aafi 0.6 MG/ML Prefilled Syringe [Nivestym] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2057207 | filgrastim-aafi 0.6 MG/ML Prefilled Syringe [Nivestym] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057208 | filgrastim-aafi 0.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2057209 | filgrastim-aafi 300 MCG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2057209 | filgrastim-aafi 300 MCG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2057209 | filgrastim-aafi 300 MCG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2057209 | filgrastim-aafi 300 MCG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205721 | amoxicillin 250 MG Oral Capsule [Senox] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205721 | amoxicillin 250 MG Oral Capsule [Senox] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057210 | filgrastim-aafi 0.3 MG/ML [Nivestym] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2057211 | filgrastim Injection [Nivestym] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2057212 | Nivestym 300 MCG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2057212 | Nivestym 300 MCG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2057212 | Nivestym 300 MCG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2057212 | Nivestym 300 MCG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2057213 | filgrastim-aafi 0.3 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057214 | filgrastim-aafi 0.3 MG/ML Injection [Nivestym] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2057214 | filgrastim-aafi 0.3 MG/ML Injection [Nivestym] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057215 | filgrastim-aafi 480 MCG in 0.8 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2057215 | filgrastim-aafi 480 MCG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2057215 | filgrastim-aafi 480 MCG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2057215 | filgrastim-aafi 480 MCG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2057216 | Nivestym 480 MCG in 0.8 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2057216 | Nivestym 480 MCG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2057216 | Nivestym 480 MCG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2057216 | Nivestym 480 MCG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2057218 | filgrastim-aafi 480 MCG in 1.6 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2057218 | filgrastim-aafi 480 MCG in 1.6 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2057218 | filgrastim-aafi 480 MCG in 1.6 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2057218 | filgrastim-aafi 480 MCG in 1.6 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2057219 | Nivestym 480 MCG in 1.6 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2057219 | Nivestym 480 MCG in 1.6 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2057219 | Nivestym 480 MCG in 1.6 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2057219 | Nivestym 480 MCG in 1.6 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205722 | amoxicillin 250 MG Oral Capsule [Wymox] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205722 | amoxicillin 250 MG Oral Capsule [Wymox] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205723 | amoxicillin 500 MG Oral Capsule [Biomox] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205723 | amoxicillin 500 MG Oral Capsule [Biomox] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205724 | amoxicillin 500 MG Oral Capsule [Wymox] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205724 | amoxicillin 500 MG Oral Capsule [Wymox] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205726 | furosemide 10 MG/ML Oral Solution [Lasix] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205726 | furosemide 10 MG/ML Oral Solution [Lasix] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205728 | furosemide 40 MG Oral Tablet [Lo-Aqua] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205728 | furosemide 40 MG Oral Tablet [Lo-Aqua] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205729 | amoxicillin 50 MG/ML Oral Suspension [Amoxil] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205729 | amoxicillin 50 MG/ML Oral Suspension [Amoxil] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205729 | amoxicillin 50 MG/ML Oral Suspension [Amoxil] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205729 | amoxicillin 50 MG/ML Oral Suspension [Amoxil] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205730 | amoxicillin 50 MG/ML Oral Suspension [Biomox] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205730 | amoxicillin 50 MG/ML Oral Suspension [Biomox] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205731 | amoxicillin 50 MG/ML Oral Suspension [Wymox] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205731 | amoxicillin 50 MG/ML Oral Suspension [Wymox] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205732 | Lasix 80 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205732 | Lasix 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205732 | Lasix 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205733 | ESGIC-PLUS 50 MG / 500 MG / 40 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205733 | ESGIC-PLUS 50 MG / 500 MG / 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205733 | ESGIC-PLUS 50 MG / 500 MG / 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205733 | ESGIC-PLUS 50 MG / 500 MG / 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205734 | amoxicillin 25 MG/ML Oral Suspension [Amoxil] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205734 | amoxicillin 25 MG/ML Oral Suspension [Amoxil] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205734 | amoxicillin 25 MG/ML Oral Suspension [Amoxil] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205735 | amoxicillin 25 MG/ML Oral Suspension [Wymox] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205735 | amoxicillin 25 MG/ML Oral Suspension [Wymox] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205735 | amoxicillin 25 MG/ML Oral Suspension [Wymox] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205736 | corticotropin 40 UNT/ML Injectable Solution [ACTH Gel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205736 | corticotropin 40 UNT/ML Injectable Solution [ACTH Gel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205737 | corticotropin 40 UNT/ML Injectable Solution [ACTH-40 HP] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205737 | corticotropin 40 UNT/ML Injectable Solution [ACTH-40 HP] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205739 | Phospholine Iodide 0.125 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205739 | Phospholine Iodide 0.125 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205739 | Phospholine Iodide 0.125 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205739 | Phospholine Iodide 0.125 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205739 | Phospholine Iodide 0.125 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205740 | echothiophate iodide 2.5 MG/ML Ophthalmic Solution [Phospholine Iodide] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205740 | echothiophate iodide 2.5 MG/ML Ophthalmic Solution [Phospholine Iodide] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205740 | echothiophate iodide 2.5 MG/ML Ophthalmic Solution [Phospholine Iodide] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205743 | Cytovene-IV 500 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205743 | Cytovene-IV 500 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205743 | Cytovene-IV 500 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205743 | Cytovene-IV 500 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205744 | ganciclovir 250 MG Oral Capsule [Cytovene] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205744 | ganciclovir 250 MG Oral Capsule [Cytovene] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205745 | Ethamolin 5 % in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205745 | Ethamolin 5 % in 2 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205745 | Ethamolin 5 % in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205745 | Ethamolin 5 % in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205746 | cimetidine 6 MG/ML Injectable Solution [Tagamet] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205746 | cimetidine 6 MG/ML Injectable Solution [Tagamet] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205746 | cimetidine 6 MG/ML Injectable Solution [Tagamet] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205747 | edetate disodium 150 MG/ML Injectable Solution [Disotate] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205747 | edetate disodium 150 MG/ML Injectable Solution [Disotate] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205750 | gemfibrozil 600 MG Oral Tablet [Gemcor] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205750 | gemfibrozil 600 MG Oral Tablet [Gemcor] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205751 | Lopid 600 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205751 | Lopid 600 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205751 | Lopid 600 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205756 | cinoxacin 250 MG Oral Capsule [Cinobac] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205756 | cinoxacin 250 MG Oral Capsule [Cinobac] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205757 | ethaverine 100 MG Oral Tablet [Ethaquin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205757 | ethaverine 100 MG Oral Tablet [Ethaquin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205758 | ethaverine 100 MG Oral Tablet [Ethatab] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205758 | ethaverine 100 MG Oral Tablet [Ethatab] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205759 | ethaverine 100 MG Oral Tablet [Ethavex-100] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205759 | ethaverine 100 MG Oral Tablet [Ethavex-100] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205760 | ethaverine 100 MG Oral Tablet [Isovex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205760 | ethaverine 100 MG Oral Tablet [Isovex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057662 | Substance with gamma-aminobutyric acid A receptor agonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2057662 | Substance with gamma-aminobutyric acid A receptor agonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2057662 | Substance with gamma-aminobutyric acid A receptor agonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2057662 | Substance with gamma-aminobutyric acid A receptor agonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057662 | Substance with gamma-aminobutyric acid A receptor agonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2057664 | goose feather extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057665 | goose feather extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057665 | goose feather extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057665 | goose feather extract 1 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057665 | goose feather extract 1 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057666 | benzalkonium chloride 0.13 % Medicated Bar Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057666 | benzalkonium chloride 0.13 % Medicated Bar Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057666 | benzalkonium chloride 0.13 % Medicated Bar Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057667 | silk allergenic extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057668 | silk allergenic extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057668 | silk allergenic extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057668 | silk allergenic extract 1 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057668 | silk allergenic extract 1 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057669 | domestic cow skin extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057670 | domestic cow skin extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057670 | domestic cow skin extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057670 | domestic cow skin extract 1 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057670 | domestic cow skin extract 1 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057675 | domestic goat skin extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057676 | domestic goat skin extract 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057676 | domestic goat skin extract 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057676 | domestic goat skin extract 1 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057676 | domestic goat skin extract 1 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057677 | guinea pig skin extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057678 | guinea pig skin extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057678 | guinea pig skin extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057678 | guinea pig skin extract 1 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057678 | guinea pig skin extract 1 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057682 | Orthosiphon aristatus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2057683 | horse skin extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057684 | horse skin extract 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057684 | horse skin extract 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057684 | horse skin extract 1 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057684 | horse skin extract 1 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057687 | horse skin extract 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057688 | horse skin extract 2 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057688 | horse skin extract 2 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057688 | horse skin extract 2 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057688 | horse skin extract 2 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205769 | Cipro 250 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205769 | Cipro 250 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205769 | Cipro 250 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205769 | Cipro 250 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2057699 | chicken feather extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 205770 | Cipro 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205770 | Cipro 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205770 | Cipro 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205770 | Cipro 500 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2057700 | chicken feather extract 1 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057700 | chicken feather extract 1 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057700 | chicken feather extract 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057700 | chicken feather extract 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057708 | parakeet feather allergenic extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057709 | parakeet feather allergenic extract 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057709 | parakeet feather allergenic extract 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057709 | parakeet feather allergenic extract 1 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057709 | parakeet feather allergenic extract 1 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205771 | Cipro 750 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205771 | Cipro 750 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205771 | Cipro 750 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2057714 | parakeet feather allergenic extract 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057715 | parakeet feather allergenic extract 25 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057715 | parakeet feather allergenic extract 25 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057715 | parakeet feather allergenic extract 25 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057715 | parakeet feather allergenic extract 25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057716 | parakeet feather allergenic extract 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057717 | parakeet feather allergenic extract 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057717 | parakeet feather allergenic extract 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057717 | parakeet feather allergenic extract 50 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057717 | parakeet feather allergenic extract 50 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057719 | parakeet feather allergenic extract 10000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057720 | parakeet feather allergenic extract 10000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057720 | parakeet feather allergenic extract 10000 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057720 | parakeet feather allergenic extract 10000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205773 | corticotropin 80 UNT/ML Injectable Solution [ACTH-80] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205773 | corticotropin 80 UNT/ML Injectable Solution [ACTH-80] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2057801 | Caesalpinia spinosa fruit pod extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 205783 | anthralin 0.005 MG/MG Topical Ointment [Anthra-Derm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205783 | anthralin 0.005 MG/MG Topical Ointment [Anthra-Derm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205783 | anthralin 0.005 MG/MG Topical Ointment [Anthra-Derm] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205784 | ethchlorvynol 200 MG Oral Capsule [Placidyl] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205784 | ethchlorvynol 200 MG Oral Capsule [Placidyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205785 | enoxacin 200 MG Oral Tablet [Penetrex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205785 | enoxacin 200 MG Oral Tablet [Penetrex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205786 | enoxacin 400 MG Oral Tablet [Penetrex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205786 | enoxacin 400 MG Oral Tablet [Penetrex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205787 | amphotericin B 30 MG/ML Topical Cream [Fungizone] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205787 | amphotericin B 30 MG/ML Topical Cream [Fungizone] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205787 | amphotericin B 30 MG/ML Topical Cream [Fungizone] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205788 | amphotericin B 30 MG/ML Topical Lotion [Fungizone] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205788 | amphotericin B 30 MG/ML Topical Lotion [Fungizone] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205788 | amphotericin B 30 MG/ML Topical Lotion [Fungizone] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205789 | cisapride 10 MG Oral Tablet [Propulsid] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205789 | cisapride 10 MG Oral Tablet [Propulsid] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205790 | cisapride 20 MG Oral Tablet [Propulsid] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205790 | cisapride 20 MG Oral Tablet [Propulsid] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057909 | Camponotus pennsylvanicus allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2057909 | Camponotus pennsylvanicus allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057910 | hog skin extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057911 | hog skin extract 1 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057911 | hog skin extract 1 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057911 | hog skin extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057911 | hog skin extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057912 | hog skin extract 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057913 | hog skin extract 2 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057913 | hog skin extract 2 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057913 | hog skin extract 2 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057913 | hog skin extract 2 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057914 | Mongolian gerbil skin allergenic extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057915 | Mongolian gerbil skin allergenic extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057915 | Mongolian gerbil skin allergenic extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057915 | Mongolian gerbil skin allergenic extract 1 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057915 | Mongolian gerbil skin allergenic extract 1 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057916 | European rabbit skin extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057917 | European rabbit skin extract 1 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057917 | European rabbit skin extract 1 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057917 | European rabbit skin extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057917 | European rabbit skin extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057918 | hamster skin extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057919 | hamster skin extract 1 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057919 | hamster skin extract 1 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057919 | hamster skin extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057919 | hamster skin extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057920 | house mouse skin extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057921 | house mouse skin extract 1 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057921 | house mouse skin extract 1 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057921 | house mouse skin extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057921 | house mouse skin extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057922 | rat skin extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057923 | rat skin extract 1 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057923 | rat skin extract 1 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057923 | rat skin extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057923 | rat skin extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057924 | canary feather extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057925 | canary feather extract 1 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057925 | canary feather extract 1 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057925 | canary feather extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057925 | canary feather extract 1 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057926 | canary feather extract 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057927 | canary feather extract 50 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057927 | canary feather extract 50 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057927 | canary feather extract 50 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057927 | canary feather extract 50 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057928 | canary feather extract 10000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057929 | canary feather extract 10000 UNT/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057929 | canary feather extract 10000 UNT/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057929 | canary feather extract 10000 UNT/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205793 | gentamicin 0.003 MG/MG Ophthalmic Ointment [Genoptic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205793 | gentamicin 0.003 MG/MG Ophthalmic Ointment [Genoptic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2057930 | mosquito allergenic extract 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057931 | mosquito allergenic extract 25 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057931 | mosquito allergenic extract 25 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057931 | mosquito allergenic extract 25 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057931 | mosquito allergenic extract 25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057932 | cat flea allergenic extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057933 | cat flea allergenic extract 1 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057933 | cat flea allergenic extract 1 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057933 | cat flea allergenic extract 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057933 | cat flea allergenic extract 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057940 | American cockroach allergenic extract 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057941 | German cockroach allergenic extract 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057942 | American cockroach allergenic extract 0.5 MG/ML / German cockroach allergenic extract 0.5 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057942 | American cockroach allergenic extract 0.5 MG/ML / German cockroach allergenic extract 0.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057942 | American cockroach allergenic extract 0.5 MG/ML / German cockroach allergenic extract 0.5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057943 | American cockroach allergenic extract 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057944 | German cockroach allergenic extract 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057945 | American cockroach allergenic extract 25 MG/ML / German cockroach allergenic extract 25 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057945 | American cockroach allergenic extract 25 MG/ML / German cockroach allergenic extract 25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057945 | American cockroach allergenic extract 25 MG/ML / German cockroach allergenic extract 25 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057946 | red imported fire ant allergenic extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057947 | red imported fire ant allergenic extract 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057947 | red imported fire ant allergenic extract 1 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057947 | red imported fire ant allergenic extract 1 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057947 | red imported fire ant allergenic extract 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057948 | black imported fire ant allergenic extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057949 | black imported fire ant allergenic extract 1 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057949 | black imported fire ant allergenic extract 1 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057949 | black imported fire ant allergenic extract 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057949 | black imported fire ant allergenic extract 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205795 | gentamicin 3 MG/ML Ophthalmic Solution [Genoptic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205795 | gentamicin 3 MG/ML Ophthalmic Solution [Genoptic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205795 | gentamicin 3 MG/ML Ophthalmic Solution [Genoptic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2057950 | black imported fire ant allergenic extract 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057951 | black imported fire ant allergenic extract 50 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057951 | black imported fire ant allergenic extract 50 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057951 | black imported fire ant allergenic extract 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057951 | black imported fire ant allergenic extract 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057952 | black carpenter ant allergenic extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057953 | black carpenter ant allergenic extract Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2057954 | black carpenter ant allergenic extract Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2057955 | black carpenter ant allergenic extract 1 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057955 | black carpenter ant allergenic extract 1 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057955 | black carpenter ant allergenic extract 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057955 | black carpenter ant allergenic extract 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057956 | black carpenter ant allergenic extract 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057957 | black carpenter ant allergenic extract 50 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057957 | black carpenter ant allergenic extract 50 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057957 | black carpenter ant allergenic extract 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057957 | black carpenter ant allergenic extract 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057958 | black carpenter ant allergenic extract 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057959 | black carpenter ant allergenic extract 100 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057959 | black carpenter ant allergenic extract 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057959 | black carpenter ant allergenic extract 100 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057959 | black carpenter ant allergenic extract 100 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205796 | gentamicin 3 MG/ML Ophthalmic Solution [Gentacidin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205796 | gentamicin 3 MG/ML Ophthalmic Solution [Gentacidin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2057960 | Seizalam | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2057961 | midazolam 5 MG/ML [Seizalam] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2057962 | midazolam Injectable Solution [Seizalam] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2057963 | Seizalam Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2057964 | Seizalam 5 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2057964 | Seizalam 5 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2057964 | Seizalam 5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2057965 | house fly extract 40000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057966 | house fly extract 40,000 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057966 | house fly extract 40,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057966 | house fly extract 40,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057967 | house fly extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2057968 | house fly extract 1 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2057968 | house fly extract 1 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2057968 | house fly extract 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2057968 | house fly extract 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205797 | gentamicin 3 MG/ML Ophthalmic Solution [Gentak] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205797 | gentamicin 3 MG/ML Ophthalmic Solution [Gentak] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205797 | gentamicin 3 MG/ML Ophthalmic Solution [Gentak] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205798 | gentamicin 3 MG/ML Ophthalmic Solution [Gentasol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205798 | gentamicin 3 MG/ML Ophthalmic Solution [Gentasol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205798 | gentamicin 3 MG/ML Ophthalmic Solution [Gentasol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205799 | gentamicin 1 MG/ML Topical Cream [Ed-Mycin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205799 | gentamicin 1 MG/ML Topical Cream [Ed-Mycin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205799 | gentamicin 1 MG/ML Topical Cream [Ed-Mycin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205800 | gentamicin 1 MG/ML Topical Cream [G-Myticin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205800 | gentamicin 1 MG/ML Topical Cream [G-Myticin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205802 | ethchlorvynol 500 MG Oral Capsule [Placidyl] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205802 | ethchlorvynol 500 MG Oral Capsule [Placidyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205803 | gentamicin 0.001 MG/MG Topical Ointment [G-Myticin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205803 | gentamicin 0.001 MG/MG Topical Ointment [G-Myticin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205803 | gentamicin 0.001 MG/MG Topical Ointment [G-Myticin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205807 | ampicillin 250 MG Oral Capsule [Amficot] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205807 | ampicillin 250 MG Oral Capsule [Amficot] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205808 | ampicillin 250 MG Oral Capsule [Omnipen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205808 | ampicillin 250 MG Oral Capsule [Omnipen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205809 | ampicillin 250 MG Oral Capsule [Principen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205809 | ampicillin 250 MG Oral Capsule [Principen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205810 | ampicillin 250 MG Oral Capsule [Totacillin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205810 | ampicillin 250 MG Oral Capsule [Totacillin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205811 | ampicillin 500 MG Oral Capsule [Marcillin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205811 | ampicillin 500 MG Oral Capsule [Marcillin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205812 | ampicillin 500 MG Oral Capsule [Omnipen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205812 | ampicillin 500 MG Oral Capsule [Omnipen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205813 | ampicillin 500 MG Oral Capsule [Principen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205813 | ampicillin 500 MG Oral Capsule [Principen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205814 | ampicillin 500 MG Oral Capsule [Totacillin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205814 | ampicillin 500 MG Oral Capsule [Totacillin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058144 | riluzole 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2058145 | riluzole Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2058146 | riluzole Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2058147 | riluzole 50 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058147 | riluzole 50 MG in 10 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058147 | riluzole 50 MG in 10 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058147 | riluzole 50 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205815 | ampicillin 25 MG/ML Oral Suspension [Omnipen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205815 | ampicillin 25 MG/ML Oral Suspension [Omnipen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205816 | ampicillin 25 MG/ML Oral Suspension [Principen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205816 | ampicillin 25 MG/ML Oral Suspension [Principen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205817 | ampicillin 25 MG/ML Oral Suspension [Totacillin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205817 | ampicillin 25 MG/ML Oral Suspension [Totacillin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205818 | ampicillin 50 MG/ML Oral Suspension [Omnipen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205818 | ampicillin 50 MG/ML Oral Suspension [Omnipen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205819 | ampicillin 50 MG/ML Oral Suspension [Principen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205819 | ampicillin 50 MG/ML Oral Suspension [Principen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205820 | ampicillin 50 MG/ML Oral Suspension [Totacillin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205820 | ampicillin 50 MG/ML Oral Suspension [Totacillin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205821 | Platinol-AQ 1 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205821 | Platinol-AQ 1 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205821 | Platinol-AQ 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205821 | Platinol-AQ 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205821 | Platinol-AQ 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205821 | Platinol-AQ 1 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205822 | ethchlorvynol 750 MG Oral Capsule [Placidyl] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205822 | ethchlorvynol 750 MG Oral Capsule [Placidyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058253 | cloBAZam 10 MG Oral Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058253 | cloBAZam 10 MG Oral Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058253 | cloBAZam 10 MG Oral Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2058254 | cloBAZam 20 MG Oral Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058254 | cloBAZam 20 MG Oral Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058254 | cloBAZam 20 MG Oral Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2058255 | cloBAZam 5 MG Oral Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058255 | cloBAZam 5 MG Oral Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058255 | cloBAZam 5 MG Oral Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2058256 | buprenorphine 16 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2058257 | buprenorphine HCl 16 MG / naloxone HCl 4 MG Sublingual Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2058257 | buprenorphine HCl 16 MG / naloxone HCl 4 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058257 | buprenorphine HCl 16 MG / naloxone HCl 4 MG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205826 | PRED-G 0.3 % / 1 % Ophthalmic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205826 | PRED-G 0.3 % / 1 % Ophthalmic Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 205826 | PRED-G 0.3 % / 1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205826 | PRED-G 0.3 % / 1 % Ophthalmic Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 205826 | PRED-G 0.3 % / 1 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205826 | PRED-G 0.3 % / 1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205828 | Glucotrol 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205828 | Glucotrol 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 205828 | Glucotrol 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205828 | Glucotrol 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205830 | Glucotrol 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205830 | Glucotrol 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 205830 | Glucotrol 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205830 | Glucotrol 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205832 | ethinyl estradiol 0.02 MG Oral Tablet [Estinyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205832 | ethinyl estradiol 0.02 MG Oral Tablet [Estinyl] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205833 | ampicillin 250 MG/ML Injectable Solution [Omnipen-N] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205833 | ampicillin 250 MG/ML Injectable Solution [Omnipen-N] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205834 | ampicillin 250 MG/ML Injectable Solution [Totacillin-N] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205834 | ampicillin 250 MG/ML Injectable Solution [Totacillin-N] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058420 | bisulfite ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2058423 | Substance with farnesoid X receptor agonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2058423 | Substance with farnesoid X receptor agonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2058423 | Substance with farnesoid X receptor agonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2058423 | Substance with farnesoid X receptor agonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058423 | Substance with farnesoid X receptor agonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 205843 | Unasyn (ampicillin 100 MG / sulbactam 50 MG) per ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205843 | Unasyn (ampicillin 100 MG / sulbactam 50 MG) per ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205843 | Unasyn (ampicillin 100 MG / sulbactam 50 MG) per ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058464 | DOPamine HCl 1600 MCG/mL in 100 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2058464 | DOPamine HCl 1600 MCG/mL in 100 mL Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2058464 | DOPamine HCl 1600 MCG/mL in 100 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058464 | DOPamine HCl 1600 MCG/mL in 100 mL Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2058464 | DOPamine HCl 1600 MCG/mL in 100 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2058464 | DOPamine HCl 1600 MCG/mL in 100 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058464 | DOPamine HCl 1600 MCG/mL in 100 mL Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2058465 | DOPamine HCl 3200 MCG/mL in 100 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2058465 | DOPamine HCl 3200 MCG/mL in 100 mL Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2058465 | DOPamine HCl 3200 MCG/mL in 100 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058465 | DOPamine HCl 3200 MCG/mL in 100 mL Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2058465 | DOPamine HCl 3200 MCG/mL in 100 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2058465 | DOPamine HCl 3200 MCG/mL in 100 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058465 | DOPamine HCl 3200 MCG/mL in 100 mL Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2058469 | DOPamine HCl 0.8 MG/mL in 100 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2058469 | DOPamine HCl 0.8 MG/mL in 100 mL Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2058469 | DOPamine HCl 0.8 MG/mL in 100 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2058469 | DOPamine HCl 0.8 MG/mL in 100 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058469 | DOPamine HCl 0.8 MG/mL in 100 mL Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2058470 | milbemycin oxime / praziquantel Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2058471 | milbemycin oxime / praziquantel Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2058472 | milbemycin oxime / praziquantel Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2058473 | milbemycin oxime / praziquantel Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2058474 | milbemycin oxime / praziquantel | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2058475 | milbemycin oxime 2.3 MG / praziquantel 22.8 MG Chewable Table | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2058475 | milbemycin oxime 2.3 MG / praziquantel 22.8 MG Chewable Table | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2058476 | Interceptor Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2058477 | milbemycin oxime 2.3 MG / praziquantel 22.8 MG [Interceptor Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2058478 | milbemycin oxime / praziquantel Chewable Tablet [Interceptor Plus] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2058479 | Interceptor Plus Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 205848 | ethinyl estradiol 0.05 MG Oral Tablet [Estinyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205848 | ethinyl estradiol 0.05 MG Oral Tablet [Estinyl] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2058480 | Interceptor Plus Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2058481 | Interceptor Plus Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2058482 | INTERCEPTOR PLUS (Dogs 2 - 8 lbs) 2.3 MG / 22.8 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2058482 | INTERCEPTOR PLUS (Dogs 2 - 8 lbs) 2.3 MG / 22.8 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058482 | INTERCEPTOR PLUS (Dogs 2 - 8 lbs) 2.3 MG / 22.8 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2058483 | milbemycin oxime 5.75 MG / praziquantel 57 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2058483 | milbemycin oxime 5.75 MG / praziquantel 57 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2058484 | milbemycin oxime 5.75 MG / praziquantel 57 MG [Interceptor Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2058485 | INTERCEPTOR PLUS (Dogs 8.1 - 25 lbs) 5.75 MG / 57 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2058485 | INTERCEPTOR PLUS (Dogs 8.1 - 25 lbs) 5.75 MG / 57 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058485 | INTERCEPTOR PLUS (Dogs 8.1 - 25 lbs) 5.75 MG / 57 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2058486 | milbemycin oxime 11.5 MG / praziquantel 114 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2058486 | milbemycin oxime 11.5 MG / praziquantel 114 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2058487 | milbemycin oxime 11.5 MG / praziquantel 114 MG [Interceptor Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2058488 | INTERCEPTOR PLUS (Dogs 25.1 - 50 lbs) 11.5 MG / 114 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2058488 | INTERCEPTOR PLUS (Dogs 25.1 - 50 lbs) 11.5 MG / 114 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058488 | INTERCEPTOR PLUS (Dogs 25.1 - 50 lbs) 11.5 MG / 114 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2058489 | milbemycin oxime 23 MG / praziquantel 228 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2058489 | milbemycin oxime 23 MG / praziquantel 228 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2058490 | milbemycin oxime 23 MG / praziquantel 228 MG [Interceptor Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2058491 | INTERCEPTOR PLUS (Dogs 50.1 - 100 lbs) 23 MG / 228 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2058491 | INTERCEPTOR PLUS (Dogs 50.1 - 100 lbs) 23 MG / 228 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058491 | INTERCEPTOR PLUS (Dogs 50.1 - 100 lbs) 23 MG / 228 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2058494 | Mucilin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2058495 | psyllium 2450 MG [Mucilin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2058496 | psyllium Powder for Oral Suspension [Mucilin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2058497 | Mucilin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2058498 | Mucilin Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2058499 | Mucilin 2.45 GM Powder for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058499 | Mucilin 2.45 GM Powder for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058499 | Mucilin 2.45 GM Powder for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 20585 | Cerium nitrate | Designated preferred name (PT) | NO | |
| RxCUI: 20585 | Cerium nitrate | Full form of descriptor (FN) | NO | |
| RxCUI: 20585 | Cerium nitrate | Designated preferred name (PT) | NO | |
| RxCUI: 20585 | Cerium nitrate | Full form of descriptor (FN) | NO | |
| RxCUI: 205850 | epinephrine 5 MG/ML Ophthalmic Solution [Epinal] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205850 | epinephrine 5 MG/ML Ophthalmic Solution [Epinal] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205850 | epinephrine 5 MG/ML Ophthalmic Solution [Epinal] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2058500 | psyllium 3500 MG [Mucilin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2058501 | Mucilin 3.5 GM Powder for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058501 | Mucilin 3.5 GM Powder for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058501 | Mucilin 3.5 GM Powder for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058502 | piperonyl butoxide 0.035 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2058503 | piperonyl butoxide 3.5 % / pyrethrins 0.3 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058503 | piperonyl butoxide 3.5 % / pyrethrins 0.3 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058503 | piperonyl butoxide 3.5 % / pyrethrins 0.3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058504 | Vanalice | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2058505 | piperonyl butoxide 0.035 MG/MG / pyrethrins 0.003 MG/MG [Vanalice] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2058506 | piperonyl butoxide / pyrethrins Topical Gel [Vanalice] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2058507 | Vanalice Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2058508 | VanaLice 3.5 % / 0.03 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058508 | VanaLice 3.5 % / 0.03 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058508 | VanaLice 3.5 % / 0.03 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058509 | Duvelisib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2058509 | Duvelisib | Designated preferred name (PT) | YES | |
| RxCUI: 2058509 | Duvelisib | Full form of descriptor (FN) | YES | |
| RxCUI: 2058509 | Duvelisib | Designated preferred name (PT) | YES | |
| RxCUI: 2058509 | Duvelisib | Full form of descriptor (FN) | YES | |
| RxCUI: 2058510 | duvelisib 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2058511 | Duvelisib-containing product in oral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2058511 | Duvelisib-containing product in oral dose form | Designated preferred name (PT) | YES | |
| RxCUI: 2058511 | Duvelisib-containing product in oral dose form | Full form of descriptor (FN) | YES | |
| RxCUI: 2058512 | duvelisib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2058513 | duvelisib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2058514 | duvelisib 15 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058514 | duvelisib 15 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058515 | Copiktra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2058516 | duvelisib 15 MG [Copiktra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2058517 | duvelisib Oral Capsule [Copiktra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2058518 | Copiktra Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2058519 | Copiktra Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2058520 | Copiktra 15 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058520 | Copiktra 15 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058520 | Copiktra 15 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058522 | duvelisib 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2058523 | duvelisib 25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058523 | duvelisib 25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058524 | duvelisib 25 MG [Copiktra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2058525 | Copiktra 25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058525 | Copiktra 25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058525 | Copiktra 25 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058528 | minocycline 135 MG [Minolira] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2058529 | minolira 135 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058529 | minolira 135 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058529 | minolira 135 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058530 | minocycline 135 MG Extended Release Oral Tablet [Minolira] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2058530 | minocycline 135 MG Extended Release Oral Tablet [Minolira] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058531 | petrolatum 78.5 % / zinc oxide 8 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058531 | petrolatum 78.5 % / zinc oxide 8 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058531 | petrolatum 78.5 % / zinc oxide 8 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058531 | petrolatum 78.5 % / zinc oxide 8 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205854 | inamrinone 5 MG/ML Injectable Solution [Inocor I. V.] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205854 | inamrinone 5 MG/ML Injectable Solution [Inocor I. V.] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205855 | epinephrine 10 MG/ML Ophthalmic Solution [Epinal] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205855 | epinephrine 10 MG/ML Ophthalmic Solution [Epinal] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205855 | epinephrine 10 MG/ML Ophthalmic Solution [Epinal] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205856 | epinephrine 10 MG/ML Ophthalmic Solution [Eppy/N] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205856 | epinephrine 10 MG/ML Ophthalmic Solution [Eppy/N] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205856 | epinephrine 10 MG/ML Ophthalmic Solution [Eppy/N] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205857 | clarithromycin 25 MG/ML Oral Suspension [Biaxin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205857 | clarithromycin 25 MG/ML Oral Suspension [Biaxin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205857 | clarithromycin 25 MG/ML Oral Suspension [Biaxin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205858 | epinephrine 20 MG/ML Ophthalmic Solution [Eppy/N] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205858 | epinephrine 20 MG/ML Ophthalmic Solution [Eppy/N] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205858 | epinephrine 20 MG/ML Ophthalmic Solution [Eppy/N] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205859 | ethinyl estradiol 0.5 MG Oral Tablet [Estinyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205859 | ethinyl estradiol 0.5 MG Oral Tablet [Estinyl] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205860 | Biaxin 250 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205860 | Biaxin 250 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205860 | Biaxin 250 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205860 | Biaxin 250 MG in 5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205862 | epinephrine 5 MG/ML Ophthalmic Solution [Epifrin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205862 | epinephrine 5 MG/ML Ophthalmic Solution [Epifrin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205862 | epinephrine 5 MG/ML Ophthalmic Solution [Epifrin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205863 | Biaxin Filmtab 250 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205863 | Biaxin Filmtab 250 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205863 | Biaxin Filmtab 250 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205864 | epinephrine 10 MG/ML Ophthalmic Solution [Epifrin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205864 | epinephrine 10 MG/ML Ophthalmic Solution [Epifrin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205864 | epinephrine 10 MG/ML Ophthalmic Solution [Epifrin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205865 | epinephrine 10 MG/ML Ophthalmic Solution [Glaucon] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205865 | epinephrine 10 MG/ML Ophthalmic Solution [Glaucon] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205865 | epinephrine 10 MG/ML Ophthalmic Solution [Glaucon] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205866 | Biaxin Filmtab 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205866 | Biaxin Filmtab 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205866 | Biaxin Filmtab 500 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205867 | epinephrine 20 MG/ML Ophthalmic Solution [Epifrin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205867 | epinephrine 20 MG/ML Ophthalmic Solution [Epifrin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205867 | epinephrine 20 MG/ML Ophthalmic Solution [Epifrin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205868 | epinephrine 20 MG/ML Ophthalmic Solution [Glaucon] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205868 | epinephrine 20 MG/ML Ophthalmic Solution [Glaucon] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205868 | epinephrine 20 MG/ML Ophthalmic Solution [Glaucon] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205869 | haloperidol 0.5 MG Oral Tablet [Haldol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205869 | haloperidol 0.5 MG Oral Tablet [Haldol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205871 | epinephrine 1 MG/ML Injectable Solution [Ana-Guard] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205871 | epinephrine 1 MG/ML Injectable Solution [Ana-Guard] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205871 | epinephrine 1 MG/ML Injectable Solution [Ana-Guard] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205872 | DiaBeta 1.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205872 | DiaBeta 1.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205872 | DiaBeta 1.25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205872 | DiaBeta 1.25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205873 | Micronase 1.25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205873 | Micronase 1.25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205873 | Micronase 1.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205873 | Micronase 1.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205875 | DiaBeta 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205875 | DiaBeta 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205875 | DiaBeta 2.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205875 | DiaBeta 2.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205876 | Micronase 2.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205876 | Micronase 2.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205876 | Micronase 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205876 | Micronase 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205878 | epinephrine 5 MG/ML Injectable Suspension [Sus-Phrine Injection] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205878 | epinephrine 5 MG/ML Injectable Suspension [Sus-Phrine Injection] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205878 | epinephrine 5 MG/ML Injectable Suspension [Sus-Phrine Injection] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205879 | DiaBeta 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205879 | DiaBeta 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205879 | DiaBeta 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205879 | DiaBeta 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205880 | Micronase 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205880 | Micronase 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205880 | Micronase 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205880 | Micronase 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205882 | haloperidol 1 MG Oral Tablet [Haldol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205882 | haloperidol 1 MG Oral Tablet [Haldol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2058825 | cemiplimab-rwlc | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2058826 | cemiplimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2058826 | cemiplimab | Designated preferred name (PT) | YES | |
| RxCUI: 2058826 | cemiplimab | Full form of descriptor (FN) | YES | |
| RxCUI: 2058826 | cemiplimab | Designated preferred name (PT) | YES | |
| RxCUI: 2058826 | cemiplimab | Full form of descriptor (FN) | YES | |
| RxCUI: 2058827 | cemiplimab-rwlc 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2058828 | cemiplimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2058829 | cemiplimab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2058829 | cemiplimab Injection | Designated preferred name (PT) | YES | |
| RxCUI: 2058829 | cemiplimab Injection | Full form of descriptor (FN) | YES | |
| RxCUI: 2058830 | cemiplimab-rwlc 350 MG in 7 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058830 | cemiplimab-rwlc 350 MG in 7 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058830 | cemiplimab-rwlc 350 MG in 7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058830 | cemiplimab-rwlc 350 MG in 7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058831 | Libtayo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2058832 | cemiplimab-rwlc 50 MG/ML [Libtayo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2058833 | cemiplimab Injection [Libtayo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2058834 | Libtayo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2058835 | LIBTAYO 350 MG in 7 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058835 | LIBTAYO 350 MG in 7 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058835 | LIBTAYO 350 MG in 7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058835 | LIBTAYO 350 MG in 7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058836 | cemiplimab-rwlc 50 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2058837 | cemiplimab-rwlc 50 MG/ML Injection [Libtayo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2058837 | cemiplimab-rwlc 50 MG/ML Injection [Libtayo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058838 | (1-cyanocyclohexyl)acetic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2058839 | (dibutylamino)methanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 205884 | glycerin 500 MG/ML Oral Solution [Osmoglyn] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205884 | glycerin 500 MG/ML Oral Solution [Osmoglyn] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058840 | 2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-1,2-propanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2058842 | levorphanol tartrate 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2058843 | levorphanol tartrate 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2058843 | levorphanol tartrate 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2058844 | levorphanol tartrate 3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2058845 | levorphanol tartrate 3 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058845 | levorphanol tartrate 3 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058846 | galcanezumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2058846 | galcanezumab | Designated preferred name (PT) | YES | |
| RxCUI: 2058846 | galcanezumab | Full form of descriptor (FN) | YES | |
| RxCUI: 2058846 | galcanezumab | Designated preferred name (PT) | YES | |
| RxCUI: 2058846 | galcanezumab | Full form of descriptor (FN) | YES | |
| RxCUI: 2058847 | microcrystalline cellulose 101 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2058848 | dacomitinib anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2058848 | dacomitinib anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 2058848 | dacomitinib anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 2058849 | dacomitinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2058849 | dacomitinib | Designated preferred name (PT) | YES | |
| RxCUI: 2058849 | dacomitinib | Full form of descriptor (FN) | YES | |
| RxCUI: 2058849 | dacomitinib | Designated preferred name (PT) | YES | |
| RxCUI: 2058849 | dacomitinib | Full form of descriptor (FN) | YES | |
| RxCUI: 205885 | Robinul 0.2 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205885 | Robinul 0.2 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205885 | Robinul 0.2 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058850 | creatine ethyl ester | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2058851 | Ryclora | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2058853 | dexchlorpheniramine Oral Solution [Ryclora] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2058854 | Ryclora Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2058855 | Ryclora Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2058857 | gemcitabine 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2058858 | gemcitabine 1200 MG in 120 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058858 | gemcitabine 1200 MG in 120 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058858 | gemcitabine 1200 MG in 120 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058859 | Infugem | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 205886 | Robinul 1 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205886 | Robinul 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205886 | Robinul 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058860 | gemcitabine 10 MG/ML [Infugem] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2058861 | gemcitabine Injection [Infugem] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2058862 | Infugem Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2058863 | Infugem 1200 MG in 120 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058863 | Infugem 1200 MG in 120 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058863 | Infugem 1200 MG in 120 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058863 | Infugem 1200 MG in 120 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058864 | gemcitabine 10 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2058865 | gemcitabine 10 MG/ML Injection [Infugem] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2058865 | gemcitabine 10 MG/ML Injection [Infugem] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058866 | gemcitabine 1400 MG in 140 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058866 | gemcitabine 1400 MG in 140 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058866 | gemcitabine 1400 MG in 140 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058867 | Infugem 1400 MG in 140 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058867 | Infugem 1400 MG in 140 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058867 | Infugem 1400 MG in 140 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058867 | Infugem 1400 MG in 140 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058868 | galcanezumab-gnlm | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2058869 | galcanezumab-gnlm 120 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2058870 | galcanezumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2058870 | galcanezumab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2058870 | galcanezumab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2058871 | galcanezumab Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2058872 | galcanezumab-gnlm 120 MG in 1 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058872 | galcanezumab-gnlm 120 MG in 1 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058872 | galcanezumab-gnlm 120 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058873 | Emgality | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2058874 | galcanezumab-gnlm 120 MG/ML [Emgality] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2058875 | galcanezumab Auto-Injector [Emgality] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2058876 | Emgality Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2058877 | Emgality 120 MG in 1 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058877 | Emgality 120 MG in 1 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058877 | Emgality 120 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058878 | galcanezumab-gnlm 120 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2058879 | galcanezumab-gnlm 120 MG/ML Auto-Injector [Emgality] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058879 | galcanezumab-gnlm 120 MG/ML Auto-Injector [Emgality] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2058880 | gemcitabine 1500 MG in 150 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058880 | gemcitabine 1500 MG in 150 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058880 | gemcitabine 1500 MG in 150 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058881 | Infugem 1500 MG in 150 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058881 | Infugem 1500 MG in 150 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058881 | Infugem 1500 MG in 150 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058881 | Infugem 1500 MG in 150 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058882 | gemcitabine 1600 MG in 160 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058882 | gemcitabine 1600 MG in 160 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058882 | gemcitabine 1600 MG in 160 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058883 | Infugem 1600 MG in 160 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058883 | Infugem 1600 MG in 160 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058883 | Infugem 1600 MG in 160 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058883 | Infugem 1600 MG in 160 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058884 | galcanezumab Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2058885 | galcanezumab-gnlm 120 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058885 | galcanezumab-gnlm 120 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058885 | galcanezumab-gnlm 120 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058886 | galcanezumab Prefilled Syringe [Emgality] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2058887 | Emgality 120 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058887 | Emgality 120 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058887 | Emgality 120 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058888 | galcanezumab-gnlm 120 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2058889 | galcanezumab-gnlm 120 MG/ML Prefilled Syringe [Emgality] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058889 | galcanezumab-gnlm 120 MG/ML Prefilled Syringe [Emgality] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2058890 | gemcitabine 1700 MG in 170 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058890 | gemcitabine 1700 MG in 170 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058890 | gemcitabine 1700 MG in 170 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058891 | Infugem 1700 MG in 170 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058891 | Infugem 1700 MG in 170 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058891 | Infugem 1700 MG in 170 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058891 | Infugem 1700 MG in 170 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058892 | gemcitabine 1800 MG in 180 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058892 | gemcitabine 1800 MG in 180 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058892 | gemcitabine 1800 MG in 180 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058893 | Infugem 1800 MG in 180 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058893 | Infugem 1800 MG in 180 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058893 | Infugem 1800 MG in 180 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058893 | Infugem 1800 MG in 180 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058894 | gemcitabine 1900 MG in 190 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058894 | gemcitabine 1900 MG in 190 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058894 | gemcitabine 1900 MG in 190 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058895 | Infugem 1900 MG in 190 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058895 | Infugem 1900 MG in 190 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058895 | Infugem 1900 MG in 190 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058895 | Infugem 1900 MG in 190 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058896 | cannabidiol 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2058897 | cannabidiol Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2058898 | Cannabidiol-containing product in oral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2058898 | Cannabidiol-containing product in oral dose form | Designated preferred name (PT) | YES | |
| RxCUI: 2058898 | Cannabidiol-containing product in oral dose form | Full form of descriptor (FN) | YES | |
| RxCUI: 2058899 | cannabidiol Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 205890 | epinephrine 10 MG/ML / pilocarpine hydrochloride 10 MG/ML Ophthalmic Solution [E-Pilo-1] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205890 | epinephrine 10 MG/ML / pilocarpine hydrochloride 10 MG/ML Ophthalmic Solution [E-Pilo-1] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2058900 | cannabidiol 100 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058900 | cannabidiol 100 MG/mL Oral Solution | Designated preferred name (PT) | YES | |
| RxCUI: 2058900 | cannabidiol 100 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058900 | cannabidiol 100 MG/mL Oral Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 2058901 | Epidiolex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2058902 | cannabidiol 100 MG/ML [Epidiolex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2058903 | cannabidiol Oral Solution [Epidiolex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2058904 | Epidiolex Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2058905 | Epidiolex Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2058906 | Epidiolex 100 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058906 | Epidiolex 100 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058906 | Epidiolex 100 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058907 | piroctone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2058908 | Lycium barbarum root bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2058909 | Amomum testaceum seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 205891 | epinephrine 10 MG/ML / pilocarpine hydrochloride 10 MG/ML Ophthalmic Solution [P1E1] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205891 | epinephrine 10 MG/ML / pilocarpine hydrochloride 10 MG/ML Ophthalmic Solution [P1E1] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2058910 | dacomitinib 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2058911 | dacomitinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2058911 | dacomitinib Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2058911 | dacomitinib Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2058912 | gemcitabine 1300 MG in 130 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058912 | gemcitabine 1300 MG in 130 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058912 | gemcitabine 1300 MG in 130 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058913 | dacomitinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2058914 | dacomitinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2058915 | dacomitinib 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058915 | dacomitinib 15 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2058915 | dacomitinib 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058915 | dacomitinib 15 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2058916 | Vizimpro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2058917 | dacomitinib 15 MG [Vizimpro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2058918 | Infugem 1300 MG in 130 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058918 | Infugem 1300 MG in 130 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058918 | Infugem 1300 MG in 130 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058918 | Infugem 1300 MG in 130 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058919 | dacomitinib Oral Tablet [Vizimpro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2058920 | Vizimpro Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2058921 | Vizimpro Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2058922 | Vizimpro 15 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058922 | Vizimpro 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058922 | Vizimpro 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058923 | dacomitinib 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2058924 | dacomitinib 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058924 | dacomitinib 30 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2058924 | dacomitinib 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058924 | dacomitinib 30 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2058925 | dacomitinib 30 MG [Vizimpro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2058926 | Vizimpro 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058926 | Vizimpro 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058926 | Vizimpro 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058927 | gemcitabine 2000 MG in 200 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058927 | gemcitabine 2000 MG in 200 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058927 | gemcitabine 2000 MG in 200 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058928 | Infugem 2000 MG in 200 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058928 | Infugem 2000 MG in 200 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058928 | Infugem 2000 MG in 200 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058928 | Infugem 2000 MG in 200 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058929 | dacomitinib 45 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2058930 | dacomitinib 45 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058930 | dacomitinib 45 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2058930 | dacomitinib 45 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058930 | dacomitinib 45 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2058931 | dacomitinib 45 MG [Vizimpro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2058932 | Vizimpro 45 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058932 | Vizimpro 45 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058932 | Vizimpro 45 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058933 | gemcitabine 2200 MG in 220 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058933 | gemcitabine 2200 MG in 220 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058933 | gemcitabine 2200 MG in 220 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058934 | Infugem 2200 MG in 220 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058934 | Infugem 2200 MG in 220 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058934 | Infugem 2200 MG in 220 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058934 | Infugem 2200 MG in 220 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205894 | epinephrine 10 MG/ML / pilocarpine hydrochloride 20 MG/ML Ophthalmic Solution [E-Pilo-2] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205894 | epinephrine 10 MG/ML / pilocarpine hydrochloride 20 MG/ML Ophthalmic Solution [E-Pilo-2] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2058941 | omalizumab 150 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2058942 | omalizumab Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2058943 | omalizumab 150 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058943 | omalizumab 150 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058943 | omalizumab 150 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058944 | omalizumab 150 MG/ML [Xolair] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2058945 | omalizumab Prefilled Syringe [Xolair] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2058946 | Xolair 150 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058946 | Xolair 150 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058946 | Xolair 150 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058946 | Xolair 150 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058947 | omalizumab 150 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2058947 | omalizumab 150 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2058947 | omalizumab 150 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058948 | Xolair 150 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2058948 | Xolair 150 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2058948 | Xolair 150 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2058949 | omalizumab 75 MG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058949 | omalizumab 75 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058949 | omalizumab 75 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205895 | epinephrine 10 MG/ML / pilocarpine hydrochloride 20 MG/ML Ophthalmic Solution [P2E1] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205895 | epinephrine 10 MG/ML / pilocarpine hydrochloride 20 MG/ML Ophthalmic Solution [P2E1] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2058950 | Xolair 75 MG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058950 | Xolair 75 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058950 | Xolair 75 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058950 | Xolair 75 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058951 | cefepime 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2058952 | cefepime Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2058953 | cefepime 100 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058953 | cefepime 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205897 | epinephrine 10 MG/ML / pilocarpine hydrochloride 30 MG/ML Ophthalmic Solution [P3E1] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205897 | epinephrine 10 MG/ML / pilocarpine hydrochloride 30 MG/ML Ophthalmic Solution [P3E1] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205898 | epinephrine 10 MG/ML / pilocarpine hydrochloride 40 MG/ML Ophthalmic Solution [E-Pilo-4] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205898 | epinephrine 10 MG/ML / pilocarpine hydrochloride 40 MG/ML Ophthalmic Solution [E-Pilo-4] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2058980 | eltrombopag 12.5 MG Powder for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058980 | eltrombopag 12.5 MG Powder for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2058981 | Promacta 12.5 MG Powder for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2058981 | Promacta 12.5 MG Powder for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2058981 | Promacta 12.5 MG Powder for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2058982 | glycereth-26 caprylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 205899 | epinephrine 10 MG/ML / pilocarpine hydrochloride 40 MG/ML Ophthalmic Solution [P4E1] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205899 | epinephrine 10 MG/ML / pilocarpine hydrochloride 40 MG/ML Ophthalmic Solution [P4E1] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205900 | epinephrine 10 MG/ML / pilocarpine hydrochloride 60 MG/ML Ophthalmic Solution [E-Pilo-6] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205900 | epinephrine 10 MG/ML / pilocarpine hydrochloride 60 MG/ML Ophthalmic Solution [E-Pilo-6] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 205901 | epinephrine 10 MG/ML / pilocarpine hydrochloride 60 MG/ML Ophthalmic Solution [P6E1] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205901 | epinephrine 10 MG/ML / pilocarpine hydrochloride 60 MG/ML Ophthalmic Solution [P6E1] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2059014 | rivaroxaban 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2059015 | rivaroxaban 2.5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2059015 | rivaroxaban 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2059015 | rivaroxaban 2.5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2059015 | rivaroxaban 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2059016 | rivaroxaban 2.5 MG [Xarelto] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2059017 | Xarelto 2.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2059017 | Xarelto 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2059017 | Xarelto 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059018 | Product containing sarecycline (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 2059018 | Product containing sarecycline (medicinal product) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2059018 | Product containing sarecycline (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 2059018 | Product containing sarecycline (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 2059018 | Product containing sarecycline (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 2059019 | sarecycline 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2059020 | Product containing sarecycline in oral dose form (medicinal product form) | Full form of descriptor (FN) | YES | |
| RxCUI: 2059020 | Product containing sarecycline in oral dose form (medicinal product form) | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2059020 | Product containing sarecycline in oral dose form (medicinal product form) | Designated preferred name (PT) | YES | |
| RxCUI: 2059021 | sarecycline Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2059022 | sarecycline Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2059023 | sarecycline 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059023 | sarecycline 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2059023 | sarecycline 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2059024 | Seysara | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2059025 | sarecycline 100 MG [Seysara] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2059026 | sarecycline Oral Tablet [Seysara] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2059027 | Seysara Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2059028 | Seysara Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2059029 | Seysara 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2059029 | Seysara 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059029 | Seysara 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205903 | griseofulvin 125 MG Oral Tablet [Fulvicin P/G] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205903 | griseofulvin 125 MG Oral Tablet [Fulvicin P/G] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2059030 | sarecycline 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2059031 | sarecycline 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059031 | sarecycline 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2059031 | sarecycline 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2059032 | sarecycline 150 MG [Seysara] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2059033 | Seysara 150 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2059033 | Seysara 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059033 | Seysara 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2059034 | sarecycline 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2059035 | sarecycline 60 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059035 | sarecycline 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2059035 | sarecycline 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2059036 | sarecycline 60 MG [Seysara] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2059037 | Seysara 60 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2059037 | Seysara 60 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059037 | Seysara 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2059038 | sarecycline hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 205904 | GRIS-PEG 125 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205904 | GRIS-PEG 125 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205904 | GRIS-PEG 125 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059040 | Duramycin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2059041 | oxytetracycline 200 MG/ML [Duramycin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2059042 | oxytetracycline Injectable Solution [Duramycin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2059043 | Duramycin Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2059044 | Duramycin 72-200 200 MG in 1 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059044 | Duramycin 72-200 200 MG in 1 ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2059044 | Duramycin 72-200 200 MG in 1 ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2059045 | diphenhydrAMINE HCl 2 % / zinc acetate 0.215 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2059045 | diphenhydrAMINE HCl 2 % / zinc acetate 0.215 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059045 | diphenhydrAMINE HCl 2 % / zinc acetate 0.215 % Topical Gel | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2059045 | diphenhydrAMINE HCl 2 % / zinc acetate 0.215 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2059045 | diphenhydrAMINE HCl 2 % / zinc acetate 0.215 % Topical Gel | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2059046 | camphor oil 0.08 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2059047 | peppermint oil 0.08 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2059048 | camphor / peppermint oil Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2059049 | camphor / peppermint oil Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 205905 | griseofulvin 250 MG Oral Tablet [Fulvicin P/G] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205905 | griseofulvin 250 MG Oral Tablet [Fulvicin P/G] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2059050 | camphor / peppermint oil | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2059051 | camphor oil 8 % / peppermint oil 8 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2059051 | camphor oil 8 % / peppermint oil 8 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2059051 | camphor oil 8 % / peppermint oil 8 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059052 | camphor 0.5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2059052 | camphor 0.5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059052 | camphor 0.5 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205906 | Gris-PEG 250 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205906 | Gris-PEG 250 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205906 | Gris-PEG 250 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205907 | griseofulvin 250 MG Oral Tablet [Grisactin Ultra] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205907 | griseofulvin 250 MG Oral Tablet [Grisactin Ultra] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205908 | haloperidol 2 MG Oral Tablet [Haldol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205908 | haloperidol 2 MG Oral Tablet [Haldol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205909 | Estrace 0.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205909 | Estrace 0.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205909 | Estrace 0.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205910 | estradiol 0.5 MG Oral Tablet [Gynodiol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205910 | estradiol 0.5 MG Oral Tablet [Gynodiol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205911 | griseofulvin 250 MG Oral Capsule [Grisactin 250] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205911 | griseofulvin 250 MG Oral Capsule [Grisactin 250] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205912 | EPOGEN 10,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205912 | EPOGEN 10,000 UNT/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205912 | EPOGEN 10,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205912 | EPOGEN 10,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205912 | EPOGEN 10,000 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205912 | EPOGEN 10,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205912 | EPOGEN 10,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205913 | PROCRIT 10,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205913 | PROCRIT 10,000 UNT/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205913 | PROCRIT 10,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205913 | PROCRIT 10,000 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205913 | PROCRIT 10,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205914 | griseofulvin 500 MG Oral Tablet [Fulvicin-U-F] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205914 | griseofulvin 500 MG Oral Tablet [Fulvicin-U-F] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2059144 | labdanum oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2059145 | camphor 3.1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2059145 | camphor 3.1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059145 | camphor 3.1 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205915 | Grifulvin V 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205915 | Grifulvin V 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205915 | Grifulvin V 500 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205916 | griseofulvin 500 MG Oral Tablet [Grisactin 500] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205916 | griseofulvin 500 MG Oral Tablet [Grisactin 500] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205917 | EPOGEN 2000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205917 | EPOGEN 2000 UNT in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205917 | EPOGEN 2000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205917 | EPOGEN 2000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205917 | EPOGEN 2000 UNT in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205917 | EPOGEN 2000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059171 | Santalum spicatum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2059172 | shikimic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2059173 | tioxolone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2059174 | Dandrene | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2059175 | zinc pyrithione 20 MG/ML [Dandrene] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2059176 | zinc pyrithione Medicated Shampoo [Dandrene] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2059177 | Dandrene Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2059178 | Dandrene 2 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2059178 | Dandrene 2 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059178 | Dandrene 2 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059178 | Dandrene 2 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2059179 | amikacin sulfate, liposomal | Designated preferred name (PT) | NO | |
| RxCUI: 2059179 | amikacin sulfate, liposomal | Full form of descriptor (FN) | NO | |
| RxCUI: 2059179 | amikacin sulfate, liposomal | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 205918 | PROCRIT 2000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205918 | PROCRIT 2000 UNT in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205918 | PROCRIT 2000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205918 | PROCRIT 2000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205918 | PROCRIT 2000 UNT in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205918 | PROCRIT 2000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059180 | amikacin liposomal | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2059180 | amikacin liposomal | Designated preferred name (PT) | YES | |
| RxCUI: 2059180 | amikacin liposomal | Full form of descriptor (FN) | YES | |
| RxCUI: 2059181 | amikacin liposomal 70.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2059184 | amikacin liposomal 590 MG in 8.4 ML Inhalation Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2059184 | amikacin liposomal 590 MG in 8.4 ML Inhalation Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059184 | amikacin liposomal 590 MG in 8.4 ML Inhalation Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2059185 | Arikayce | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2059186 | amikacin liposomal 70.3 MG/ML [Arikayce] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2059188 | Arikayce Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2059189 | ARIKAYCE 590 MG in 8.4 ML Inhalation Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2059189 | ARIKAYCE 590 MG in 8.4 ML Inhalation Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2059189 | ARIKAYCE 590 MG in 8.4 ML Inhalation Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059189 | ARIKAYCE 590 MG in 8.4 ML Inhalation Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 20592 | Cerumenex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 205921 | EPOGEN 3000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205921 | EPOGEN 3000 UNT in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205921 | EPOGEN 3000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205921 | EPOGEN 3000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205921 | EPOGEN 3000 UNT in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205921 | EPOGEN 3000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059218 | elapegademase-lvlr | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2059219 | Elapegademase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2059219 | Elapegademase | Designated preferred name (PT) | YES | |
| RxCUI: 2059219 | Elapegademase | Full form of descriptor (FN) | YES | |
| RxCUI: 2059219 | Elapegademase | Designated preferred name (PT) | YES | |
| RxCUI: 2059219 | Elapegademase | Full form of descriptor (FN) | YES | |
| RxCUI: 205922 | PROCRIT 3000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205922 | PROCRIT 3000 UNT in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205922 | PROCRIT 3000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205922 | PROCRIT 3000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205922 | PROCRIT 3000 UNT in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205922 | PROCRIT 3000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059220 | elapegademase-lvlr 1.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2059221 | Elapegademase-containing product in parenteral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2059221 | Elapegademase-containing product in parenteral dose form | Designated preferred name (PT) | YES | |
| RxCUI: 2059221 | Elapegademase-containing product in parenteral dose form | Full form of descriptor (FN) | YES | |
| RxCUI: 2059222 | elapegademase Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2059223 | elapegademase-lvlr 2.4 MG in 1.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2059223 | elapegademase-lvlr 2.4 MG in 1.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2059223 | elapegademase-lvlr 2.4 MG in 1.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059224 | Revcovi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2059225 | elapegademase-lvlr 1.6 MG/ML [Revcovi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2059226 | elapegademase Injection [Revcovi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2059227 | Revcovi Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2059228 | Recovi 2.4 MG in 1.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2059228 | Recovi 2.4 MG in 1.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059228 | Recovi 2.4 MG in 1.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2059228 | Recovi 2.4 MG in 1.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059229 | elapegademase-lvlr 1.6 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 205923 | EPOGEN 4000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205923 | EPOGEN 4000 UNT in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205923 | EPOGEN 4000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205923 | EPOGEN 4000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205923 | EPOGEN 4000 UNT in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205923 | EPOGEN 4000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059230 | elapegademase-lvlr 1.6 MG/ML Injection [Revcovi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2059230 | elapegademase-lvlr 1.6 MG/ML Injection [Revcovi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059231 | Eucalyptus cinerea whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 205924 | PROCRIT 4000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205924 | PROCRIT 4000 UNT in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 205924 | PROCRIT 4000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205924 | PROCRIT 4000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205924 | PROCRIT 4000 UNT in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205924 | PROCRIT 4000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059261 | Tiglutik | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2059262 | riluzole 5 MG/ML [Tiglutik] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2059263 | riluzole Oral Suspension [Tiglutik] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2059264 | Tiglutik Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2059265 | Tiglutik Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2059266 | Tiglutik 50 MG in 10 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2059266 | Tiglutik 50 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059266 | Tiglutik 50 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059266 | Tiglutik 50 MG in 10 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2059266 | Tiglutik 50 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059268 | omadacycline tosylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2059269 | omadacycline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2059269 | omadacycline | Designated preferred name (PT) | YES | |
| RxCUI: 2059269 | omadacycline | Full form of descriptor (FN) | YES | |
| RxCUI: 2059269 | omadacycline | Designated preferred name (PT) | YES | |
| RxCUI: 2059269 | omadacycline | Full form of descriptor (FN) | YES | |
| RxCUI: 2059270 | omadacycline 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2059271 | omadacycline Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2059271 | omadacycline Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2059271 | omadacycline Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2059272 | omadacycline Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2059273 | omadacycline Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2059274 | omadacycline 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2059274 | omadacycline 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2059275 | Nuzyra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2059276 | omadacycline 150 MG [Nuzyra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2059277 | omadacycline Oral Tablet [Nuzyra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2059278 | Nuzyra Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2059279 | Nuzyra Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2059280 | NUZYRA 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2059280 | NUZYRA 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059280 | NUZYRA 150 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2059281 | omadacycline 7-Day Oral Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2059281 | omadacycline 7-Day Oral Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2059281 | omadacycline 7-Day Oral Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059282 | NUZYRA 7-Day Oral Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 2059282 | NUZYRA 7-Day Oral Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2059282 | NUZYRA 7-Day Oral Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059283 | omadacycline 7-Day Oral Pack incuding loading dose | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2059283 | omadacycline 7-Day Oral Pack incuding loading dose | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2059283 | omadacycline 7-Day Oral Pack incuding loading dose | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059284 | NUZYRA 7-Day Oral Pack including loading dose | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 2059284 | NUZYRA 7-Day Oral Pack including loading dose | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2059284 | NUZYRA 7-Day Oral Pack including loading dose | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059285 | omadacycline 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2059286 | omadacycline Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2059286 | omadacycline Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2059286 | omadacycline Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2059287 | omadacycline Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2059288 | omadacycline 100 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059288 | omadacycline 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2059288 | omadacycline 100 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2059289 | omadacycline 100 MG [Nuzyra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2059290 | omadacycline Injection [Nuzyra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2059291 | Nuzyra Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2059292 | NUZYRA 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2059292 | NUZYRA 100 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2059292 | NUZYRA 100 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2059293 | propylene glycol 2-methylbutyrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2059294 | ammonium laureth-7 sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2059295 | 3-hexyloxypropylene glycol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2059298 | Anabolic steroid | Designated preferred name (PT) | NO | |
| RxCUI: 2059298 | Anabolic steroid | Full form of descriptor (FN) | NO | |
| RxCUI: 2059298 | Anabolic steroid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059298 | Anabolic steroid | Designated preferred name (PT) | NO | |
| RxCUI: 2059298 | Anabolic steroid | Full form of descriptor (FN) | NO | |
| RxCUI: 2059305 | Histamine receptor antagonist | Designated preferred name (PT) | NO | |
| RxCUI: 2059305 | Histamine receptor antagonist | Designated preferred name (PT) | NO | |
| RxCUI: 2059305 | Histamine receptor antagonist | Full form of descriptor (FN) | NO | |
| RxCUI: 2059305 | Histamine receptor antagonist | Full form of descriptor (FN) | NO | |
| RxCUI: 2059306 | Hydroperoxide isomerase | Designated preferred name (PT) | NO | |
| RxCUI: 2059306 | Hydroperoxide isomerase | Full form of descriptor (FN) | NO | |
| RxCUI: 2059306 | Hydroperoxide isomerase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059318 | Dystrophy-associated fer-1-like protein | Designated preferred name (PT) | NO | |
| RxCUI: 2059318 | Dystrophy-associated fer-1-like protein | Full form of descriptor (FN) | NO | |
| RxCUI: 2059318 | Dystrophy-associated fer-1-like protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059322 | Cyoctol | Designated preferred name (PT) | NO | |
| RxCUI: 2059322 | Cyoctol | Full form of descriptor (FN) | NO | |
| RxCUI: 2059322 | Cyoctol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205933 | griseofulvin 330 MG Oral Tablet [Grisactin Ultra] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205933 | griseofulvin 330 MG Oral Tablet [Grisactin Ultra] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2059338 | Glucose powder | Designated preferred name (PT) | NO | |
| RxCUI: 2059338 | Glucose powder | Full form of descriptor (FN) | NO | |
| RxCUI: 205934 | griseofulvin 330 MG Oral Tablet [Griseofulicin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205934 | griseofulvin 330 MG Oral Tablet [Griseofulicin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205935 | griseofulvin 25 MG/ML Oral Suspension [Grifulvin V] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205935 | griseofulvin 25 MG/ML Oral Suspension [Grifulvin V] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205939 | gonadorelin 0.1 MG/ML Injectable Solution [Lutrepulse] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205939 | gonadorelin 0.1 MG/ML Injectable Solution [Lutrepulse] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205941 | gonadorelin 0.4 MG/ML Injectable Solution [Lutrepulse] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205941 | gonadorelin 0.4 MG/ML Injectable Solution [Lutrepulse] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205943 | gonadorelin 0.1 MG/ML Injectable Solution [Factrel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205943 | gonadorelin 0.1 MG/ML Injectable Solution [Factrel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205944 | gonadorelin 0.25 MG/ML Injectable Solution [Factrel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205944 | gonadorelin 0.25 MG/ML Injectable Solution [Factrel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2059473 | Saccharopine dehydrogenase (nicotinamide adenine dinucleotide phosphate ^+^,L-glutamate-forming) | Designated preferred name (PT) | NO | |
| RxCUI: 2059473 | Saccharopine dehydrogenase (nicotinamide adenine dinucleotide phosphate ^+^,L-glutamate-forming) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059473 | Saccharopine dehydrogenase (nicotinamide adenine dinucleotide phosphate ^+^,L-glutamate-forming) | Full form of descriptor (FN) | NO | |
| RxCUI: 2059521 | Promethazine teoclate 25 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2059521 | Promethazine teoclate 25 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059521 | Promethazine teoclate 25 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2059540 | Product containing precisely zinc 25 milligram/1 each conventional release oral capsule (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2059540 | Product containing precisely zinc 25 milligram/1 each conventional release oral capsule (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 205958 | haloperidol 20 MG Oral Tablet [Haldol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205958 | haloperidol 20 MG Oral Tablet [Haldol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2059587 | Technetium (99m-Tc) hydroxymethylene diphosphonate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059587 | Technetium (99m-Tc) hydroxymethylene diphosphonate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059587 | Technetium (99m-Tc) hydroxymethylene diphosphonate | Designated preferred name (PT) | NO | |
| RxCUI: 2059587 | Technetium (99m-Tc) hydroxymethylene diphosphonate | Full form of descriptor (FN) | NO | |
| RxCUI: 205959 | ergoloid mesylates, USP 1 MG Oral Capsule [Hydergine LC] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205959 | ergoloid mesylates, USP 1 MG Oral Capsule [Hydergine LC] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205960 | ergoloid mesylates, USP 1 MG Oral Tablet [Gerimal] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205960 | ergoloid mesylates, USP 1 MG Oral Tablet [Gerimal] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205961 | ergoloid mesylates, USP 1 MG Oral Tablet [Hydergine] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205961 | ergoloid mesylates, USP 1 MG Oral Tablet [Hydergine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205964 | clindamycin 150 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 205964 | clindamycin 150 MG/ML Injectable Solution | Designated preferred name (PT) | YES | |
| RxCUI: 205964 | clindamycin 150 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 205964 | clindamycin 150 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 205964 | clindamycin 150 MG/ML Injectable Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 205968 | ergoloid mesylates, USP 1 MG/ML Oral Solution [Hydergine] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205968 | ergoloid mesylates, USP 1 MG/ML Oral Solution [Hydergine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205973 | gramicidin 0.025 MG/ML / neomycin 1.75 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Solution [AK-Spore] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205973 | gramicidin 0.025 MG/ML / neomycin 1.75 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Solution [AK-Spore] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205973 | gramicidin 0.025 MG/ML / neomycin 1.75 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Solution [AK-Spore] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2059744 | Substance with neurokinin 1 receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2059744 | Substance with neurokinin 1 receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 2059744 | Substance with neurokinin 1 receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2059744 | Substance with neurokinin 1 receptor antagonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059744 | Substance with neurokinin 1 receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 205975 | gramicidin 0.025 MG/ML / neomycin 1.75 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Solution [Neocin PG] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205975 | gramicidin 0.025 MG/ML / neomycin 1.75 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Solution [Neocin PG] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205976 | gramicidin 0.025 MG/ML / neomycin 1.75 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Solution [Neoptic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205976 | gramicidin 0.025 MG/ML / neomycin 1.75 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Solution [Neoptic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059767 | Chlorotoxin (131-I) | Designated preferred name (PT) | NO | |
| RxCUI: 2059767 | Chlorotoxin (131-I) | Full form of descriptor (FN) | NO | |
| RxCUI: 2059767 | Chlorotoxin (131-I) | Designated preferred name (PT) | NO | |
| RxCUI: 2059767 | Chlorotoxin (131-I) | Full form of descriptor (FN) | NO | |
| RxCUI: 2059778 | Antigen of Eastern equine encephalitis virus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059778 | Antigen of Eastern equine encephalitis virus | Full form of descriptor (FN) | NO | |
| RxCUI: 2059778 | Antigen of Eastern equine encephalitis virus | Designated preferred name (PT) | NO | |
| RxCUI: 2059778 | Antigen of Eastern equine encephalitis virus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2059778 | Antigen of Eastern equine encephalitis virus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205986 | clindamycin 10 MG/ML Topical Solution [C/T/S] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205986 | clindamycin 10 MG/ML Topical Solution [C/T/S] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205986 | clindamycin 10 MG/ML Topical Solution [C/T/S] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205986 | clindamycin 10 MG/ML Topical Solution [C/T/S] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 205988 | Clinda-Derm 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205988 | Clinda-Derm 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 205988 | Clinda-Derm 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205988 | Clinda-Derm 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 205988 | Clinda-Derm 1 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 20599 | cesium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |